{"title":"Base price discount -7%","description":"","products":[{"product_id":"femelle-fermenti-lattici-30-capsule","title":"Femelle Lactic Ferments 30 Capsules","description":"\u003cp\u003eFemelle is a food supplement based on \u003cstrong\u003elactic ferments with probiotic action\u003c\/strong\u003e useful for \u003cstrong\u003ere-establishing the balance of the intestinal bacterial flora\u003c\/strong\u003e compromised by incorrect diet, antibiotic therapy and intestinal disorders such as diarrhea or constipation. \u003cspan data-mce-fragment=\"1\"\u003eThe lactic ferments contained in \u003cstrong\u003eFemelle\u003c\/strong\u003e\u003c\/span\u003e \u003cstrong\u003ealso act on the intimate bacterial flora\u003c\/strong\u003e , protecting and supporting the urogenital system in cases of \u003cstrong\u003ecystitis, candida, various bacterial and fungal infections.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e Its rebalancing function is due to the presence of probiotic lactic ferments capable of producing \u003cstrong\u003ebacteriocins,\u003c\/strong\u003e small peptides that prevent the growth of pathogenic bacteria thus preventing \u003cstrong\u003eintestinal infections\u003c\/strong\u003e and \u003cstrong\u003eurogenital infections\u003c\/strong\u003e .\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cdiv align=\"justify\"\u003e\n\n \u003cstrong\u003eMEDIA ANALYSIS\u003c\/strong\u003e\u003cbr\u003e Lactobacillus jensenii 121.1 less than 1 x 109\u003cbr\u003e Lactobacillus plantarum LP 115 less than 1 x 109\u003cbr\u003e Lactobacillus rhamnosus LR 32 less than 1 x 109\u003cbr\u003e Lactobacillus acidophilus LA 14 equal to 1 x 109 (1 billion) \u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\n\n \u003cstrong\u003eINGREDIENTS\u003c\/strong\u003e\u003cbr\u003e Corn maltodextrin, corn starch, gelatin (capsule ingredient), mixture of lactic ferments (Lactobacillus plantarum LP 115, Lactobacillus acidophilus LA 14, Lactobacillus jensenii KS 121.1, Lactobacillus rhamnosus LR 32); anti-caking agents: magnesium salts of fatty acids, silicon dioxide. The raw materials are produced and the packaging is made in factories that also process milk and soy derivatives. \u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e \u003cstrong\u003eHOW TO USE\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e We recommend 2 capsules per day, after meals, with a glass of water. \u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\n\n\u003cbr\u003e \u003cstrong\u003eWARNINGS\u003c\/strong\u003e\n\n\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e Do not exceed the recommended dose. Keep out of reach of children under 3 years of age. Supplements are not intended as a substitute for a varied and balanced diet and a healthy lifestyle. Store in a cool, dry place away from light and heat, keep at a temperature below 25°C. Validity for unopened package: 20 months.\u003c\/div\u003e","brand":"BROMATECH Srl","offers":[{"title":"Default Title","offer_id":40093367271539,"sku":"912033673","price":20.46,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/bromatech-srl-femelle-fermenti-lattici-30-capsule-farmacia-dottor-tili-1213792929.jpg?v=1767122589"},{"product_id":"enterelle-plus-24-capsule","title":"Enterelle Plus 24 Capsules","description":"\u003cp\u003e \u003cstrong\u003eEnterelle Plus\u003c\/strong\u003e is a food supplement based on probiotics, designed to promote the balance of intestinal flora and support the well-being of the digestive system. The formulation of Enterelle Plus is enriched with selected bacterial strains that help restore the intestinal microflora compromised by antibiotics, poor diet or intestinal disorders such as diarrhea and constipation. Thanks to its balanced and delicate action, Enterelle Plus is suitable for daily use and to improve intestinal functionality.\u003c\/p\u003e\n\n\u003ch2\u003e Dosage and method of use\u003c\/h2\u003e\n\n\u003ch3\u003e How to take Enterelle Plus?\u003c\/h3\u003e\n\n\u003cp\u003e The recommended dose is \u003cstrong\u003e1 or 2 capsules\u003c\/strong\u003e per day, preferably taken away from meals. The capsules should be swallowed whole with plenty of water. For prolonged action, it is possible to continue the treatment for 15-30 days, according to the instructions of the doctor or pharmacist.\u003c\/p\u003e\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n         \u003ch3\u003eWhat ingredients does Enterelle Plus contain?\u003c\/h3\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSaccharomyces boulardii\u003c\/strong\u003e : probiotic yeast that promotes the rebalancing of intestinal flora.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eLactobacillus rhamnosus\u003c\/strong\u003e : probiotic bacterium that helps protect the gut from pathogens and support the immune system.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eEnterococcus faecium\u003c\/strong\u003e : aids digestion and supports intestinal health.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eExcipients\u003c\/strong\u003e : gelatin (capsule), silica, magnesium stearate.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings of Enterelle Plus?\u003c\/h3\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e Do not exceed the recommended daily dose.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children under 3 years.\u003c\/li\u003e\n\n\u003cli\u003e Food supplements should not be considered as a substitute for a varied and balanced diet and a healthy lifestyle.\u003c\/li\u003e\n\n\u003cli\u003e Consult a doctor before use if you are pregnant or breastfeeding or are taking any medications.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n         \u003ch2\u003eExpiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Enterelle Plus?\u003c\/h3\u003e\n\n\u003cp\u003e Store \u003cstrong\u003eEnterelle Plus\u003c\/strong\u003e in a cool, dry place, away from heat and direct light. Check the expiry date on the package before use.\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e Enterelle Plus is available in a pack of \u003cstrong\u003e24 capsules\u003c\/strong\u003e , practical and convenient for prolonged treatment.\u003c\/p\u003e\n\n","brand":"BROMATECH Srl","offers":[{"title":"Default Title","offer_id":40093367369843,"sku":"974373159","price":19.53,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/bromatech-srl-enterelle-plus-24-capsule-farmacia-dottor-tili-1213792941.jpg?v=1767122670"},{"product_id":"monurelle-plus-af-15-capsule","title":"Monurelle Plus AF 15 Capsules","description":"\u003cp\u003e\u003cstrong\u003eMonurelle Plus AF\u003c\/strong\u003e is a food supplement based on \u003cstrong\u003ecranberry extract\u003c\/strong\u003e and \u003cstrong\u003eD-mannose\u003c\/strong\u003e , formulated to promote urinary tract health and prevent recurrent urinary infections. Cranberry extract is rich in proanthocyanidins, which help prevent bacteria from adhering to the walls of the bladder, while D-mannose is a natural sugar that is eliminated through urine, helping to eliminate the bacteria responsible for infections.\u003c\/p\u003e\n\n\n\u003ch2\u003e Dosage and method of use\u003c\/h2\u003e\n\n\u003ch3\u003e How to take Monurelle Plus AF?\u003c\/h3\u003e\n\n\u003cp\u003e It is recommended to take \u003cstrong\u003e1 capsule per day\u003c\/strong\u003e with a glass of water, preferably between meals or before bedtime. For effective prevention, a treatment cycle of at least 15 days is recommended, unless otherwise indicated by your doctor. The capsules are easy to swallow and can be taken at any time of the day.\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e \n\u003ch3\u003eWhat ingredients does Monurelle Plus AF contain?\u003c\/h3\u003e\n\n\u003cp\u003e Monurelle Plus AF contains:\n\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eCranberry Extract\u003c\/strong\u003e : 120 mg, rich in proanthocyanidins (PAC), which help protect the urinary tract from bacteria.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eD-mannose\u003c\/strong\u003e : 500 mg, a natural sugar that helps fight urinary tract infections.\u003c\/li\u003e\n\n\u003cli\u003e Excipients: gelatin (for the capsule), magnesium stearate, silica.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Monurelle Plus AF?\u003c\/h3\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e Do not exceed the recommended daily dose.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children under 3 years.\u003c\/li\u003e\n\n\u003cli\u003e Supplements should not replace a varied and balanced diet and a healthy lifestyle.\u003c\/li\u003e\n\n\u003cli\u003e Consult a doctor if pregnant or breastfeeding before use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Monurelle Plus AF?\u003c\/h3\u003e\n\n         \u003cp\u003eStore \u003cstrong\u003eMonurelle Plus AF\u003c\/strong\u003e in a cool, dry place, below 25°C, away from heat and humidity. Check the expiry date on the package and do not use the product beyond that date.\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e Monurelle Plus AF is available in a pack of \u003cstrong\u003e15 capsules\u003c\/strong\u003e , ideal for a complete treatment cycle.\u003c\/p\u003e\n\n","brand":"ZAMBON ITALIA Srl","offers":[{"title":"Default Title","offer_id":40093368254579,"sku":"984733562","price":20.45,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/zambon-italia-srl-monurelle-plus-af-15-capsule-farmacia-dottor-tili-1213792912.jpg?v=1767123089"},{"product_id":"nutriflor-60-cps","title":"Nutriflor 60 caps","description":"\u003cp\u003e Food supplement based on probiotics with plant extracts, useful for promoting the balance of intestinal bacterial flora, thanks also to the contribution of probiotic fibers contained in Helianthus tuberosus. Bamboo extract favors the elimination of intestinal gas\u003c\/p\u003e\n\u003cbr\u003e --\u003cbr\u003e \u003cp\u003eRecommended: - in case of reduced or compromised intestinal flora and as probiotic support during or after antibiotic therapy; - defecation of the immune system. It can be useful in vaginitis and urinary infections, Candida, skin infections and inflammations (Herpes, acne), post-flu recovery and respiratory problems. The supplementation of quality bifidobacteria can also be important in osteoporosis and in case of excess cholesterol.\u003c\/p\u003e","brand":"NUTRIGEA","offers":[{"title":"Default Title","offer_id":40207821832307,"sku":"924784933","price":24.18,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/nutrigea-nutriflor-60-cps-farmacia-dottor-tili-1213792795.jpg?v=1767111990"},{"product_id":"arnica-compositum-heel-50-compresse","title":"Arnica Compositum Heel 50 Tablets","description":"\u003cp\u003eArnica Compositum Heel is a homeopathic medicine in tablet form indicated in all \u003cstrong\u003einflammatory pathologies\u003c\/strong\u003e , \u003cstrong\u003epains from inflammation, neuralgia\u003c\/strong\u003e and \u003cstrong\u003einflammatory pathologies\u003c\/strong\u003e of \u003cstrong\u003emuscular, tendon and skeletal origin\u003c\/strong\u003e , in injuries and \u003cstrong\u003ewounds\u003c\/strong\u003e . \u003cspan data-mce-fragment=\"1\"\u003eAlso useful in the presence of pelvic inflammatory diseases such as\u003c\/span\u003e \u003cstrong data-mce-fragment=\"1\"\u003eVulvodynia and Pelvic Neuropathy\u003c\/strong\u003e \u003cspan data-mce-fragment=\"1\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eArnica Compositum Heel tablets are \u003cstrong\u003eindicated in sports\u003c\/strong\u003e as they are \u003cstrong\u003enot included in the list of medicines banned by the Wada (World Anti-Doping Agency).\u003c\/strong\u003e Arnica Compositum Heel tablets can be taken in case of \u003cstrong\u003ebruises\u003c\/strong\u003e , \u003cstrong\u003ehematomas\u003c\/strong\u003e , \u003cstrong\u003esprains\u003c\/strong\u003e , muscle strains, non-traumatic inflammations of tissues of mesenchymal derivation (muscles, bones, tendons, ligaments, muscle bands).\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003c\/strong\u003eArnica Compositum Heel contains Arnica, Calendula, Hamamelis, Millefolium and Belladonna and extracts of 9 other plants. These substances have the following properties:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eArnica montana\u003c\/strong\u003e : stimulates wound healing; it is useful in case of fractures, dislocations, contusions, hematomas, weakness of the heart muscle, neuralgia, myalgia, analgesic and haemostatic.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCalendula\u003c\/strong\u003e : it is used in homeopathy for difficult healing wounds; favors granulations; has analgesic effect.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHamamelis\u003c\/strong\u003e : active on venous stasis, varicose veins, crural ulcer, haemorrhoids, venous haemorrhages; prevents inflammation; has analgesic effect.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMillefolium\u003c\/strong\u003e : used in case of haemorrhages, especially oozing, precapillary, arteriovenous haemorrhages.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBelladonna\u003c\/strong\u003e : active on localized reaction phases; states of cerebral irritation with spasms and delusions.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAconitum\u003c\/strong\u003e : action on the neurogenic phase of inflammation and the phases of generalized inflammation; analgesic and haemostatic through increased capillary tone.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMercurius solubilis Hannemani\u003c\/strong\u003e : modulates suppurations, action on abscesses and edema.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepar sulfuris carbonicum\u003c\/strong\u003e : antiseptic action, in case of: tendency to suppurations, tonsillar and lymphatic abscesses, pain like pins and needles.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChamomile\u003c\/strong\u003e : natural analgesic and anti-inflammatory properties. Stimulates the healing of difficult wounds.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSymphytum\u003c\/strong\u003e : accelerates the formation of bone callus and tissues of mesenchymal origin (tendons, ligaments), bruises.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBellis perennis\u003c\/strong\u003e : used in case of dislocations, bruises and edema.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEchinacea Angustifolia\u003c\/strong\u003e : antiseptic action. It helps to modulate the vascular phase of inflammation, making it useful in the presence of localized inflammation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eEchinacea purpurea\u003c\/strong\u003e : stimulates fibroblasts, activates macrophages, dendrocytes and monocytes.\u003c\/li\u003e\n\u003cli\u003e\nSt. John's \u003cstrong\u003eWort\u003c\/strong\u003e : healing action on nerve tissue and skin.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\u003c\/ul\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cstrong\u003eHOW TO USE\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cp\u003eTake 1 tablet of Arnica Compositum, letting it dissolve in the mouth, 3 times a day.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCOMPOSITION 1 TABLET\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eArnica D2, Calendula D2, Hamamelis D2, Millefolium D3 ana 15 mg; Belladonna D4 75mg; Aconitum D3, Mercurius solubiIis Hahnemanni D8, Hepar sulfuris D8 ana 30 mg; Chamomilla D3, Symphytum D8 ana 24 mg; Bellis perennis D2, Echinacea D2, Echinacea purpurea D2 ana 6 mg; Hypericum D2 3 mg.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn some cases it is possible to experience side effects such as headache, tachycardia, abdominal and respiratory pain. Do not take in case of hypersensitivity to any of the components of the product. Do not exceed the recommended daily dose. In case of bandaging, use materials that allow the skin to breathe. For use during pregnancy and while breastfeeding, seek medical advice. Spicy foods, mint and stimulants can reduce the effectiveness of homeopathic medicines. Keep out of the reach of children under 3 years of age.\u003c\/p\u003e","brand":"GUNA SpA","offers":[{"title":"Default Title","offer_id":40207822192755,"sku":"909474912","price":11.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/guna-spa-arnica-compositum-heel-50-compresse-farmacia-dottor-tili-1213792779.jpg?v=1767112109"},{"product_id":"buscofen-12-capsule-molli-200mg","title":"Buscofen 12 Soft Capsules 200mg","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBuscofen 12 Soft Capsules is a drug based on\u003c\/span\u003e \u003cspan\u003eibuprofen\u003c\/span\u003e \u003cspan\u003e(200 mg per capsule), an active ingredient belonging to the category of nonsteroidal anti-inflammatory drugs (NSAIDs), indicated for the treatment of\u003c\/span\u003e \u003cspan\u003epain of various origins\u003c\/span\u003e \u003cspan\u003e. It is particularly effective for relieving pain related to conditions such as\u003c\/span\u003e \u003cspan\u003emenstrual pain\u003c\/span\u003e \u003cspan\u003e,\u003c\/span\u003e \u003cspan\u003eheadache\u003c\/span\u003e \u003cspan\u003e,\u003c\/span\u003e \u003cspan\u003etoothache\u003c\/span\u003e \u003cspan\u003e,\u003c\/span\u003e \u003cspan\u003eneuralgia\u003c\/span\u003e \u003cspan\u003e, and\u003c\/span\u003e \u003cspan\u003eosteoarticular\u003c\/span\u003e \u003cspan\u003eand\u003c\/span\u003e \u003cspan\u003emuscular\u003c\/span\u003e pain \u003cspan\u003e. Thanks to its formulation in\u003c\/span\u003e \u003cspan\u003esoft capsules\u003c\/span\u003e \u003cspan\u003e, it is rapidly absorbed by the body, offering faster relief than other solid formulations.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eBuscofen 12 Soft Capsules is indicated for the symptomatic treatment of mild to moderate pain, including:\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eMenstrual cramps\u003c\/span\u003e \u003cspan\u003e(dysmenorrhea);\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n \u003cp role=\"presentation\" dir=\"ltr\"\u003e\u003cspan\u003eHeachache\u003c\/span\u003e \u003cspan\u003e;\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eToothache\u003c\/span\u003e \u003cspan\u003e;\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eNeuralgia\u003c\/span\u003e \u003cspan\u003e;\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eMuscle and joint pain\u003c\/span\u003e \u003cspan\u003e(such as lumbago, back pain and arthralgia);\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eRheumatic\u003c\/span\u003e \u003cspan\u003eand inflammatory pain of musculoskeletal origin.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Buscofen 12 Soft Capsules 200mg - What is the active ingredient of Buscofen 12 Soft Capsules 200mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eCoated tablets, 1 tablet contains: ibuprofen 200 mg. Soft gelatin capsules: 1 soft capsule contains: ibuprofen 200 mg. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Buscofen 12 Soft Capsules 200mg - What does Buscofen 12 Soft Capsules 200mg contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eCoated tablets - blister pack of 20 tablets: corn starch, sodium carboxymethyl starch, magnesium stearate, hydroxypropyl methylcellulose, polyethylene glycol 6000, talc, titanium dioxide, antifoam emulsion. Soft capsules - blister pack of 12 or 24 capsules: macrogol 600, potassium hydroxide, purified water, gelatin, partially dehydrated liquid sorbitol.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eDIRECTIONS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Buscofen 12 Soft Capsules 200mg - Why is Buscofen 12 Soft Capsules 200mg used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003ePain of various origins and natures (menstrual pain, headache, toothache, neuralgia, osteoarticular and muscular pain).\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Buscofen 12 Soft Capsules 200mg - When should Buscofen 12 Soft Capsules 200mg not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eHypersensitivity to the active substance or to any of the excipients. Subjects with hypersensitivity to acetylsalicylic acid or other analgesics, antipyretics, nonsteroidal anti-inflammatory drugs (NSAIDs), in particular when hypersensitivity is associated with nasal polyposis, angioedema and\/or asthma. Severe hepatic insufficiency. Severe renal insufficiency (glomerular filtration rate less than 30 ml\/min). Severe cardiac insufficiency (NYHA class IV). Subjects with blood dyscrasias of unknown origin, porphyria, hypertension, severe uncontrolled coronary insufficiency. Severe or active peptic ulcer. History of gastrointestinal bleeding or perforation related to previous active treatments or history of recurrent peptic ulcer\/haemorrhage (two or more distinct episodes of proven ulceration or bleeding). Subjects with clinical conditions that determine an increased tendency to bleeding. In conjunction with surgical procedures (including dental operations). Subjects who have undergone significant fluid loss (through vomiting, diarrhoea or insufficient fluid intake). During the third trimester of pregnancy (see section 4.6). Children under 12 years of age.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Buscofen 12 Soft Capsules 200mg - How to take Buscofen 12 Soft Capsules 200mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eDo not administer to children under 12 years of age. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration of treatment necessary to control symptoms (see section 4.4). Coated tablets. Adults and adolescents over 12 years: 1-2 tablets, two - three times a day, preferably on a full stomach. However, do not exceed the dose of 1200 mg (6 tablets) per day. Do not exceed the recommended doses. If the use of the medicine is necessary for more than 3 days in adolescents, or in the event of worsening of symptoms, a doctor should be consulted. Elderly: elderly patients should stick to the minimum doses indicated. Patients with renal insufficiency: in the presence of renal insufficiency, elimination may be reduced and the dosage should be adjusted accordingly. Soft capsules. Adults and adolescents over 12 years: 1-2 soft capsules, two - three times a day, preferably on a full stomach. Do not exceed the dose of 1200 mg (6 soft capsules) per day. Do not exceed the recommended doses. If the use of the medicine is necessary for more than 3 days in adolescents, or in case of worsening of the symptoms, a doctor must be consulted. Elderly: elderly patients must stick to the minimum doses indicated. Patients with renal insufficiency: in the presence of renal insufficiency, elimination may be reduced and the dosage must be adjusted accordingly. Buscofen must not be used for more than 7 days. If higher doses are necessary or if a more prolonged treatment is required, then it is necessary to contact your doctor. The coated tablets and soft capsules must be swallowed without chewing, preferably with a little water. It is recommended to take them during or after meals, especially for people with gastric disorders.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Buscofen 12 Soft Capsules 200mg - How to store Buscofen 12 Soft Capsules 200mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eCoated tablets - blister pack of 20 tablets: store at room temperature. Soft capsules - blister pack of 12 or 24 capsules: no storage conditions.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eWARNINGS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Buscofen 12 Soft Capsules 200mg - About Buscofen 12 Soft Capsules 200mg it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe use of Buscofen with concomitant NSAIDs, including cyclooxygenase-2 (COX-2) selective inhibitors, should be avoided due to an increased risk of ulceration or bleeding (see section 4.5). Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see sections below on gastrointestinal and cardiovascular risks). Paediatric population: There is a risk of impaired renal function in dehydrated adolescents. Elderly: Elderly patients have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (see section 4.2). Gastrointestinal bleeding, ulceration and perforation: Gastrointestinal bleeding, ulceration and perforation, which can be fatal, have been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events. The risk of gastrointestinal bleeding, ulceration or perforation is higher with increasing NSAID doses, in the elderly and in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3). These patients should start treatment on the lowest dose available. The concomitant use of protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients and also for patients who are taking low dose acetylsalicylic acid or other drugs likely to increase gastrointestinal risk (see below and section 4.5). Patients with a history of gastrointestinal toxicity, particularly when elderly, should report any unusual gastrointestinal symptoms (especially gastrointestinal bleeding), particularly in the initial stages of treatment. Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin reuptake inhibitors (SSRIs) or anti-platelet agents such as acetylsalicylic acid (see section 4.5). When gastrointestinal bleeding or ulceration occurs in patients receiving Buscofen, the treatment should be withdrawn. NSAIDs should be given with caution to patients with a history of gastrointestinal disease (ulcerative colitis, Crohn's disease) as these conditions may be exacerbated (see section 4.8). Use with caution in patients with coagulation defects. Cardiovascular and cerebrovascular effects: Appropriate monitoring and advice are necessary in patients with a history of hypertension and\/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy. Clinical trials suggest that use of ibuprofen, particularly at high doses (2400 mg\/day), may be associated with a small increased risk of arterial thrombotic events (e.g. myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low doses of ibuprofen (e.g. \u0026lt;= 1200 mg\/day) are associated with an increased risk of arterial thrombotic events. Patients with uncontrolled hypertension, congestive heart failure (NYHA II-III), established ischaemic heart disease, peripheral arterial disease, and\/or cerebrovascular disease should only be treated with ibuprofen after careful consideration and high doses (2400 mg\/day) should be avoided. Careful consideration should also be exercised before initiating long-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking), particularly if high doses (2400 mg\/day) of ibuprofen are required. Severe skin reactions: Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk early in the course of therapy, with the onset of the reaction occurring in the majority of cases within the first month of treatment. Acute generalised exanthematous pustulosis (AGEP) has been reported in connection with medicinal products containing ibuprofen. Treatment with Buscofen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity. Masking of symptoms of underlying infections: Buscofen may mask the symptoms of infection, which may delay the initiation of adequate treatment and therefore worsen the outcome of the infection. This has been observed in community-acquired bacterial pneumonia and bacterial complications of varicella. When Buscofen is administered for the relief of infection-related fever or pain, monitoring for infection is advised. In non-hospital settings, the patient should seek medical attention if symptoms persist or worsen. Renal effects: Caution should be exercised in patients with considerable dehydration when initiating treatment with ibuprofen.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Buscofen 12 Soft Capsules 200mg - Which medicines or foods can modify the effect of Buscofen 12 Soft Capsules 200mg?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eIbuprofen (like other NSAIDs) should be used with caution in association with: corticosteroids: increased risk of gastrointestinal ulceration or bleeding (see section 4.4); anticoagulants: NSAIDs may increase the effects of anticoagulants such as warfarin (see section 4.4). It is advisable to monitor patients treated with coumarins; acetylsalicylic acid and other NSAIDs: these substances may increase the risk of adverse reactions affecting the gastrointestinal tract (see section 4.4). The concomitant administration of ibuprofen and acetylsalicylic acid is generally not recommended due to the potential for increased undesirable effects. Experimental data suggest that ibuprofen may competitively inhibit low dose acetylsalicylic acid on platelet aggregation when the two drugs are administered concomitantly. Although there are uncertainties regarding the extrapolation of these data to the clinical situation, the possibility that regular, long-term use of ibuprofen may reduce the cardioprotective effect of low-dose acetylsalicylic acid cannot be excluded. No clinically relevant effect is considered likely following occasional use of ibuprofen (see section 5.1). It is however advisable not to combine ibuprofen with aspirin or other NSAIDs; antiplatelet agents and selective serotonin reuptake inhibitors (SSRIs): increased risk of gastrointestinal bleeding (see section 4.4); diuretics, ACE inhibitors and angiotensin II antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs. Diuretics may also increase the risk of nephrotoxicity associated with NSAIDs. In some patients with compromised renal function (e.g. dehydrated patients or elderly patients) the co-administration of an ACE inhibitor or an angiotensin II antagonist and agents that inhibit the cyclo-oxygenase system may lead to further deterioration of renal function, including possible acute renal failure, which is usually reversible. These interactions should be considered in patients taking Buscofen concomitantly with ACE inhibitors or angiotensin II antagonists. Therefore, this combination should be administered with caution, especially in elderly patients. Patients should be adequately hydrated and consideration should be given to monitoring renal function after initiation of concomitant therapy and periodically thereafter; lithium: concomitant administration of lithium and NSAIDs causes an increase in lithium levels in the blood due to reduced elimination, with the possibility of reaching the toxic threshold. If this combination is necessary, monitor lithium levels in order to adapt the lithium dosage during concomitant treatment with ibuprofen; methotrexate: NSAIDs may inhibit the tubular secretion of methotrexate and reduce its clearance, resulting in an increased risk of toxicity; aminoglycosides: NSAIDs may decrease the excretion of aminoglycosides; cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce the glomerular filtration rate and increase plasma levels of cardiac glycosides; phenytoin: NSAIDs may lead to an increase in plasma concentrations of phenytoin; cholestyramine: concomitant administration of ibuprofen and cholestyramine may reduce the absorption of ibuprofen from the gastrointestinal tract. However, the clinical relevance of this interaction is unknown; ciclosporin: increased risk of nephrotoxicity with NSAIDs; COX-2 inhibitors and other NSAIDs: concomitant use with other NSAIDs, including cyclooxygenase-2 selective inhibitors, should be avoided due to the potential additive effect (see section 4.4); herbal extracts: Ginkgo Biloba may increase the risk of bleeding in association with NSAIDs; mifepristone: due to the antiprostaglandin properties of NSAIDs, a decrease in the efficacy of the medicinal product may theoretically occur. Limited evidence suggests that co-administration of NSAIDs on the day of prostaglandin administration does not adversely influence the effects of mifepristone or the prostaglandin on cervical ripening or uterine contractility and does not reduce the clinical efficacy of the medicinal product on pregnancy termination; quinolone antibiotics: animal data indicate that NSAIDs may increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions; sulfonylureas: NSAIDs may increase sulfonylureas. Rare cases of hypoglycaemia have been reported in patients treated with sulfonylureas who were taking ibuprofen; tacrolimus: possible increased risk of nephrotoxicity when NSAIDs are administered with tacrolimus; zidovudine: increased risk of haematotoxicity in case of co-administration with NSAIDs. There is evidence of an increased risk of haemarthrosis and haematoma in HIV-infected haemophiliac patients receiving concomitant treatment with zidovudine and other NSAIDs; ritonavir: possible increase in the concentration of NSAIDs; probenecid: slows the excretion of NSAIDs with possible increase in their plasma concentrations; sulfinpyrazone: may delay the excretion of ibuprofen; CYP2C9 inhibitors: concomitant administration of ibuprofen and CYP2C9 inhibitors may increase exposure to ibuprofen (CYP2C9 substrate). In a study with voriconazole and fluconazole (CYP2C9 inhibitors), an increased exposure to S(+)-ibuprofen by approximately 80% to 100% was observed. A reduction of the ibuprofen dose should be considered when strong CYP2C9 inhibitors are co-administered, particularly when high doses of ibuprofen are administered with voriconazole and fluconazole.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Buscofen 12 Soft Capsules 200 mg can cause side effects - What are the side effects of Buscofen 12 Soft Capsules 200mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe undesirable effects observed with ibuprofen are generally common to other analgesics, antipyretics, non-steroidal anti-inflammatory drugs. Gastrointestinal disorders: the most commonly observed adverse events are gastrointestinal in nature. Peptic ulcers, perforation or gastrointestinal haemorrhage, sometimes fatal, particularly in the elderly, may occur (see section 4.4). Gastrointestinal perforation with the use of ibuprofen has been observed rarely. After administration of Buscofen the following have been reported: nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, epigastric pain, heartburn, abdominal pain, melaena, haematemesis, ulcerative stomatitis, exacerbation of colitis and Crohn's disease (see section 4.4). Less frequently, gastritis has been observed. Pancreatitis has also been observed very rarely. Immune system disorders: hypersensitivity reactions have been reported following treatment with NSAIDs. These may consist of a) non-specific allergic reaction and anaphylaxis, b) respiratory tract reactions including asthma, including severe asthma, bronchospasm or dyspnoea or c) skin disorders including rashes of various types, pruritus, urticaria, purpura, angioedema and, more rarely, exfoliative and bullous dermatitis (including Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme). Cardiac and vascular disorders: Oedema and fatigue, hypertension and cardiac failure have been reported in association with NSAID treatment. Clinical trials suggest that use of ibuprofen, particularly at high doses (2400 mg\/day), may be associated with a modest increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4). Other adverse events reported less frequently and for which causality has not necessarily been established include: Blood and lymphatic system disorders: leukopenia, thrombocytopenia, neutropenia, agranulocytosis, aplastic anaemia and haemolytic anaemia. Psychiatric disorders: insomnia, anxiety, depression, confusional state, hallucinations. Nervous system disorders: headache, paraesthesia, dizziness, somnolence, optic neuritis. Infections and infestations: aseptic rhinitis and meningitis (especially in patients with pre-existing autoimmune disorders, such as systemic lupus erythematosus and mixed connective tissue disease) with symptoms of stiff neck, headache, nausea, vomiting, fever or disorientation (see section 4.4). Respiratory, thoracic and mediastinal disorders: bronchospasm, dyspnoea, apnoea. Eye disorders: rare cases of ocular alteration resulting in visual disturbances, toxic optic neuropathy. Ear and labyrinth disorders: impaired hearing, tinnitus, vertigo. Hepatobiliary disorders: impaired liver function, liver failure, hepatitis and jaundice. Skin and subcutaneous tissue disorders: bullous reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis (very rare), photosensitivity reactions and drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) (frequency not known), acute generalized exanthematous pustulosis (AGEP) (frequency not known). Renal and urinary disorders: impaired renal function and toxic nephropathy in various forms, including interstitial nephritis, nephrotic syndrome and renal failure. General disorders and administration site conditions: malaise, fatigue. Reporting of suspected adverse reactions Reporting of suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Buscofen 12 Soft Capsules 200mg.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePregnancy: Inhibition of prostaglandin synthesis may adversely affect the pregnancy and\/or embryo\/fetal development. Data from epidemiological studies suggest an increased risk of miscarriage, cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor during early pregnancy. The absolute risk of cardiac malformations increases from less than 1%, up to approximately 1.5%. The risk is believed to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to result in increased pre- and post-implantation loss and embryo-fetal mortality. In addition, an increased incidence of various malformations, including cardiovascular, has been reported in animals given prostaglandin synthesis inhibitors during the organogenetic period. During the first and second trimester of pregnancy, ibuprofen should not be given unless clearly necessary. If used by women attempting to conceive or during the first and second trimester of pregnancy, the dose and duration of treatment should be as low and as short as possible, respectively. During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to: cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension); renal dysfunction, which may progress to renal failure with oligo-hydroamniosis; the mother and the neonate, at the end of pregnancy, to: possible prolongation of bleeding time and antiaggregant effect which may occur even at very low doses; inhibition of uterine contractions resulting in delayed or prolonged labor. Consequently, ibuprofen is contraindicated during the third trimester of pregnancy. Breastfeeding: in the few studies available to date, NSAIDs may be found in breast milk in very low concentrations. NSAIDs should, if possible, be avoided during breastfeeding. Fertility: The use of ibuprofen may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of fertility, discontinuation of ibuprofen should be considered.\u003c\/span\u003e\u003c\/p\u003e","brand":"SANOFI SpA","offers":[{"title":"Default Title","offer_id":40207822389363,"sku":"029396037","price":7.91,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sanofi-spa-buscofen-12-capsule-molli-200mg-farmacia-dottor-tili-1213792773.jpg?v=1767112233"},{"product_id":"okitask-20-bustine-granulato-40-mg","title":"Okitask 20 granulated sachets 40 mg.","description":"\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eOkitask 20 orosoluble sachets 40 mg is an over-the-counter anti-inflammatory medicine based on Ketoprofen Lysine salt. Okitask 20 granulated sachets 40 mg belongs to a group of medicines called “Non-Steroidal Anti-Inflammatory Drugs” (NSAIDs), which can be sold without a prescription. The active ingredient in Okitask 20 granulated sachets 40 mg, ketoprofen,\u003c\/span\u003e \u003cb\u003eworks by blocking the chemicals that normally cause inflammation in our body\u003c\/b\u003e \u003cspan style=\"font-weight: 400;\"\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp\u003e \u003cspan style=\"font-weight: 400;\"\u003eOkitask 20 orosoluble sachets 40 mg can be used for\u003c\/span\u003e \u003cb\u003epain of different origins and\u003c\/b\u003e \u003cstrong\u003enatures\u003c\/strong\u003e \u003cspan style=\"font-weight: 400;\"\u003e\u003cstrong\u003e,\u003c\/strong\u003e in particular: headache, toothache, neuralgia (nerve pain), menstrual pain, muscle pain and osteoarticular pain (bone pain and joint inflammation).\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eActive ingredients contained in Okitask 20 sachets granules 40 mg. - What is the active ingredient in Okitask 20 sachets granules 40 mg.?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eEach sachet contains. Active ingredient: ketoprofen lysine salt 40 mg (corresponding to 25 mg of ketoprofen) Excipients with known effect: aspartame, sodium dodecyl sulphate. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Okitask 20 sachets granules 40 mg. - What does Okitask 20 sachets granules 40 mg contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003ePovidone, colloidal silica, hydroxypropyl methylcellulose, eudragit EPO, sodium dodecyl sulfate, stearic acid, magnesium stearate, aspartame, mannitol, xylitol, talc, lime flavouring, lemon flavouring, frescofort flavouring.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Okitask 20 sachets granules 40 mg. - Why is Okitask 20 sachets granules 40 mg used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePain of various origins and natures, and in particular: headache, toothache, neuralgia, menstrual pain, muscular and osteoarticular pain.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Okitask 20 sachets granules 40 mg. - When should Okitask 20 sachets granules 40 mg not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eOkitask 40 mg granules must not be administered in the following cases: hypersensitivity to the active substance, to other nonsteroidal anti-inflammatory drugs (NSAIDs) or to any of the excipients listed in section 6.1; asthma, bronchospasm, acute rhinitis, urticaria, skin rashes, nasal polyps, angioneurotic oedema or other allergic-type reactions caused by ketoprofen, or by medicinal products with a similar mechanism of action (for example acetylsalicylic acid, other NSAIDs and selective cyclooxygenase 2 inhibitors), see section 4.8; previous bronchial asthma; severe cardiac insufficiency; gastritis; active peptic ulcer\/haemorrhage or history of recurrent peptic ulcer\/haemorrhage (two or more distinct episodes of proven ulceration or haemorrhage); previous history of gastrointestinal bleeding, ulceration or perforation or chronic dyspepsia; history of gastrointestinal bleeding or perforation following previous NSAID therapy; Crohn's disease or ulcerative colitis; severe hepatic insufficiency (liver cirrhosis, severe hepatitis); severe renal insufficiency; leukopenia and thrombocytopenia; haemorrhagic diathesis and other coagulation disorders, haemostatic disorders; use of high doses of diuretics; third trimester of pregnancy; children under 15 years of age.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Okitask 20 sachets granules 40 mg. - How to take Okitask 20 sachets granules 40 mg.?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eDosage. Adults and over 15 years: the recommended dose is 40 mg (corresponding to 1 sachet), in a single dose, or repeated 2-3 times a day, in the most intense painful forms. Do not exceed the recommended doses. Special populations. Elderly. The dosage must be carefully established, taking into account a possible reduction of the dosages indicated above. Patients with hepatic or renal insufficiency. Therapy at the minimum daily dosage and careful monitoring are recommended (see section 4.4). In case of renal insufficiency, it is recommended to check the volume of diuresis and renal function (see section 4.4). Okitask 40 mg granules must not be used in patients with severe hepatic or renal dysfunction (see section 4.3). Paediatric population. The safety and efficacy of Okitask 40 mg granules in children have not yet been established. Method of administration: the contents of the sachet can be placed directly on the tongue. It dissolves with saliva: this allows its use without water. It is preferable to take the product on a full stomach. Duration of treatment: The duration of therapy should be limited to overcoming the painful episode. The lowest effective dose should be used for the shortest period necessary to relieve symptoms (see paragraph 4.4).\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Okitask 20 sachets granules 40 mg. - How do you store Okitask 20 sachets granules 40 mg.?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThis medicinal product does not require any special storage conditions.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Okitask 20 sachets granules 40 mg. - About Okitask 20 sachets granules 40 mg. it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eWarnings. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2 and sections below on gastrointestinal and cardiovascular risks). The concomitant use of Okitask 40 mg granules with other NSAIDs, including cyclooxygenase-2 selective inhibitors, should be avoided. Gastrointestinal reactions. Gastrointestinal bleeding, ulceration and perforation: gastrointestinal bleeding, ulceration and perforation, which can be fatal, have been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious gastrointestinal events. The risk of gastrointestinal bleeding, ulceration or perforation is higher with increasing NSAID doses in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3). These patients should start treatment on the lowest possible dose. Concomitant use of protective agents (misoprostol or proton pump inhibitors) should be considered for these patients and also for patients receiving concomitant low dose acetylsalicylic acid or other drugs likely to increase the risk of gastrointestinal events (see below and section 4.5). Patients with a history of gastrointestinal toxicity, especially the elderly, should report any abdominal symptoms and\/or signs (including gastrointestinal bleeding) also at the beginning of treatment. Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin reuptake inhibitors or anti-platelet agents such as acetylsalicylic acid (see section 4.5). Elderly. The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (see section 4.2). Patients with active or previous gastrointestinal disease should be carefully observed for digestive disturbances, especially gastrointestinal bleeding. When gastrointestinal bleeding or ulceration occurs in patients receiving Okitask 40 mg granules, the treatment should be withdrawn. Patients with active or previous peptic ulcer. Some epidemiological evidence suggests that ketoprofen may be associated with a higher risk of serious gastrointestinal toxicity than other NSAIDs, particularly at high doses (see sections 4.2 and 4.3). Skin reactions. Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at higher risk at the beginning of treatment. Okitask 40 mg granules should be discontinued at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity. Precautions. Cardiovascular, renal and hepatic dysfunction: in patients with impaired renal function, the administration of ketoprofen should be carried out with particular caution in view of the essentially renal elimination of the drug. Renal function should be carefully monitored in patients with heart failure, cirrhosis and nephrosis, in patients receiving diuretic therapy, in patients with chronic renal impairment, particularly if the patients are elderly. In these patients, the administration of ketoprofen may cause a decrease in renal blood flow caused by prostaglandin inhibition and lead to renal failure (see section 4.3). Caution is also required in patients subject to diuretic therapy or likely to be hypovolemic because the risk of nephrotoxicity is increased. As with all NSAIDs, Okitask 40 mg granules may increase plasma urea nitrogen and creatinine. As with other inhibitors of prostaglandin synthesis, Okitask 40 mg granules may be associated with adverse events on the renal system that can lead to glomerular nephritis, renal papillary necrosis, nephrotic syndrome and acute renal failure (see section 4.8). In patients with abnormal liver function values ​​or with a history of liver disease, transaminase levels should be periodically evaluated. As with other NSAIDs, Okitask 40 mg granules may cause increases in some liver parameters and also significant increases in SGOT and SGPT (see section 4.8). In case of significant increases in these parameters, therapy should be discontinued. With the use of ketoprofen, cases of jaundice and hepatitis have been reported (see section 4.8). Elderly patients are more predisposed to reduction of renal, cardiovascular or hepatic function. Cardiovascular and cerebrovascular effects. As with other NSAIDs, patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease and\/or cerebrovascular disease should only be treated with ketoprofen after careful consideration. Similar consideration should be made before initiating treatment in patients with risk factors for cardiovascular disease (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking). Caution is required before initiating treatment in patients with a history of hypertension and\/or mild to moderate congestive heart failure since fluid retention and oedema have been reported in association with NSAID treatment. Clinical trial and epidemiological data suggest that the use of some NSAIDs may be associated with an increased risk of arterial thrombotic events (e.g. myocardial infarction or stroke). There are insufficient data to exclude such a risk for Okitask 40 mg granules. An increased risk of atrial fibrillation associated with the use of NSAIDs has been reported. Hyperkalaemia may occur, especially in patients with underlying diabetes, renal insufficiency, and\/or concomitant treatment with agents promoting hyperkalaemia (see section 4.5). In these circumstances, potassium levels should be periodically assessed. Infections. Masking of symptoms of underlying infections. Okitask 40 mg granules may mask the symptoms of infection, which may delay initiation of adequate treatment and therefore worsen the outcome of the infection. This has been observed in community-acquired bacterial pneumonia and in bacterial complications of varicella.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Okitask 20 sachets granules 40 mg. - What medicines or foods can modify the effect of Okitask 20 sachets granules 40 mg.?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eCombinations not recommended. Other NSAIDs (including selective inhibitors of cyclooxygenase 2) and high doses of salicylates (\u0026gt; 3 g\/day): the simultaneous administration of several NSAIDs may increase the risk of gastrointestinal ulcers and bleeding, due to a synergistic effect. Anticoagulants (heparin and warfarin): NSAIDs may amplify the effects of anticoagulants. If administration cannot be avoided, the patient must be closely monitored. Platelet aggregation inhibitors (ticlopidine and clopidogrel): the concomitant administration of an NSAID may increase the risk of bleeding by inhibition of platelet function and damage to the gastrointestinal mucosa (see section 4.4). If administration cannot be avoided, the patient must be closely monitored. Lithium: the simultaneous administration of several NSAIDs may increase plasma lithium levels, which may reach toxic values, due to reduced renal excretion. Plasma lithium levels should be carefully monitored and the lithium dosage should be adjusted during and after discontinuation of treatment with ketoprofen and other NSAIDs. Methotrexate, at doses greater than 15 mg\/week: concomitant administration of an NSAID may increase the risk of haematological toxicity of methotrexate, especially if administered at high doses, probably due to a displacement of binding to plasma proteins and a decrease in renal clearance. The intake of the two medicinal products should be separated by at least 12 hours. Hydantoins and sulphonamides: the toxic effects of these substances may be increased; since the protein binding of ketoprofen is high, it may be necessary to reduce the dosage of diphenylhydantoin or sulphonamides, in case of concomitant administration. Combinations requiring precaution. Drugs or therapeutic categories that may promote hyperkalaemia: potassium salts, potassium-sparing diuretics, ACE inhibitors, angiotensin II receptor blockers, NSAIDs, heparins (low molecular weight or unfractionated), ciclosporin, tacrolimus and trimethoprim. The occurrence of hyperkalaemia may depend on the presence of cofactors. The risk is increased in case of concomitant administration of the above mentioned drugs. Tenofovir: concomitant administration of tenofovir disoproxil fumarate and NSAIDs may increase the risk of renal failure. Diuretics: subjects treated with diuretics, especially if dehydrated, are at increased risk of developing renal failure secondary to the reduction in renal blood flow caused by prostaglandin inhibition. Hydration before initiating concomitant therapy and close monitoring of renal function after initiation of treatment are recommended (see section 4.4). NSAIDs may reduce diuretics. ACE inhibitors and angiotensin II antagonists: co-administration with cyclooxygenase inhibitors may lead to further deterioration of renal function and possible acute renal failure, especially in dehydrated and elderly subjects. Caution, hydration and monitoring of renal function are recommended in case of concomitant therapy. Methotrexate at doses lower than 15 mg\/week: anti-inflammatory drugs cause a decrease in renal clearance of methotrexate with consequent increase in haematological toxicity. In case of impaired renal function or advanced age, monitoring must be more frequent. Corticosteroids: concomitant administration of NSAIDs may increase the risk of gastrointestinal ulceration or bleeding (see section 4.4). Pentoxifylline: co-administration may increase the risk of bleeding: monitoring of bleeding time is recommended. Zidovudine: the combination with NSAIDs increases the risk of toxicity on reticulocytes, with severe anaemia occurring one week after the start of treatment with NSAIDs. Complete blood count and reticulocyte count should be checked one week after starting treatment with the NSAID. Sulfonylureas: NSAIDs may increase the hypoglycaemic effect of sulfonylureas by displacing them from plasma protein binding sites. Possible interactions with other oral hypoglycaemic agents should also be taken into account. Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce the glomerular filtration rate and increase cardiac glycoside levels; however, the pharmacokinetic interaction between ketoprofen and active glycosides has not been demonstrated. Associations that need to be taken into account. Antihypertensive agents (Beta-blockers, ACE inhibitors, diuretics): treatment with an NSAID may reduce the hypoglycaemic effect of antihypertensive drugs by inhibiting the synthesis of vasodilatory prostaglandins. Mifepristone: The efficacy of the contraceptive method may theoretically be reduced due to the antiprostaglandin properties of NSAIDs including acetylsalicylic acid. There is some evidence to suggest that concomitant administration of NSAIDs on the day of administration of the prostaglandin dose does not adversely affect the effects of mifepristone or the prostaglandin on cervical ripening or uterine contractility and does not reduce the clinical efficacy of medical termination of pregnancy. Intrauterine contraceptive devices (IUDs): The efficacy of the device may be reduced resulting in pregnancy. Ciclosporin and tacrolimus: Concomitant treatment with NSAIDs may involve an increased risk of nephrotoxicity especially in the elderly. Thrombolytics: Concomitant administration with NSAIDs may increase the risk of bleeding. Anti-platelet agents (ticlopidine and clopidogrel) and Selective serotonin reuptake inhibitors (SSRIs): NSAIDs may increase the risk of gastrointestinal bleeding (see section 4.4). Probenecid: Concomitant administration of probenecid may markedly reduce the plasma clearance of ketoprofen by inhibiting tubular secretion and glucuronide conjugation, therefore an adjustment of the ketoprofen dose is necessary. Quinolone antibiotics: Animal data indicate that NSAIDs may increase the risk of convulsions related to the use of quinolones. Patients treated with NSAIDs and quinolones may have an increased risk of developing convulsions.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Okitask 20 sachets granules 40 mg. can cause side effects - What are the side effects of Okitask 20 sachets granules 40 mg.?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe most commonly observed adverse events are gastrointestinal in nature. Classification of expected frequencies: very common (1\/10), common (from 1\/100 to \u0026lt;=1\/10), uncommon (from 1\/1000 to \u0026lt;=1\/100), rare (from 1\/10000 to \u0026lt;=1\/1000), very rare (\u0026lt;=1\/10000), not known (frequency cannot be estimated from the available data). The following adverse reactions have been observed with the use of ketoprofen in adults. Blood and lymphatic system disorders. Rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000): haemorrhagic anaemia; frequency not known: thrombocytopenia, agranulocytosis, bone marrow failure, haemolytic anaemia, leukopenia, neutropenia, aplastic anaemia, leukocytosis, thrombocytopenic purpura. Immune system disorders. Frequency not known: anaphylactic reaction (including shock), hypersensitivity. Gastrointestinal disorders. Common (\u0026gt;=1\/100, \u0026lt;1\/10): dyspepsia, nausea, abdominal pain, vomiting; uncommon (\u0026gt;=1\/1,000, \u0026lt;1\/100): constipation, diarrhoea, flatulence, gastritis; rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000): stomatitis, peptic ulcer; frequency not known: exacerbation of colitis and Crohn's disease, gastrointestinal haemorrhage, gastrointestinal perforation (sometimes fatal, particularly in the elderly - see section 4.4), gastric ulcer, mouth ulceration, duodenal ulcer, duodenal perforation, melaena, haematemesis, abdominal discomfort, colitis, heartburn, mouth oedema, pancreatitis, hyperchlorhydria, gastric pain, erosive gastritis, tongue oedema. Skin and subcutaneous tissue disorders: Uncommon (\u0026gt;=1\/1,000, \u0026lt;1\/100): rash, pruritus; very rare (\u0026lt;1\/10,000): erythema; frequency not known: photosensitivity reaction, alopecia, urticaria, angioedema, bullous dermatitis including Stevens-Johnson syndrome and toxic epidermal necrolysis, oedema, exanthema, Lyell syndrome, maculo-papular rash, purpura, acute generalized exanthematous pustulosis, dermatitis. General disorders and administration site conditions. Uncommon (\u0026gt;=1\/1,000, \u0026lt;1\/100): fatigue; very rare (\u0026lt;1\/10,000): facial oedema; frequency not known: peripheral oedema, chills, asthenia. Nervous system disorders. Uncommon (\u0026gt;=1\/1,000, \u0026lt;1\/100): headache, dizziness, somnolence; rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000): paraesthesia; frequency not known: seizure, dysgeusia, dizziness, dyskinesia, syncope, tremor, hyperkinesia. Eye disorders. Rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000): blurred vision (see section 4.4); frequency not known: periorbital oedema. Ear and labyrinth disorders. Rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000): tinnitus. Hepatobiliary disorders. Rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000): hepatitis, increased transaminases, increased blood bilirubin; frequency not known: jaundice. Respiratory, thoracic and mediastinal disorders. Rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000): asthma; frequency not known: bronchospasm (especially in patients with known hypersensitivity to acetylsalicylic acid and other NSAIDs), rhinitis, dyspnoea, laryngeal oedema, laryngospasm, acute respiratory failure (one case, with fatal outcome, has been reported in an asthmatic patient sensitive to acetylsalicylic acid). Renal and urinary disorders. Frequency not known: acute renal failure, tubulointerstitial nephritis, nephritic syndrome, abnormal renal function test, haematuria, nephritis, nephrotic syndrome, glomerulonephritis, fluid\/sodium retention with possible oedema, acute tubular necrosis, renal papillary necrosis, oliguria. Psychiatric disorders. Frequency not known: altered mood, depression, hallucination, confusional state, agitation, insomnia. Cardiac disorders. Frequency not known: cardiac failure, atrial fibrillation, palpitations, tachycardia. Vascular disorders. Frequency not known: hypertension, vasodilation, hypotension, vasculitis (including leukocytoclastic vasculitis). Metabolism and nutrition disorders. Frequency not known: hyperkalaemia, hyponatraemia. Infections and infestations. Frequency not known: aseptic meningitis, lymphangitis. Investigations. Rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000): weight increased. Clinical trial and epidemiological data suggest that use of some NSAIDs (particularly at high doses and in long-term treatment) may be associated with an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4). Reporting of suspected adverse reactions: Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Okitask 20 sachets granules 40 mg.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePregnancy: The use of ketoprofen during the first and second trimester of pregnancy should be avoided, the administration of ketoprofen should be considered only if the expected benefit for the mother outweighs the risk to the embryo or fetus. Inhibition of prostaglandin synthesis may adversely affect the pregnancy and\/or embryo\/fetal development. Results of epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increased from less than 1%, up to approximately 1.5%. The risk was considered to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to cause an increase in pre- and post-implantation loss and embryo-fetal mortality. In addition, an increased incidence of various malformations, including cardiovascular, has been reported in animals given prostaglandin synthesis inhibitors during the organogenetic period. From the twentieth week of pregnancy onwards, the use of ketoprofen may cause oligohydramnios resulting from fetal renal dysfunction. This may be seen soon after initiation of treatment and is usually reversible upon discontinuation of treatment. In addition, cases of constriction of the ductus arteriosus have been reported following treatment in the second trimester, most of which resolved after discontinuation of treatment. Therefore, during the first and second trimesters of pregnancy, ketoprofen should not be administered unless clearly necessary. If ketoprofen is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dosage should be kept as low as possible for the shortest duration possible. Following exposure to ketoprofen for several days from the 20th week of gestation onwards, antenatal monitoring for oligohydramnios and constriction of the ductus arteriosus should be considered. If oligohydramnios or constriction of the ductus arteriosus occurs, treatment with ketoprofen should be discontinued. During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to: cardiopulmonary toxicity (premature constriction\/closure of the ductus arteriosus and pulmonary hypertension); renal dysfunction, which may progress to renal failure with oligohydramnios (see above). The mother and the neonate, at the end of pregnancy, to: possible prolongation of bleeding time and antiaggregant effect which may occur even at very low doses; inhibition of uterine contractions resulting in delayed or prolonged labor. Use of the medicinal product close to delivery may cause alterations in the haemodynamics of the small circulation of the newborn with serious consequences for respiration. Consequently, ketoprofen is contraindicated during the third trimester of pregnancy (see sections 4.3 and 5.3). Breastfeeding: there is no information available on the excretion of ketoprofen in breast milk. Ketoprofen is not recommended during breastfeeding. Fertility: the use of NSAIDs may reduce female fertility and is therefore not recommended in women intending to become pregnant. The administration of NSAIDs, as well as Okitask 40 mg granules, must be suspended in women who have fertility problems or who are undergoing investigation of fertility.\u003c\/span\u003e\u003c\/p\u003e","brand":"DOMPE' FARMACEUTICI SpA","offers":[{"title":"Default Title","offer_id":40207822422131,"sku":"042028023","price":10.23,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/dompe-farmaceutici-spa-okitask-20-bustine-granulato-40-mg-farmacia-dottor-tili-1213792778.jpg?v=1767112213"},{"product_id":"codex-30-capsule-5-miliardi-250-mg-blister","title":"Codex 30 Capsules 5 Billion 250 mg Blister","description":"\u003cp\u003e \u003cstrong\u003eCodex\u003c\/strong\u003e is a food supplement based on \u003cstrong\u003eSaccharomyces boulardii\u003c\/strong\u003e , a natural probiotic that helps restore the balance of the intestinal flora, especially in situations of imbalance caused by diarrhea, antibiotics or an unbalanced diet. Each Codex capsule contains \u003cstrong\u003e5 billion live cells\u003c\/strong\u003e of Saccharomyces boulardii, for a targeted and rapid action. The capsule format is convenient to take and ideal for adults and children.\u003c\/p\u003e\n\n \n\u003ch2\u003eDosage and method of use\u003c\/h2\u003e\n\n\u003ch3\u003e How to take Codex?\u003c\/h3\u003e\n\n\u003cp\u003e It is recommended to take \u003cstrong\u003e1 or 2 capsules\u003c\/strong\u003e per day, as needed and as directed by your doctor. The capsules should be swallowed whole, preferably away from meals, with plenty of water. In case of treatment with antibiotics, it is preferable to take Codex at least 2 hours after the antibiotic to ensure the effectiveness of the product.\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Codex contain?\u003c\/h3\u003e\n\n\u003cp\u003e Codex contains:\n\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSaccharomyces boulardii\u003c\/strong\u003e : 5 billion live cells per capsule, for targeted support of the intestinal flora.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eExcipients\u003c\/strong\u003e : gelatin (for the capsule), silicon dioxide, magnesium stearate.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the Codex warnings?\u003c\/h3\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e Do not exceed the recommended daily dose.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children under 3 years.\u003c\/li\u003e\n\n         \u003cli\u003eFood supplements should not be considered a substitute for a varied and balanced diet and a healthy lifestyle.\u003c\/li\u003e\n\n\u003cli\u003e Consult your doctor if you are pregnant or breastfeeding before using this product.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration and storage of Codex?\u003c\/h3\u003e\n\n\u003cp\u003e Store \u003cstrong\u003eCodex\u003c\/strong\u003e in a cool, dry place, away from heat and direct light. Check the expiry date on the package before use.\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e Codex is available in \u003cstrong\u003eblister packs of 30 capsules\u003c\/strong\u003e of 250 mg, with 5 billion live cells per capsule.\u003c\/p\u003e\n\n","brand":"ZAMBON ITALIA Srl","offers":[{"title":"Default Title","offer_id":40207822585971,"sku":"029032087","price":24.18,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/zambon-italia-srl-codex-30-capsule-5-miliardi-250-mg-blister-farmacia-dottor-tili-1213792770.jpg?v=1767125410"},{"product_id":"elmex-protezione-carie-dentifricio-fluoruro-amminico-2-x-75-ml","title":"Elmex Cavity Protection Amine Fluoride Toothpaste 2 x 75 ml","description":"\u003cp\u003e\u003cstrong\u003eElmex Cavity Protection\u003c\/strong\u003e is a toothpaste formulated with \u003cstrong\u003eamine fluoride\u003c\/strong\u003e , a highly effective active ingredient in protecting against cavities. Amine fluoride creates a long-lasting protective layer on the teeth, which strengthens the enamel and remineralises demineralised areas, making the teeth more resistant to acid attack. Thanks to its advanced formula, Elmex Cavity Protection is suitable for daily use and helps maintain a healthy and protected mouth over time.\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Elmex Cavity Protection Toothpaste?\u003c\/h3\u003e\n\n\u003cp\u003e For best results, we recommend brushing your teeth with \u003cstrong\u003eElmex Cavity Protection\u003c\/strong\u003e at least twice a day or as directed by your dentist. Gently brush your teeth for at least 2 minutes, making sure to reach all tooth surfaces. Do not swallow. Rinse with water after use.\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Elmex Cavity Protection contain?\u003c\/h3\u003e\n\n         \u003cp\u003eElmex Cavity Protection contains:\n\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eAmine Fluoride\u003c\/strong\u003e : 1400 ppm, which helps prevent tooth decay and strengthen enamel.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eHydrated silica\u003c\/strong\u003e : for effective, yet gentle cleaning.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eWater\u003c\/strong\u003e , \u003cstrong\u003eGlycerin\u003c\/strong\u003e , \u003cstrong\u003eSorbitol\u003c\/strong\u003e , and other excipients.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Elmex Cavity Protection Toothpaste?\u003c\/h3\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e Not suitable for children under 6 years of age unless otherwise directed by a dentist.\u003c\/li\u003e\n\n\u003cli\u003e If you take fluoride from other sources, consult your dentist or doctor.\u003c\/li\u003e\n\n\u003cli\u003e Avoid ingesting the product.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiry dates and storage of Elmex Cavity Protection?\u003c\/h3\u003e\n\n         \u003cp\u003eStore \u003cstrong\u003eElmex Cavity Protection\u003c\/strong\u003e in a cool, dry place, at room temperature, away from heat sources. Check the expiry date on the package and do not use the product beyond that date.\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e Elmex Cavity Protection is available in the format of \u003cstrong\u003e2 tubes of 75 ml\u003c\/strong\u003e each, ideal for prolonged and continuous use.\u003c\/p\u003e\n\n","brand":"COLGATE-PALMOLIVE COMMERC.Srl","offers":[{"title":"Default Title","offer_id":40207822848115,"sku":"973145889","price":7.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/colgate-palmolive-commerc-srl-elmex-protezione-carie-dentifricio-fluoruro-amminico-2-x-75-ml-farmacia-dottor-tili-1213792768.jpg?v=1767125542"},{"product_id":"dicloreum-antinfiammatorio-locale-10-cerotti-medicati-180-mg","title":"Dicloreum Local Anti-inflammatory 10 Medicated Patches 180 mg","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eDicloreum Local Anti-Inflammatory\u003c\/span\u003e \u003cspan\u003eis a medicated patch based on\u003c\/span\u003e \u003cspan\u003ediclofenac sodium\u003c\/span\u003e \u003cspan\u003e(180 mg per patch) indicated for the local treatment of pain and inflammation. It is particularly effective in the treatment of muscle and joint pain of traumatic or rheumatic origin, such as strains, bruises, sprains or tendonitis. The patches gradually release the active ingredient directly on the affected area, offering a prolonged anti-inflammatory and analgesic action.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Dicloreum Local Anti-Inflammatory 10 Medicated Patches 180mg - What is the active ingredient in Dicloreum Local Anti-Inflammatory 10 Medicated Patches 180mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eOne 180 mg medicated plaster contains: Diclofenac hydroxyethylpyrrolidine 180 mg (equivalent to 140 mg of Diclofenac sodium). Excipients with known effect: 14 mg of methyl parahydroxybenzoate (E218), 7 mg of propyl parahydroxybenzoate (E216), 420 mg of propylene glycol and 2.8 mg of perfume (containing amyl cinnamal, amyl cinnamyl alcohol, benzyl alcohol, benzyl benzoate, benzyl salicylate, cinnamal, cinnamyl alcohol, citronellol, d-Limonene, eugenol, farnesol, geraniol, hexyl cinnamic aldehyde, hydroxycitronellal, isoeugenol, linalool, methyl heptine carbonate). For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Dicloreum Local Anti-inflammatory 10 Medicated Patches 180 mg - What does Dicloreum Local Anti-inflammatory 10 Medicated Patches 180 mg contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eGelatin, povidone, D-Sorbitol 70% solution, kaolin, titanium dioxide, propylene glycol, methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), disodium edetate, tartaric acid, dihydroxyaluminium aminoacetate, sodium carmel, sodium polyacrylate, 1,3-butylene glycol, polysorbate 80, perfume, purified water, synthetic felt, plastic film.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Dicloreum Local Anti-inflammatory 10 Medicated Patches 180mg - Why is Dicloreum Local Anti-inflammatory 10 Medicated Patches 180 mg used? What is it for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eLocal treatment of painful and inflammatory conditions of rheumatic or traumatic nature of joints, muscles, tendons and ligaments.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Dicloreum Local Anti-Inflammatory 10 Medicated Patches 180mg - When should Dicloreum Local Anti-Inflammatory 10 Medicated Patches 180mg not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eHypersensitivity to diclofenac, acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs (NSAIDs) or to any of the excipients of the finished product, as well as to isopropanol. Patients who have experienced asthmatic attacks, urticaria or acute rhinitis after taking acetylsalicylic acid or other nonsteroidal inflammatory drugs (NSAIDs). Damaged skin, regardless of the type of lesion: exudative dermatitis, eczema, infected lesion, burns or wounds. Third trimester of pregnancy and breastfeeding (see section 4.6). Patients with active peptic ulcer. Children and adolescents: use in children and adolescents under 16 years of age is contraindicated.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Dicloreum Local Anti-Inflammatory 10 Medicated Patches 180mg - How do you take Dicloreum Local Anti-Inflammatory 10 Medicated Patches 180mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eFor cutaneous use only. Dosage: The product should only be applied to intact, healthy skin and should not be applied while bathing or showering. Diclofenac medicated plaster should be used for the shortest possible time in relation to the indication for use. Adults: The usual dosage regimen is 1 or 2 patches (or any other frequency evaluated in clinical trials for a specific product) per day (one application every 12 or 24 hours) for up to 14 days (or any other number of days evaluated in clinical trials for a specific product). If no improvement is seen following the recommended treatment period, a doctor should be consulted. Children and adolescents under 16 years: The use of this medicated plaster is not recommended in children and adolescents under 16 years of age because there are insufficient data to evaluate the safety and efficacy of the medicinal product (see section 4.3). In adolescents aged 16 years and over, if the product is required for a treatment period longer than 7 days for pain relief or if symptoms worsen, the patient or the adolescent's relatives are advised to consult a doctor. Elderly: This medicinal product should be used with caution in elderly patients as they are more susceptible to side effects (see section 4.4). Patients with hepatic or renal insufficiency. For the use of diclofenac medicated plasters in patients with hepatic or renal insufficiency, see section 4.4. Method of administration: Cut the sachet containing the medicated plaster as indicated. Take out a medicated plaster, remove the plastic film used to protect the adhesive surface and apply the plaster to the joint on the painful area. If necessary, the plaster can be held in place with an elastic band. Carefully close the sachet by pressing the edge where the drawstring is located. The plaster must be used whole.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Dicloreum Local Anti-Inflammatory 10 Medicated Patches 180mg - How do you store Dicloreum Local Anti-Inflammatory 10 Medicated Patches 180mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eStore at a temperature not exceeding 30 degrees C.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Dicloreum Local Anti-inflammatory 10 Medicated Patches 180mg - About Dicloreum Local Anti-inflammatory 10 Medicated Patches 180mg it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eIf diclofenac medicated plasters are used on large areas of skin and for a prolonged period of time, the possibility of systemic adverse events cannot be excluded (see the Summary of Product Characteristics of the systemic formulations of diclofenac). The medicated plaster should only be applied to intact, healthy skin and should not be applied to broken skin or open wounds. The plasters should not come into contact with the eyes or mucous membranes. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms. Do not use with an occlusive dressing that does not allow air to pass through. Treatment should be discontinued immediately if a skin rash develops after application of the medicated plaster. Do not administer another medicinal product containing diclofenac or other NSAIDs topically or systemically at the same time. Although systemic effects should be limited, the medicated plaster should be used with caution in patients with renal, cardiac or hepatic impairment, history of peptic ulcer or inflammatory bowel disease or haemorrhagic diathesis. Nonsteroidal anti-inflammatory drugs should be used with particular caution in elderly patients who are more predisposed to adverse effects. Patients should be advised not to expose themselves to direct sunlight or sun lamps for approximately one day after removal of the medicated plaster in order to reduce the risk of photosensitivity. Dicloreum local anti-inflammatory contains: methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) which may cause allergic reactions (possibly delayed). 420 mg of propylene glycol per patch which may cause skin irritation; a perfume containing in turn allergens (amyl cinnamal, amyl cinnamyl alcohol, benzyl alcohol, benzyl benzoate, benzyl salicylate, cinnamal, cinnamyl alcohol, citronellol, d-Limonene, eugenol, farnesol, geraniol, hexyl cinnamic aldehyde, hydroxycitronellal, isoeugenol, linalool, methyl heptine carbonate) which can cause allergic reactions.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Dicloreum Local Anti-inflammatory 10 Medicated Patches 180mg - Which medicines or foods can modify the effect of Dicloreum Local Anti-inflammatory 10 Medicated Patches 180 mg?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eSince systemic absorption of diclofenac following the use of medicated plasters is very low, the risk of developing clinically significant interactions with other medicinal products is negligible.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Dicloreum Antinflammatory Locale 10 Medicated Patches 180 mg can cause side effects - What are the side effects of Dicloreum Antinflammatory Locale 10 Medicated Patches 180 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eAdverse reactions are listed by frequency, the most frequent first, using the following convention: common (\u0026gt;= 1\/100, \u0026lt; 1\/10); uncommon (\u0026gt;= 1\/1,000, \u0026lt; 1\/100); rare (\u0026gt;= 1\/10,000, \u0026lt; 1\/1,000); very rare (\u0026lt; 1\/10,000); Not known: cannot be estimated from the available data. Infections and infestations. Very rare: rash with pustules. Immune system disorders. Very rare: hypersensitivity (including urticaria), angioneurotic oedema, anaphylactoid reaction. Respiratory, thoracic and mediastinal disorders. Very rare: asthma. Skin and subcutaneous tissue disorders. Common: rash, eczema, erythema, dermatitis (including allergic dermatitis and contact dermatitis), pruritus; rare: bullous dermatitis (e.g. erythema bullosum), dry skin; very rare: photosensitivity reactions. General disorders and administration site conditions. Common: administration site reactions. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Dicloreum Local Anti-inflammatory 10 Medicated Patches 180 mg\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePregnancy: The systemic concentration of diclofenac, compared to oral formulations, is lower after topical administration. Based on the experience of treatment with systemically administered NSAIDs, the following is recommended: Inhibition of prostaglandin synthesis may adversely affect pregnancy and\/or embryo\/foetal development. Results of epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increases from less than 1%, up to approximately 1.5%. The risk was considered to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to result in increased pre- and post-implantation loss and embryo-foetal mortality. Furthermore, an increased incidence of various malformations, including cardiovascular, has been reported in animals given prostaglandin synthesis inhibitors during the organogenetic period. During the first and second trimester of pregnancy, diclofenac should not be given unless clearly necessary. If diclofenac is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible. During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to: cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension); renal dysfunction, which may progress to renal failure with oligo-hydroamniosis; the mother and neonate, at the end of pregnancy, to: possible prolongation of bleeding time, and an anti-aggregating effect which may occur even at very low doses; inhibition of uterine contractions resulting in delayed or prolonged labor. Consequently, diclofenac is contraindicated during the third trimester of pregnancy. Breastfeeding: Like other NSAIDs, diclofenac passes into breast milk in small amounts. However, at therapeutic doses of diclofenac medicated plasters, no effects on the infant are anticipated. Due to the lack of controlled studies in breastfeeding women, the product should be used during breastfeeding only under the advice of a healthcare professional. In this circumstance, diclofenac medicated plasters should not be applied to the breasts of nursing mothers, nor elsewhere on large areas of skin or for a prolonged period of time (see section 4.4).\u003c\/span\u003e\u003c\/p\u003e","brand":"ALFASIGMA SpA","offers":[{"title":"Default Title","offer_id":40207822913651,"sku":"042685014","price":23.81,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/alfasigma-spa-dicloreum-antinfiammatorio-locale-10-cerotti-medicati-180-mg-farmacia-dottor-tili-1213792767.jpg?v=1767125528"},{"product_id":"benagol-miele-e-limone-36-pastiglie-mal-di-gola","title":"Benagol Honey and Lemon 36 Tablets Sore Throat","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eBenagol Pastiglie is an oral antiseptic useful for\u003c\/span\u003e \u003cspan\u003esoothing throat inflammation\u003c\/span\u003e \u003cspan\u003eand in cases of\u003c\/span\u003e \u003cspan\u003ecold-related illnesses of the upper respiratory tract\u003c\/span\u003e \u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Benagol Honey and Lemon 36 Sore Throat Lozenges - What is the active ingredient in Benagol Honey and Lemon 36 Sore Throat Lozenges?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eBenagol Ginger and Spice flavoured lozenges. Active ingredients: 2,4-dichlorobenzyl alcohol 1.2 mg; amylmetacresol 0.6 mg. Excipients with known effects: liquid sucrose, liquid glucose (containing sulphites and wheat starch), spice flavouring and ginger flavouring (containing cinnamal, citral, citronellol, eugenol, farnesol, geraniol, isoeugenol and linalool). Benagol Honey and Lemon flavoured lozenges. Active ingredients: 2,4-dichlorobenzyl alcohol 1.2 mg; amylmetacresol 0.6 mg. Excipients with known effects: liquid glucose (containing sulphites and wheat starch), liquid sucrose, mint essence and lemon essence (containing citral, d-limonene, geraniol and linalool), honey (invert sugar). Benagol Lemon Flavor Sugar Free Lozenges. Active ingredients: 2,4-dichlorobenzyl alcohol 1.2 mg; amylmetacresol 0.6 mg. Excipients with known effects: liquid maltitol, isomalt, lemon flavoring (containing benzyl alcohol, citral, citronellol, d-limonene, geraniol and linalool). Benagol Strawberry Flavor Sugar Free Lozenges. Active ingredients: 2,4-dichlorobenzyl alcohol 1.2 mg; amylmetacresol 0.6 mg. Excipients with known effects: liquid maltitol, isomalt, strawberry flavoring (containing propylene glycol and benzyl alcohol). Benagol Cold Mint Flavor Lozenges. Active ingredients: 2,4-dichlorobenzyl alcohol 1.2 mg; amylmetacresol 0.6 mg. Excipients with known effects: liquid sucrose, liquid glucose (containing sulphites and wheat starch), mint flavour and eucalyptus essence (containing propylene glycol, benzyl alcohol, cinnamyl alcohol, citral, citronellol, d-limonene, eugenol and linalool). Benagol Pastilles Menthol-Eucalyptus flavour. Active ingredients: 2,4-dichlorobenzyl alcohol 1.2 mg; amylmetacresol 0.6 mg; menthol 8.0 mg. Excipients with known effects: liquid sucrose, liquid glucose (containing sulphites and wheat starch) and eucalyptus essence (containing d-limonene). Benagol Pastilles with Vitamin C Orange flavour. Active ingredients: 2,4-dichlorobenzyl alcohol 1.2 mg; amylmetacresol 0.6 mg; sodium ascorbate 74.9 mg; ascorbic acid 33.5 mg. Excipients with known effect: liquid sucrose, liquid glucose (containing sulphites and wheat starch), orange flavour (containing citral, citronellol, d-limonene, geraniol, linalool), propylene glycol. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Benagol Honey and Lemon 36 Sore Throat Lozenges - What does Benagol Honey and Lemon 36 Sore Throat Lozenges contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eBenagol Ginger and Spice Flavor Lozenges. One lozenge contains: liquid sucrose, liquid glucose (containing sulphites and wheat starch), tartaric acid, enocyanin (E163) (containing sodium), plum flavor, cream flavor, spice flavor and ginger flavor (containing cinnamal, citral, citronellol, eugenol, farnesol, geraniol, isoeugenol and linalool), medium chain saturated triglycerides. Benagol Honey and Lemon Flavor Lozenges. One lozenge contains: mint essence and lemon essence (containing citral, d-limonene, geraniol and linalool), tartaric acid, honey (invert sugar), liquid glucose (containing sulphites and wheat starch), liquid sucrose. Benagol Menthol-Eucalyptol Flavor Lozenges. One tablet contains: indigo carmine (E 132) (containing sodium), eucalyptus essence (containing d-limonene), tartaric acid, liquid sucrose, liquid glucose (containing sulphites and wheat starch). Benagol Orange flavoured lozenges with Vitamin C. One tablet contains: liquid sucrose, liquid glucose (containing sulphites and wheat starch), tartaric acid, orange flavouring (containing citral, citronellol, d-limonene, geraniol and linalool), levomenthol, propylene glycol. Benagol Lemon flavoured lozenges without sugar. One tablet contains: lemon flavouring (containing benzyl alcohol, citral, citronellol, d-limonene, geraniol and linalool), sodium saccharin, tartaric acid, liquid maltitol, isomalt. Benagol Strawberry flavoured lozenges without sugar. One lozenge contains: strawberry flavour (containing propylene glycol and benzyl alcohol), anthocyanins (E163) (containing sodium), sodium saccharin, tartaric acid, liquid maltitol, isomalt. Benagol Cold Mint flavour lozenges. One lozenge contains: xylitol, levomenthol, mint flavour and eucalyptus essence (containing propylene glycol, benzyl alcohol, cinnamyl alcohol, citral, citronellol, d-limonene, eugenol and linalool), liquid sucrose, liquid glucose (containing sulphites and wheat starch).\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Benagol Honey and Lemon 36 Sore Throat Pastilles - Why is Benagol Honey and Lemon 36 Sore Throat Pastilles used? What is it for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eOral antiseptic.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Benagol Honey and Lemon 36 Sore Throat Lozenges - When should Benagol Honey and Lemon 36 Sore Throat Lozenges not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eHypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. Do not administer to children under 6 years of age. Benagol Menthol-Eucalyptus flavour is contraindicated in children with a history of epilepsy or febrile convulsions. Do not administer Benagol Cold Mint flavour and Benagol Ginger and Spice flavour to children under 12 years of age.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eQuantity and method of taking Benagol Honey and Lemon 36 Sore Throat Lozenges - How to take Benagol Honey and Lemon 36 Sore Throat Lozenges?\u003c\/span\u003e\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eDosage: the lowest effective dose should be used for the shortest duration necessary to relieve symptoms. Adults and children over 6 years of age: one lozenge every 2 or 3 hours. In children over 6 years of age, consult your doctor for an appropriate dosage. Do not exceed the recommended doses and in particular, for Benagol with Vitamin C Orange flavour and Benagol Cold Mint flavour, do not exceed the maximum daily dose of 8 lozenges. For all other Benagol flavours, do not exceed the maximum daily dose of 12 lozenges. Administer Benagol Cold Mint flavour and Benagol Ginger and Spice flavour to adults and children over 12 years of age. The duration of treatment with Benagol Menthol-Eucalyptus flavour should not exceed 3 days. Benagol Lemon flavour Sugar Free and Benagol Strawberry flavour Sugar Free are suitable for those patients who need to control their sugar and calorie intake. Elderly population: no data are available. Method of administration: oromucosal administration. The tablet should be dissolved slowly in the mouth.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Benagol Honey and Lemon 36 Sore Throat Lozenges - How do you store Benagol Honey and Lemon 36 Sore Throat Lozenges?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eDo not store above 25 degrees C.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Benagol Honey and Lemon 36 Sore Throat Lozenges - About Benagol Honey and Lemon 36 Sore Throat Lozenges it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eBe careful with preschool children as if the tablets are swallowed whole they may cause choking. If sensitization or irritation occurs, administration should be stopped and appropriate treatment should be instituted. Benagol Menthol-Eucalyptus flavour contains terpene derivatives which, in excessive doses, may cause neurological disorders such as convulsions in infants and children. Treatment with Benagol Menthol-Eucalyptus flavour should not be prolonged for more than 3 days due to the risks associated with the accumulation of terpene derivatives, such as camphor, cineole, niaouli, wild thyme, terpineol, terpin, citral, menthol and essential oils of pine needles, eucalyptus and turpentine (due to their lipophilic properties the speed of metabolism and disposal is unknown) in the tissues and brain, in particular neuropsychological disorders. A higher dose than recommended should not be used to avoid a higher risk of adverse reactions to the medicinal product and disorders associated with overdose (see section 4.9). Benagol Menthol-Eucalyptus flavour is flammable, it should not be brought close to flames. Important information about some of the excipients. Benagol Ginger and Spice flavour Lozenges, Benagol Honey and Lemon flavour Lozenges, Benagol Menthol-Eucalyptus flavour Lozenges, Benagol Orange flavour Lozenges with Vitamin C, Benagol Cold Mint flavour Lozenges contain liquid Glucose: patients with rare hereditary problems of glucose-galactose malabsorption should not take this medicine. To be taken into consideration in people with diabetes mellitus: Benagol Ginger and Spice flavour Lozenges contain 1.10 g of glucose per lozenge; Benagol Honey and Lemon flavour Lozenges contain 0.98 g of glucose per lozenge; Benagol Pastilles Menthol-Eucalyptus flavour contains 1.01 g of glucose per lozenge; Benagol Pastilles with Vitamin C Orange flavour contains 0.97 g of glucose per lozenge; Benagol Pastilles Cold Mint flavour contains 1.10 g of glucose per lozenge; the liquid glucose contains sulphites. These medicines can rarely cause serious hypersensitivity reactions and bronchospasm; the liquid glucose contains wheat starch. These medicines contain only a very small amount of gluten (from wheat starch). These medicines are considered \"gluten-free\" and are very unlikely to cause problems if the patient is coeliac. One lozenge of Benagol Pastilles Ginger and Spice flavour contains no more than 22.04 micrograms of gluten. One lozenge of Benagol Pastilles Honey and Lemon flavour contains no more than 19.52 micrograms of gluten. One Benagol Menthol-Eucalyptus flavour lozenge contains no more than 20.26 micrograms of gluten. One Benagol Pastiglie with Vitamin C Orange flavour lozenge contains no more than 19.38 micrograms of gluten. One Benagol Pastiglie Cold Mint flavour lozenge contains no more than 22.04 micrograms of gluten. If the patient is allergic to wheat (other than coeliac disease) he\/she should not take these medicines. Liquid sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine. To be taken into consideration in people with diabetes mellitus: Benagol Pastiglie Ginger and Spice flavour contains 1.38 g of sucrose per lozenge; Benagol Pastiglie Honey and Lemon flavour contains 1.44 g of sucrose per lozenge; Benagol Menthol-Eucalyptus flavour lozenges contain 1.50 g of sucrose per lozenge; Benagol Orange flavour lozenges with Vitamin C contain 1.44 g of sucrose per lozenge; Benagol Cold Mint flavour lozenges contain 1.38 g of sucrose per lozenge. Benagol Ginger and Spice flavour lozenges, Benagol Menthol-Eucalyptus flavour lozenges, Benagol Orange flavour lozenges with Vitamin C, Benagol Lemon flavour lozenges Sugar Free, Benagol Strawberry flavour lozenges Sugar Free: these medicines contain less than 1 mmol sodium (23 mg) per dose, that is to say essentially \"sodium-free\". Benagol Lemon flavour lozenges Sugar Free and Benagol Strawberry flavour lozenges Sugar Free: these medicines contain liquid maltitol and isomalt. Patients with rare hereditary problems of fructose intolerance should not take this medicine. They may have a mild laxative effect. The caloric value of maltitol and isomalt is 2.3 kcal\/g. Benagol Pastilles Ginger and Spice flavour: this medicine contains a flavouring containing cinnamal, citral, citronellol, eugenol, farnesol, geraniol, isoeugenol and linalool. Cinnamal, citral, citronellol, eugenol, farnesol, geraniol, isoeugenol and linalool may cause allergic reactions. This medicine contains excipients that can induce a sensation of heat in the mouth and throat when sucking the lozenge. Benagol Pastilles Honey and Lemon flavour: this medicine contains a flavouring containing citral, d-limonene, geraniol and linalool. Citral, d-limonene, geraniol and linalool may cause allergic reactions. This medicinal product contains honey (invert sugar). Patients with rare hereditary problems of fructose intolerance or glucose-galactose malabsorption should not take this medicine. Benagol Pastilles Menthol-Eucalyptol flavour: this medicinal product contains a flavouring containing d-limonene. D-limonene may cause allergic reactions. Benagol Pastilles with Vitamin C Orange flavour: this medicinal product contains a flavouring containing citral, citronellol, d-limonene, geraniol and linalool. Citral, citronellol, d-limonene, geraniol and linalool may cause allergic reactions. This medicinal product contains 3 mg of propylene glycol per lozenge. Benagol Lemon Flavor Sugar Free Lozenges: This medicine contains a flavoring containing benzyl alcohol, citral, citronellol, d-limonene, geraniol and linalool. Benzyl alcohol, citral, citronellol, d-limonene, geraniol and linalool may cause allergic reactions. Benagol Strawberry Flavor Sugar Free Lozenges: This medicine contains a flavoring containing benzyl alcohol. Benzyl alcohol may cause allergic reactions. This medicine contains 7.30 mg of propylene glycol in each lozenge. Benagol Cold Mint Flavor Lozenges: This medicine contains a flavoring containing benzyl alcohol, cinnamyl alcohol, citral, citronellol, d-limonene, eugenol and linalool. Benzyl alcohol, cinnamyl alcohol, citral, citronellol, d-limonene, eugenol and linalool may cause allergic reactions. This medicine contains 1.89 mg propylene glycol in each lozenge.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Benagol Honey and Lemon 36 Sore Throat Pastilles - Which medicines or foods can modify the effect of Benagol Honey and Lemon 36 Sore Throat Pastilles?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eNo interactions with other drugs are known. Benagol Menthol-Eucalyptus flavour should not be used in conjunction with other products (medicines or cosmetics) containing terpene derivatives, regardless of the route of administration (oral, rectal, cutaneous, nasal or inhalation).\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Benagol Honey and Lemon 36 Pastiglie Mal di Gola can cause side effects - What are the side effects of Benagol Honey and Lemon 36 Pastiglie Mal di Gola?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eBenagol flavour Menthol. Eucalyptol: due to the presence of menthol and in case of non-compliance with the recommended doses, a risk of convulsions may occur in children and infants. Adverse reactions associated with the use of 2,4 dichlorobenzyl alcohol, amylmetacresol, levomenthol and ascorbic acid are listed below, divided by frequency and organ class. The frequencies are defined as: very common (\u0026gt;=1\/10); common (\u0026gt;=1\/100 and \u0026lt;1\/10); uncommon (\u0026gt;=1\/1000 and \u0026lt;1\/100); rare (\u0026gt;=1\/10000 and \u0026lt;1\/1000); very rare (\u0026lt;1\/10000); not known (frequency cannot be estimated from the available data). Within each frequency grouping, adverse reactions are presented in decreasing order of seriousness. Immune system disorders. Rare: hypersensitivity. Gastrointestinal disorders. Rare: glossitis; not known: abdominal pain, nausea, gastrointestinal discomfort. Skin and subcutaneous tissue disorders. Not known: rash.Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Benagol Honey and Lemon 36 Tablets Sore Throat\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eIn pregnant women and during breastfeeding, the product should be administered only in case of real need. Pregnancy: there are no, or limited, data on the use of the active ingredients of Benagol in pregnant women. Benagol Menthol-Eucalyptus flavour is not recommended during pregnancy and in women of childbearing age who do not use contraceptive measures. Breastfeeding: it is not known whether the active ingredients or their metabolites are excreted in breast milk. A risk for newborns and infants cannot be excluded. Ascorbic acid or its metabolites are excreted in breast milk. Fertility: no data on fertility are available. Benagol Menthol-Eucalyptus flavour is not recommended in women of childbearing age who do not use contraceptive measures.\u003c\/span\u003e\u003c\/p\u003e","brand":"RECKITT BENCKISER H.(IT.) SpA","offers":[{"title":"Default Title","offer_id":40207822946419,"sku":"016242149","price":15.72,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/reckitt-benckiser-h-it-spa-benagol-miele-e-limone-36-pastiglie-mal-di-gola-farmacia-dottor-tili-1213792763.webp?v=1767125572"},{"product_id":"moment-200mg-analgesico-36-compresse-rivestite","title":"Moment 200mg Analgesic 36 Coated Tablets","description":"\u003cp\u003eMoment 200 mg 36 Coated Tablets is an over-the-counter drug without a prescription based on ibuprofen, \u003cstrong\u003ean analgesic, anti-inflammatory and antipyretic molecule\u003c\/strong\u003e . Moment 36 Tablets is indicated for the treatment of \u003cstrong\u003epain of various origins and natures\u003c\/strong\u003e such as: \u003cstrong\u003eheadache, toothache\u003c\/strong\u003e , \u003cstrong\u003eneuralgia\u003c\/strong\u003e , \u003cstrong\u003eosteoarticular and muscular pain, menstrual pain\u003c\/strong\u003e .\u003c\/p\u003e\n\n\u003cp\u003e The \u003cstrong\u003eantipyretic action\u003c\/strong\u003e of ibuprofen in Moment 36 Tablets \u003cstrong\u003elowers temperature\u003c\/strong\u003e and contributes to the symptomatic treatment of feverish and flu-like conditions.\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Moment 200mg Analgesic 36 Coated Tablets - What is the active ingredient in Moment 200mg Analgesic 36 Coated Tablets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eEach coated tablet contains active substance: ibuprofen 200 mg. Excipients with known effect: sucrose, sodium. For a full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n \u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Moment 200mg Analgesic 36 Coated Tablets - What does Moment 200mg Analgesic 36 Coated Tablets contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eEach tablet contains: maize starch, sodium starch glycolate, povidone, colloidal anhydrous silica, talc, hydroxypropylcellulose, gum arabic, sucrose, macrogol 6000, light magnesium carbonate, titanium dioxide.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Moment 200 Mg Ibuprofen 12 Coated Tablets - Why is Moment 200mg Analgesic 36 Coated Tablets used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003ePain of various origins and natures (headache, toothache, neuralgia, osteo-articular and muscular pain, menstrual pain). Adjuvant in the symptomatic treatment of feverish and flu states.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eContraindications Moment 200mg Analgesic 36 Coated Tablets - When should Moment 200mg Analgesic 36 Coated Tablets not be used?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eHypersensitivity to the active substance, to other antirheumatics (acetylsalicylic acid, etc.) or to any of the excipients listed in section 6.1; children under 12 years of age; third trimester of pregnancy and breastfeeding (see section 4.6); active or severe gastroduodenal ulcer or other gastropathies; history of gastrointestinal bleeding or perforation related to previous active treatments or history of recurrent peptic ulcer\/haemorrhage (two or more distinct episodes of proven ulceration or bleeding); severe hepatic or renal insufficiency; severe cardiac insufficiency (NYHA class IV); severe dehydration (caused by vomiting, diarrhoea or insufficient fluid intake).\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eQuantity and method of taking Moment 200mg Analgesic 36 Coated Tablets - How to take Moment 200 Mg Ibuprofen 12 Coated Tablets?\u003c\/span\u003e\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eDosage, adults and adolescents over 12 years: 1-2 tablets, 2-3 times a day. Do not exceed the dose of 1200 mg (6 tablets) per day. If the use of the medicinal product is necessary for more than 3 days in adolescents aged 12 years and over, or in case of worsening of symptoms, a doctor should be consulted. Do not exceed the recommended doses. Elderly patients should adhere to the minimum dosages indicated above (see section 4.4). Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). Renal impairment: in patients with mild or moderate reduction of renal function, the dosage should be kept as low as possible for the shortest duration necessary to control symptoms and renal function should be monitored. Hepatic impairment: In patients with mild or moderate reduction of liver function, the dosage should be kept as low as possible for the shortest duration necessary to control symptoms and liver function should be monitored. Moment is contraindicated in patients with severe hepatic impairment (see section 4.3). Paediatric population: Moment is contraindicated in children under 12 years of age (see section 4.3). Method of administration: Moment can be taken on an empty stomach. In subjects with gastric tolerability problems, it is preferable to take the medicine on a full stomach.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Moment 200mg Analgesic 36 Coated Tablets - How to store Moment 200mg Analgesic 36 Coated Tablets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThis medicine does not require any special storage temperatures.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Moment 200mg Analgesic 36 Coated Tablets - About Moment 200mg Analgesic 36 Coated Tablets it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eIn asthmatic patients the product should be used with caution, following medical evaluation. The use of Moment, as with any drug inhibiting the synthesis of prostaglandins and cyclooxygenase is not recommended in women who intend to become pregnant. The administration of Moment should be suspended in women who have fertility problems or who are undergoing investigation of fertility. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see paragraphs below on gastrointestinal and cardiovascular risks). Elderly: elderly patients have an increased frequency of adverse reactions to NSAIDs, especially gastrointestinal bleeding and perforation, which may be fatal (see section 4.2). Cardiovascular and cerebrovascular effects Clinical trials suggest that use of ibuprofen, particularly at high doses (2400 mg\/day), may be associated with a modest increased risk of arterial thrombotic events (e.g. myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low doses of ibuprofen (e.g. \u0026lt;= 1200 mg\/day) are associated with an increased risk of arterial thrombotic events. Patients with uncontrolled hypertension, congestive heart failure (NYHA II-III), established ischaemic heart disease, peripheral arterial disease, and\/or cerebrovascular disease should only be treated with ibuprofen after careful consideration and high doses (2400 mg\/day) should be avoided. Careful consideration should also be exercised before initiating long-term treatment of patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking), particularly if high doses (2400 mg\/day) of ibuprofen are required. Caution is advised before initiating treatment in patients with a history of hypertension and\/or heart failure since fluid retention, hypertension and oedema have been reported in association with NSAID therapy. NSAIDs may reduce the effect of diuretics, unlike other antihypertensive agents (see section 4.5). Gastrointestinal bleeding, ulceration and perforation: the use of Moment should be avoided in combination with NSAIDs, including selective cyclooxygenase-2 (COX-2) inhibitors due to an increased risk of ulceration and bleeding (see section 4.5). Gastrointestinal bleeding, ulceration and perforation, which may be fatal, have been reported with all NSAIDs at anytime during treatment, with or without warning symptoms or a previous history of serious GI events. The risk of GI bleeding, ulceration or perforation is higher with increasing NSAID doses, in the elderly and in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation (see section 4.3). These patients should start treatment on the lowest dose available. Concomitant use of protective agents (e.g. misoprostol or proton pump inhibitors) should be considered for these patients, and also for patients taking low dose aspirin or other drugs likely to increase GI risk (see below and section 4.5). Patients with a history of GI toxicity, particularly when elderly, should report any unusual GI symptoms (especially GI bleeding) particularly in the initial stages of treatment. Carefully monitor patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin reuptake inhibitors or anti-platelet agents such as aspirin (see section 4.5). When gastrointestinal bleeding or ulceration occurs in patients receiving Moment, the treatment should be withdrawn. NSAIDs should be given with caution to patients with a history of gastrointestinal disease (ulcerative colitis, Crohn's disease) as these conditions may be exacerbated (see section 4.8). Renal effects: Caution should be exercised in patients with considerable dehydration when initiating treatment with ibuprofen. Ibuprofen may cause water, sodium and potassium retention in patients with no history of renal disease due to its effects on renal perfusion. This may lead to oedema or cardiac failure or hypertension in predisposed patients. Long-term use of ibuprofen, as with other NSAIDs, has led to renal papillary necrosis and other pathological renal changes. In general, the habitual use of analgesics, especially combinations of several analgesic active ingredients, can lead to permanent renal damage, with risk of onset of renal failure (analgesic nephropathy). Renal toxicity has been observed in patients in whom renal prostaglandins have a compensatory role in maintaining renal perfusion. The administration of NSAIDs in these patients may lead to a dose-dependent reduction in prostaglandin formation and, as a secondary effect, renal blood flow which can quickly lead to renal failure. Patients most at risk of these reactions are those with reduced renal function, heart failure, liver dysfunction, the elderly and all those patients taking diuretics and ACE inhibitors. Discontinuation of NSAID therapy is usually followed by recovery to the pre-treatment state. There is a risk of impaired renal function in dehydrated adolescents. In case of prolonged use, renal function should be monitored, particularly in cases of diffuse lupus erythematosus. Severe skin reactions: Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported rarely in association with the use of NSAIDs (see section 4.8). Patients appear to be at highest risk early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Acute generalized exanthematous pustulosis (AGEP) has been reported in relation to medicinal products containing ibuprofen.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Moment 200mg Analgesic 36 Coated Tablets - Which medicines or foods can modify the effect of Moment 200mg Analgesic 36 Coated Tablets?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eIbuprofen (like other NSAIDs) should be used with caution in combination with the substances listed below. Corticosteroids: increased risk of gastrointestinal ulceration or bleeding (see section 4.4). Anticoagulants: NSAIDs may increase the effects of anticoagulants, such as warfarin or heparin (see section 4.4). In case of concomitant treatment, monitoring of the coagulation status is recommended. Acetylsalicylic acid: concomitant administration of ibuprofen and acetylsalicylic acid is generally not recommended due to the potential for increased adverse effects. Experimental data suggest that ibuprofen may competitively inhibit platelet aggregation with low dose acetylsalicylic acid when the two drugs are administered concomitantly. Although there are uncertainties regarding the extrapolation of these data to the clinical situation, the possibility that regular, long-term use of ibuprofen may reduce the cardioprotective effect of low-dose acetylsalicylic acid cannot be excluded. No clinically relevant effect is considered likely following occasional use of ibuprofen (see section 5.1). Cyclooxygenase-2 (COX-2) inhibitors and other NSAIDs: These substances may increase the risk of adverse reactions affecting the gastrointestinal tract (see section 4.4). However, it is advisable not to combine ibuprofen with acetylsalicylic acid or other NSAIDs, including selective COX-2 inhibitors, due to the potential additive effect (see section 4.4). Anti-platelet agents and selective serotonin reuptake inhibitors (SSRIs): Increased risk of gastrointestinal bleeding (see section 4.4). Diuretics, ACE inhibitors (such as captopril), beta blockers and angiotensin II antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs. Diuretics may also increase the risk of nephrotoxicity associated with NSAIDs. In some patients with compromised renal function (e.g. dehydrated patients or elderly patients with compromised renal function) the co-administration of an ACE inhibitor or an angiotensin II antagonist and agents that inhibit cyclooxygenase may result in further deterioration of renal function, including possible acute renal failure, which is usually reversible. These interactions should be considered in patients taking Moment concomitantly with ACE inhibitors or angiotensin II antagonists. Therefore, the combination should be administered with caution, especially in elderly patients. Patients should be adequately hydrated and consideration should be given to monitoring renal function after initiation of concomitant therapy and thereafter. Phenytoin and lithium: Concomitant administration of ibuprofen and phenytoin or lithium preparations may result in reduced elimination of these drugs with consequent increase in their plasma levels with the possibility of reaching the toxic threshold. If this combination is deemed necessary, monitoring of plasma levels of phenytoin and lithium is recommended in order to adapt the dosage during concomitant treatment with ibuprofen. Methotrexate: NSAIDs may inhibit the tubular secretion of methotrexate and some metabolic interactions may occur resulting in reduced methotrexate clearance and increased risk of toxicity. Moclobemide: increases ibuprofen. Aminoglycosides: NSAIDs may decrease the excretion of aminoglycosides increasing toxicity. Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce the glomerular filtration rate and increase plasma levels of cardiac glycosides. Monitoring of serum glycoside levels is recommended. Cholestyramine: Concomitant administration of ibuprofen and cholestyramine may reduce the absorption of ibuprofen from the gastrointestinal tract. However, the clinical relevance of this interaction is unknown. Ciclosporin: Concomitant administration of ciclosporin and some NSAIDs causes an increased risk of renal damage. This effect cannot be excluded for the combination of ciclosporin and ibuprofen. Plant extracts: Ginkgo Biloba may increase the risk of bleeding in association with NSAIDs. Mifepristone: Due to the anti-prostaglandin properties of NSAIDs, their use after mifepristone administration may result in a reduction of mifepristone. Limited evidence suggests that co-administration of NSAIDs and prostaglandins on the same day does not adversely affect the effects of mifepristone or the prostaglandin on cervical ripening or uterine contractility and does not reduce the clinical efficacy of the medicinal product on pregnancy termination. Quinolone antibiotics: Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions. Sulfonylureas: NSAIDs may increase the hypoglycaemic effect of sulfonylureas. Monitoring of blood glucose levels is recommended in the case of simultaneous treatment. Tacrolimus: Co-administration of NSAIDs and tacrolimus may increase the risk of nephrotoxicity. Zidovudine: There is evidence of an increased risk of haemarthrosis and haematoma in HIV-positive haemophiliac patients receiving concomitant treatment with zidovudine and other NSAIDs. A blood test is recommended 1-2 weeks after starting treatment. Ritonavir: may cause an increase in plasma concentrations of NSAIDs. Probenecid: slows the excretion of ibuprofen, with possible increase in its plasma concentrations. CYP2C9 inhibitors: Concomitant administration of ibuprofen with CYP2C9 inhibitors may slow the elimination of ibuprofen (CYP2C9 substrate) resulting in increased exposure to ibuprofen. In a study with voriconazole and fluconazole (CYP2C9 inhibitors), an increased exposure to S(+)-ibuprofen of approximately 80% to 100% was observed. Consideration should be given to reducing the dose of ibuprofen when co-administered with strong CYP2C9 inhibitors, particularly when high doses of ibuprofen are administered with voriconazole or fluconazole. Alcohol, bisphosphonates and oxpentifylline (pentoxifylline): may enhance gastrointestinal side effects and the risk of bleeding and ulceration. Baclofen: high toxicity of baclofen.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Moment 200mg Analgesic 36 Coated Tablets can cause side effects - What are the side effects of Moment 200mg Analgesic 36 Coated Tablets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe undesirable effects observed with ibuprofen are generally common to other analgesics, antipyretics, non-steroidal anti-inflammatory drugs and are reported below using the following convention: very common (\u0026gt;=1\/10); common (\u0026gt;=1\/100, \u0026lt; 1\/10); uncommon (\u0026gt;= 1\/ 1,000, \u0026lt; 1\/100); rare (\u0026gt;=1\/10,000, \u0026lt; 1\/1,000); very rare (\u0026lt;1\/10,000); not known (frequency cannot be estimated from the available data). The most commonly observed adverse events are gastrointestinal in nature. Gastrointestinal disorders: peptic ulcers, perforation or gastrointestinal bleeding, sometimes fatal, particularly in the elderly, may occur (see section 4.4). Gastrointestinal perforation with the use of ibuprofen has been observed rarely. After administration of Moment the following have been reported: feeling of heaviness in the stomach, nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, epigastric pain, heartburn, abdominal pain, melaena, haematemesis, ulcerative stomatitis, exacerbation of colitis and Crohn's disease (see section 4.4). Uncommon: gastritis; very rare: pancreatitis. Immune system disorders: following treatment with NSAIDs the following undesirable effects have been reported: non-specific allergic reaction and anaphylaxis; uncommon: hypersensitivity reactions such as various types of skin rash, urticaria, pruritus, purpura, angioedema, exanthema, respiratory tract reactions including bronchospasm, dyspnoea, asthmatic attack (sometimes with hypotension); rare: lupus erythematosus syndrome; very rare: severe hypersensitivity reactions. Symptoms may include: severe asthma, facial oedema, tongue oedema, laryngeal oedema, airway oedema with bronchospasm, dyspnoea, tachycardia, anaphylaxis, exfoliative and bullous dermatitis. Cardiac and vascular disorders: Clinical trials suggest that use of ibuprofen, particularly at high doses (2400 mg\/day), may be associated with a small increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4). Very rare: palpitations, heart failure, myocardial infarction, acute pulmonary oedema, hypertension. Other adverse events for which causality has not necessarily been established include: Blood and lymphatic system disorders: Rare: leucopenia, thrombocytopenia, neutropenia, agranulocytosis, aplastic anaemia and haemolytic anaemia, inhibition of platelet aggregation. Psychiatric disorders. Uncommon: insomnia, anxiety; rare: depression, confusional state, hallucinations. Nervous system disorders. Common: dizziness; uncommon: paraesthesia, somnolence, rare: optic neuritis. Infections and infestations. Uncommon: rhinitis; rare: aseptic meningitis. Rhinitis and aseptic meningitis have been observed especially in patients with pre-existing autoimmune disorders (such as systemic lupus erythematosus and mixed connective tissue disease) with symptoms of stiff neck, headache, nausea, vomiting, fever or disorientation (see section 4.4). Exacerbation of infection-related inflammation (e.g. development of necrotising fasciitis) has been described. Respiratory, thoracic and mediastinal disorders. Uncommon: bronchospasm, dyspnoea, apnoea. Eye disorders. Uncommon: visual disturbances; rare: ocular impairment resulting in visual disturbances, toxic optic neuropathy. Ear and labyrinth disorders. Uncommon: impaired hearing, tinnitus, vertigo. Hepatobiliary disorders. Uncommon: abnormal liver function, hepatitis and jaundice; very rare: liver failure. Skin and subcutaneous tissue disorders. Allergic skin rashes (erythema, pruritus, urticaria) may occasionally occur. Uncommon: photosensitivity reactions; very rare: bullous dermatitis including Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme. In exceptional cases, serious skin infections and soft tissue disorders may occur during chickenpox infection (see \"Infections and infestations\"). Not known: drug reaction with eosinophilia and systemic symptoms (DRESS syndrome), acute generalized exanthematous pustulosis (AGEP). Renal and urinary disorders. Uncommon: impaired renal function and toxic nephropathy in various forms, including interstitial nephritis, nephrotic syndrome and renal failure; rare: azotaemia. General disorders and administration site conditions. Common: malaise, fatigue; rare: oedema. Diagnostic tests. Rare: increased transaminases, increased alkaline phosphatase, decreased haemoglobin, decreased haematocrit, prolonged bleeding time, decreased blood calcium, increased blood uric acid. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Moment 200mg Analgesic 36 Coated Tablets.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePregnancy: Inhibition of prostaglandin synthesis may adversely affect the pregnancy and\/or embryo\/fetal development. Results of epidemiological studies suggest an increased risk of miscarriage and cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increased from less than 1%, up to approximately 1.5%. The risk was believed to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to result in increased pre- and post-implantation loss and embryo-fetal mortality. In addition, an increased incidence of various malformations, including cardiovascular, has been reported in animals administered prostaglandin synthesis inhibitors during the organogenetic period. From the twentieth week of pregnancy onwards, the use of Moment may cause oligohydramnios resulting from fetal renal dysfunction. This may occur soon after initiation of treatment and is usually reversible upon discontinuation. In addition, cases of constriction of the ductus arteriosus have been reported after treatment in the second trimester, most of which resolved upon discontinuation of treatment. Therefore, during the first and second trimester of pregnancy, Moment should not be given unless clearly necessary. If Moment is used by a woman attempting to conceive or during the first and second trimester of pregnancy, the dose and duration of treatment should be kept as low as possible. Following exposure to Moment for several days from gestational week 20 onwards, antenatal monitoring for oligohydramnios and constriction of the ductus arteriosus should be considered. Moment should be discontinued if oligohydramnios or constriction of the ductus arteriosus is observed. During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose the fetus to: cardiopulmonary toxicity (premature constriction\/closure of the ductus arteriosus and pulmonary hypertension); renal dysfunction (see above); the mother and the neonate, at the end of pregnancy, to: possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses; inhibition of uterine contractions resulting in delayed or prolonged labor. Consequently, Moment is contraindicated during the third trimester of pregnancy (see and sections 4.3 and 5.3). Breast-feeding: Ibuprofen is excreted in breast milk, but at therapeutic doses during short-term treatment, the risk of influence on the neonate seems unlikely. If, however, treatment is longer term, early weaning should be considered. NSAIDs should be avoided during breast-feeding. Fertility: The use of Ibuprofen may impair female fertility and is not recommended in women attempting to conceive. This effect is reversible upon discontinuation of treatment. In women who have difficulties conceiving or who are undergoing investigation of infertility, discontinuation of ibuprofen should be considered.\u003c\/span\u003e\u003c\/p\u003e","brand":"ANGELINI SpA","offers":[{"title":"Default Title","offer_id":40207823011955,"sku":"025669185","price":14.42,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/angelini-spa-moment-200mg-analgesico-36-compresse-rivestite-farmacia-dottor-tili-1213792749.jpg?v=1767125589"},{"product_id":"lactoflorene-plus-fermenti-lattici-vivi-18-flaconcini-180-ml","title":"Lactoflorene Plus Live Lactic Ferments 18 vials 180 ml.","description":"\u003cp\u003eLactoflorene Plus is a food supplement based on \u003cstrong\u003elive lactic ferments with probiotic action\u003c\/strong\u003e enriched with \u003cstrong\u003eZinc and B vitamins\u003c\/strong\u003e . The Florene Blend (containing live and active lactic ferments) promotes the balance of intestinal bacterial flora. Taking Lactoflorene Plus Live Lactic Ferments is important when the \u003cstrong\u003ebacterial flora is deficient or altered\u003c\/strong\u003e , following the intake of \u003cstrong\u003eantibiotics or eating disorders\u003c\/strong\u003e that weaken it. \u003cstrong\u003eZinc contributes to the proper functioning of the immune system\u003c\/strong\u003e and to the protection of cells from oxidative stress. It also contains B vitamins.\u003c\/p\u003e\n\n\u003cp\u003eLactoflorene Plus Vivi Lactic Ferments is \u003cstrong\u003egluten-free and lactose-free.\u003c\/strong\u003e \u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\n\u003ch3 align=\"justify\"\u003eIngredients and nutritional characteristics Lactoflorene Plus Live Lactic Ferments 18 vials 180 ml.\u003c\/h3\u003e\n\n \u003cp\u003eIn the separator cap: hydrolyzed corn dextrin, maltodextrin, anti-caking agents: talc and silicon dioxide (nano); Florene Blend; (LA-5; (Lactobacillus acidophilus DSM13241), BB-12; (Bifidobacterium animalis subsp. lactis DSM15954) and L. CASEI 431; (Lactobacillus paracasei ATCC55544) with maltodextrin); brewer's yeast lysate (glucans), hydroxypropyl methylcellulose, sodium phosphate, Bacillus coagulans BC513 LMG S-24828 (maltodextrin). In the vial: purified water, fructose, honey, short-chain fructo-oligosaccharides, flavourings, zinc bisglycinate (maltodextrin from corn, cellulose, sodium carbonate), preservatives: potassium sorbate and sodium benzoate; acidifier: citric acid; Nicotinamide (Niacin), colour: caramel; Calcium D-pantothenate (Vitamin B5), Pyridoxine hydrochloride (Vitamin B6), Riboflavin (Vitamin B2), Thiamine hydrochloride (Vitamin B1), Cyanocobalamin (Vitamin B12, citric acid, corn maltodextrin, trisodium citrate).\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\n \u003ch3\u003e\u003cb\u003eHow to use Lactoflorene Plus Live Lactic Ferments 18 vials 180 ml.\u003c\/b\u003e\u003c\/h3\u003e\n\n\u003ch4\u003eHow to take Lactoflorene Plus Live Lactic Ferments 18 vials 180 ml.?\u003c\/h4\u003e\n\n\u003cp\u003eTake 1-2 vials of Lactoflorene Plus a day, preferably away from meals.\u003cbr\u003e \u003cstrong\u003eIn case of simultaneous administration of antibiotic therapies\u003c\/strong\u003e it is recommended to take Lactoflorene Plus a few hours after the drug.\u003c\/p\u003e\n\n\u003cp\u003e\u003cbr data-mce-fragment=\"1\"\u003eHow to take Lactoflorene Plus from the vial:\u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003eFirmly press the stopper with both thumbs so that its contents fall into the solution; this may require 2 shots.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp\u003eor\u003c\/p\u003e\n\n\u003cul\u003e\n\n \u003cli\u003ePlace the vial on a flat surface and push the stopper firmly all the way in with the palm of your hand.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eShake well before drinking the contents\u003c\/strong\u003e . During the opening of the vial it is possible to observe a slight leakage of the powders.\u003cbr data-mce-fragment=\"1\"\u003e\u003cbr data-mce-fragment=\"1\"\u003e\u003c\/p\u003e\n\n\u003ch3\u003e\u003cb\u003eWarnings Lactoflorene Plus Live Lactic Ferments 18 vials 180 ml.\u003c\/b\u003e\u003c\/h3\u003e\n\n\u003cp\u003eSupplements are not intended as substitutes for a varied, balanced diet and a healthy lifestyle.\u003cbr data-mce-fragment=\"1\"\u003e Keep out of the reach of children under 3 years of age.\u003cbr data-mce-fragment=\"1\"\u003e Do not exceed the recommended daily dose.\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch3\u003e\u003cb\u003eConservation Lactoflorene Plus Live Lactic Ferments 18 vials 180 ml.\u003c\/b\u003e\u003c\/h3\u003e\n\n \u003cp\u003eStore away from light in a cool, dry place. Validity with unopened package: 24 months. \u003cspan style=\"text-align: justify;\" data-mce-style=\"text-align: justify;\"\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"MONTEFARMACO OTC SpA","offers":[{"title":"Default Title","offer_id":40207823044723,"sku":"939143703","price":20.83,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/montefarmaco-otc-spa-lactoflorene-plus-fermenti-lattici-vivi-18-flaconcini-180-ml-farmacia-dottor-tili-1213792757.jpg?v=1767125690"},{"product_id":"magnesio-supremo-300-gr","title":"Supreme Magnesium 300 gr.","description":"\u003cp\u003e\u003cspan style=\"text-align: justify;\"\u003eMagnesium Supreme is a dietary supplement of magnesium, a mineral useful for combating \u003cstrong\u003etiredness and fatigue\u003c\/strong\u003e especially in periods of greater psycho-physical stress. Magnesium also \u003cstrong\u003esupports the physiological functioning of the muscles and nervous system\u003c\/strong\u003e .\u003c\/span\u003e Suitable for Vegans.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e \u003cstrong\u003eDOSAGE SCHEMES\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e The Cistite.info association in collaboration with numerous professionals in the sector has developed schemes that help to use this product in the correct ways and timing. Download them now from the links below!\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e \u003cstrong\u003eSchemes that include the product:\u003c\/strong\u003e \u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e\u003cspan style=\"color: #2b00ff;\"\u003e\u003c\/span\u003e\u003cspan style=\"color: #2b00ff;\"\u003e\u003c\/span\u003e \u003cspan style=\"color: #2b00ff;\"\u003e- \u003ca style=\"color: #2b00ff;\" title=\"Treat Prevent Chronic Cystitis\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Schema-Cura-Cistite-Cronica.pdf?v=1666792371\" data-mce-fragment=\"1\" target=\"_blank\"\u003eDownload the Chronic Cystitis diagram\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e \u003cstrong\u003eDiagrams that do not include the product:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e \u003cspan style=\"color: #2b00ff;\"\u003e- \u003ca style=\"color: #2b00ff;\" title=\"How to take D-mannose\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Assunzione-Mannosio-Schema.pdf?v=1666792371\" target=\"_blank\"\u003eDownload the generic D-mannose intake chart\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e \u003cspan style=\"color: #2b00ff;\"\u003e- \u003ca style=\"color: #2b00ff;\" title=\"Treating acute bacterial cystitis\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Schema-Cura-Cistite-Acuta.pdf?v=1666792371\" target=\"_blank\"\u003eDownload the Acute Cystitis diagram\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e \u003cspan style=\"color: #2b00ff;\"\u003e- \u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Schema-Cura-Cistite-Postcoitale.pdf?v=1666792371\" title=\"Cure Prevent Honeymoon Post Coital Cystitis\" style=\"color: #2b00ff;\" target=\"_blank\"\u003eDownload the Post-coital Cystitis diagram\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e\u003cspan style=\"color: #2b00ff;\"\u003e\u003c\/span\u003e \u003cspan style=\"color: #2b00ff;\"\u003e- \u003ca style=\"color: #2b00ff;\" title=\"Treat and prevent cystitis during pregnancy and breastfeeding\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Schema_gravidanza_allattamento.pdf?v=1666792371\" target=\"_blank\"\u003eDownload the Cystitis in Pregnancy and Breastfeeding chart\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e \u003cspan style=\"color: #2b00ff;\"\u003e- \u003ca style=\"color: #2b00ff;\" href=\"https:\/\/www.dottortili.it\/img\/cms\/Schema_Protocollo_Dada.pdf\"\u003eDownload\u003c\/a\u003e \u003ca style=\"color: #2b00ff;\" title=\"Treat Prevent Cystitis in Menopause\" href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/Schema_Protocollo_Dada.pdf?v=1666792371\" target=\"_blank\"\u003ethe Dada Cystitis in Menopause diagram\u003c\/a\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e\u003c\/p\u003e\n\u003cp style=\"margin-bottom: 12pt;\"\u003e \u003cb\u003eIngredients\u003c\/b\u003e\u003cbr\u003e Acidifier: citric acid, magnesium carbonate. Gluten free \u003cb\u003e.\u003c\/b\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv align=\"justify\"\u003e \u003cb\u003eNutritional characteristics\u003c\/b\u003e \u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\n\n\u003ctable border=\"1\" cellpadding=\"1\" cellspacing=\"0\" width=\"400\"\u003e\n\n\u003ctbody\u003e\n\n\u003ctr align=\"center\"\u003e\n\n\u003ctd\u003e Medium Contents\u003c\/td\u003e\n\n\u003ctd\u003e for 2 teaspoons\u003c\/td\u003e\n\n\u003ctd\u003e %NRV*\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\u003ctr\u003e\n\n\u003ctd\u003e Magnesium\u003c\/td\u003e\n\n\u003ctd align=\"center\"\u003e 430 mg\u003c\/td\u003e\n\n\u003ctd align=\"center\"\u003e 114.6\u003c\/td\u003e\n\n\n\u003c\/tr\u003e\n\n\n\u003c\/tbody\u003e\n\n\n\u003c\/table\u003e\n\n\u003cbr\u003e *Nutritional Reference Values according to EU Reg. 1169\/2011\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\n\n\u003cbr\u003e\u003cbr\u003e \u003cb\u003eHow to use\u003c\/b\u003e\u003cbr\u003e Dissolve one teaspoon of Supreme Magnesium (about 2.4 g) in hot water, once or twice a day. Wait until the powder has dissolved before drinking. Supreme Magnesium, once dissolved in water, transforms into magnesium citrate.\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\n\n\u003cbr\u003e\u003cbr\u003e \u003cb\u003eWarnings\u003c\/b\u003e\u003cbr\u003e Keep the package out of reach of children under three years. Do not exceed the recommended dose. Supplements are not intended as a substitute for a varied and balanced diet and a healthy lifestyle. \u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\n\n\u003cbr\u003e \u003cb\u003eConservation\u003c\/b\u003e\u003cbr\u003e Keep away from heat sources. Slight variations in taste and smell, from one batch to another, do not affect the quality and goodness of the product. \u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003cdiv align=\"justify\"\u003e\n\n\u003cbr\u003e \u003cb\u003eFormat\u003c\/b\u003e\u003cbr\u003e Net weight: 300 g.\u003c\/div\u003e","brand":"NATURAL POINT Srl","offers":[{"title":"Default Title","offer_id":40207823077491,"sku":"905972081","price":27.34,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/natural-point-srl-magnesio-supremo-300-gr-farmacia-dottor-tili-1213792759.jpg?v=1767125672"},{"product_id":"mag-2-orosolubile-20-bustine-2-25-g","title":"Mag 2 Orosolubile 20 Sachets 2.25 g","description":"\u003cp\u003e\u003cstrong\u003eMag 2 Orosolubile\u003c\/strong\u003e is a \u003cstrong\u003emagnesium\u003c\/strong\u003e -based food supplement formulated to combat magnesium deficiency states that can manifest themselves with tiredness, fatigue, muscle cramps or irritability. Magnesium is an essential mineral for the correct functioning of muscles, the nervous system and to reduce the feeling of tiredness and fatigue. The orosoluble sachets of Mag 2 offer a practical and fast method of intake, without the need for water.\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Mag 2 Orosolubile 20 Sachets 2.25 g - What is the active ingredient in Mag 2 Orosolubile 20 Sachets 2.25 g?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eOne vial of oral solution contains, active ingredient: 1,500 g of magnesium pidolate (corresponding to 122 mg of Mg^++ ion). Excipients with known effects: sucrose, sodium methyl parahydroxybenzoate E219, sodium propyl parahydroxybenzoate E217, ethanol (contained in the orange flavour excipient). One single-dose sachet of oral solution contains, active ingredient: 1,500 g of magnesium pidolate (corresponding to 122 mg of Mg^++ ion). Excipients with known effects: sucrose, sodium methyl parahydroxybenzoate E219, sodium propyl parahydroxybenzoate E217, ethanol (contained in the orange flavour excipient). One sachet of powder for oral solution contains, active ingredient: 2,250 g of magnesium pidolate (corresponding to 184 mg of Mg^++ ion). Excipients with known effect: sucrose. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Mag 2 Orosolubile 20 Sachets 2.25 g - What does Mag 2 Orosolubile 20 Sachets 2.25 g contain?\u003c\/span\u003e\n\u003c\/h2\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eMag2 1.5 g\/10 ml oral solution: sucrose, orange flavouring (containing ethanol), sodium methyl parahydroxybenzoate E 219, sodium propyl parahydroxybenzoate E217, purified water. Mag2 2.25 g powder for oral solution: sodium saccharin, citric acid monohydrate, sucrose, lemon flavouring.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eDIRECTIONS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Mag 2 Orosolubile 20 Sachets 2.25 g - Why is Mag 2 Orosolubile 20 Sachets 2.25 g used? What is it for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eMagnesium deficiency states.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eCONTRAINDICATIONS - SIDE EFFECTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Mag 2 Orosolubile 20 Sachets 2.25 g - When should Mag 2 Orosolubile 20 Sachets 2.25 g not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1; severe renal insufficiency (creatinine clearance less than 30 mL\/min); not to be administered to subjects undergoing digitalis therapy.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eDOSAGE\u003c\/span\u003e\n\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eQuantity and method of taking Mag 2 Orosolubile 20 Sachets 2.25 g - How do you take Mag 2 Orosolubile 20 Sachets 2.25 g?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eDosage, for adults only: 3 vials or 3 single-dose sachets of solution or 2 sachets of powder per day. Paediatric population: in children, the dosage may be established by a previously consulted doctor. Caution: use only for short periods of treatment. Instructions for use, Mag2 1.5 g\/10 ml oral solution: it is advisable to shake before use. To open the vial, twist the top and detach it. Take the contents of the vial as is or dilute it in water. Mag2 2.25 g powder for oral solution: dissolve the contents of one sachet in water.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eCONSERVATION\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Mag 2 Orosolubile 20 Sachets 2.25 g - How do you store Mag 2 Orosolubile 20 Sachets 2.25 g?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eOral solution: Store below 25 degrees C. Powder for oral solution: This medicine does not require any special storage conditions.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eWARNINGS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Mag 2 Orosolubile 20 Sachets 2.25 g - About Mag 2 Orosolubile 20 Sachets 2.25 g it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eIn case of concomitant calcium deficiency, magnesium deficiency should be corrected before administering supplemental calcium. In patients with moderate renal insufficiency, it is necessary to reduce the dosage and monitor renal function and magnesium levels, due to the risk associated with hypermagnesemia. It is advisable to consider the possibility that cardiovascular depression may occur during treatment. MAG2 oral solution contains sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. Parahydroxybenzoates (sodium methyl parahydroxybenzoate E219 and sodium propyl parahydroxybenzoate E217): may cause allergic reactions (possibly delayed); sodium: this medicine contains less than 1 mmol sodium (23 mg) per vial or sachet, i.e. essentially \"sodium-free\"; ethanol: This medicine contains 18 mg of alcohol (ethanol) in each vial or sachet, which is equivalent to 1.8 mg\/ml. The amount in each dose of this medicine is equivalent to less than 0.2 ml of wine or 0.5 ml of beer. The small amount of alcohol in this medicine will not produce any relevant effects. MAG2 powder for oral solution contains sucrose: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. Sodium: This medicine contains less than 1 mmol (23 mg) per dose, that is to say essentially 'sodium-free'.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Mag 2 Orosolubile 20 Sachets 2.25 g - Which medicines or foods can modify the effect of Mag 2 Orosolubile 20 Sachets 2.25 g?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eIn case of concomitant treatment with oral tetracyclines, the administration of MAG2 should be delayed by at least 3 hours. Quinolones should be administered at least 2 hours before or 6 hours after the administration of magnesium-containing products to avoid interference with their absorption. The concomitant administration of magnesium-containing products and cholecalciferol (vitamin D3) may lead to the onset of hypercalcemia. The concomitant use of preparations containing calcium or phosphate salts is not recommended because these products prevent intestinal absorption of magnesium. The simultaneous intake of magnesium-containing products with drugs that depress the Central Nervous System may potentiate the effects of magnesium on the CNS and should be carefully evaluated.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n \u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Mag 2 Orosolubile 20 Sachets 2.25 g can cause side effects - What are the side effects of Mag 2 Orosolubile 20 Sachets 2.25 g?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe following convention has been used for the classification of undesirable effects: very common \u0026gt;= 1\/10; common \u0026gt;= 1\/100 and \u0026lt; 1\/10; uncommon \u0026gt;= 1\/1,000 and \u0026lt; 1\/100; rare \u0026gt;= 1\/10,000 and \u0026lt; 1\/1,000); very rare \u0026lt; 1\/10,000 and not known (frequency cannot be estimated from the available data). Gastrointestinal disorders. Frequency Not known: gastrointestinal disorders, diarrhoea, abdominal pain. Skin and subcutaneous tissue disorders. Frequency not known: skin reactions. Immune system disorders. Frequency not known: hypersensitivity. Exceptional cases of individual intolerance to magnesium have been reported, which can be treated with oral or parenteral antihistamines. Reporting of suspected adverse reactions. Reporting of suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003cb\u003e \u003cbr\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Mag 2 Orosolubile 20 Sachets 2.25 g\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThere are limited data on the use of MAG2 in pregnant women. However, no conclusions can be drawn as to whether the use of MAG2 is safe during pregnancy. MAG2 can be used during pregnancy only if the potential benefits to the mother outweigh the potential risks, including those to the fetus. Magnesium is considered compatible with breastfeeding.\u003c\/span\u003e\u003c\/p\u003e","brand":"SANOFI SpA","offers":[{"title":"Default Title","offer_id":40207823143027,"sku":"025519048","price":16.65,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/sanofi-spa-mag-2-orosolubile-20-bustine-2-25-g-farmacia-dottor-tili-1213792760.jpg?v=1767125746"},{"product_id":"aspirina-dolore-infiammazione-20-compresse-500-mg","title":"Aspirin Pain Inflammation 20 Tablets 500mg","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eAspirin Pain and Inflammation\u003c\/span\u003e \u003cspan\u003eis a drug based on\u003c\/span\u003e \u003cspan\u003eacetylsalicylic acid\u003c\/span\u003e \u003cspan\u003e(500 mg per tablet) indicated for the symptomatic treatment of mild and moderate pain, as well as to reduce inflammatory conditions. Thanks to its analgesic, anti-inflammatory and antipyretic properties, Aspirin is effective in reducing muscle pain, headache, toothache and in controlling fever.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Aspirin Pain Inflammation 20 Tablets 500 mg - What is the active ingredient of Aspirin Pain Inflammation 20 Tablets 500 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eEach tablet contains 500 mg of acetylsalicylic acid. Excipients with known effect: One coated tablet contains 3.12 mmol (or 71.7 mg) of sodium. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eComposition of Aspirin Pain Inflammation 20 Tablets 500 mg - What does Aspirin Pain Inflammation 20 Tablets 500 mg contain?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eTablet core: colloidal silicon dioxide, sodium carbonate. Coating: carnauba wax, hypromellose, zinc stearate.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Aspirin Pain Inflammation 20 Tablets 500 mg - Why is Aspirin Pain Inflammation 20 Tablets 500 mg used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eSymptomatic treatment of fever and\/or mild to moderate pain, such as headache, flu-like syndrome, toothache, muscle aches.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Aspirin Pain Inflammation 20 Tablets 500 mg - When should Aspirin Pain Inflammation 20 Tablets 500 mg not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e\/SECONDARY EFFECTS Hypersensitivity to acetylsalicylic acid or other salicylates, or to any of the excipients listed in section 6.1; history of asthma or hypersensitivity reactions (e.g. urticaria, angioedema, severe rhinitis, shock) induced by the administration of salicylates or substances with a similar action, in particular non-steroidal anti-inflammatory drugs (NSAIDs); active peptic ulcer; haemorrhagic diathesis; severe renal insufficiency (GFR \u0026lt; 30 ml\/min\/ 1.73 m^2); severe hepatic insufficiency; severe uncontrolled cardiac insufficiency; concomitant administration of methotrexate in doses greater than 15 mg per week, for anti-inflammatory doses of acetylsalicylic acid, or for analgesic or antipyretic doses (see section 4.5); concomitant administration of oral anticoagulants for anti-inflammatory doses of acetylsalicylic acid, or for analgesic or antipyretic doses and in patients with a history of gastroduodenal ulcers (see section 4.5); from the beginning of the sixth month of pregnancy (beyond the twenty-fourth week of amenorrhea) (see section 4.6); children and adolescents under 16 years of age.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Aspirin Pain Inflammation 20 Tablets 500 mg - How to take Aspirin Pain Inflammation 20 Tablets 500 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eDosage. Adults and children (16 years and older): 1 to 2 tablets for each dose to be repeated as needed after a minimum period of 4 hours. The maximum daily dose must not exceed 6 tablets. Elderly (65 years and older): 1 tablet for each dose to be repeated as needed after a minimum period of 4 hours. The maximum daily dose must not exceed 4 tablets. Acetylsalicylic acid should not be taken for more than 3 days (in case of fever) or 3 - 4 days (in case of pain) unless otherwise indicated by the doctor. Paediatric population: Acetylsalicylic acid should not be used in children and children under 16 years without a medical prescription. Acetylsalicylic acid should be used with caution in patients with abnormal liver or kidney function or with circulatory problems. Method of administration: for oral use. The tablets should be taken with an adequate amount of water. To open the strip, tear from the edge in any position.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Aspirin Pain Inflammation 20 Tablets 500 mg - How do you store Aspirin Pain Inflammation 20 Tablets 500 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eDo not store above 30 degrees C. Store in the original package to protect from light and moisture.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Aspirin Pain Inflammation 20 Tablets 500 mg - About Aspirin Pain Inflammation 20 Tablets 500 mg it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eIn case of combination with other medicinal products, to avoid any risk of overdose, check that acetylsalicylic acid is not in the composition of these other medicinal products. Reye's syndrome, a very rare and potentially fatal disease, has been described in children with symptoms of viral infections (especially chickenpox and flu-like episodes) with or without taking acetylsalicylic acid. Consequently, acetylsalicylic acid should be administered to children in these conditions only after medical advice and when other measures have proven ineffective. In case of persistent vomiting, altered state of consciousness or abnormal behaviour, treatment with acetylsalicylic acid should be stopped. In case of prolonged administration of high dose analgesics, the headache attack should not be treated with higher doses. Regular use of analgesics, especially a combination of analgesics, may lead to permanent kidney damage, with risk of kidney failure. The medicinal product should be used with particular caution in the following cases: patients with mild to moderate renal impairment (GFR \u0026gt;= 30 to \u0026lt; 90 ml\/min\/ 1.73 m^2) or patients with impaired cardiovascular circulation (e.g. renal vascular disease, congestive heart failure, volume depletion, major surgery, sepsis or major haemorrhagic events) since acetylsalicylic acid may further increase the risk of renal impairment and acute renal failure. In some severe forms of G6PD deficiency, high doses of acetylsalicylic acid may cause haemolysis. In case of G6PD deficiency, acetylsalicylic acid should be administered under medical supervision. Treatment monitoring should be intensified in the following cases: in patients with a history of gastric or duodenal ulcer, gastrointestinal bleeding, or gastritis; in patients with renal insufficiency; in patients with hepatic insufficiency; in patients with asthma: the occurrence of an asthma attack, in some patients, may be linked to an allergy to nonsteroidal anti-inflammatory drugs or to acetylsalicylic acid; in this case, this medicinal product is contraindicated (see section 4.3); in patients with metrorrhagia or menorrhagia (risk of an increase in the volume and duration of the cycle). Gastrointestinal bleeding or ulcers\/perforations may occur at any time during treatment, without necessarily having any warning signs or medical history in the patient. The relative risk increases in elderly subjects, in subjects with low body weight, and in patients receiving anticoagulants or platelet aggregation inhibitors (see section 4.5). In case of gastrointestinal bleeding, treatment must be stopped immediately. Given the inhibitory effect of acetylsalicylic acid on platelet aggregation, which occurs even at very low doses and persists for several days, the patient should be aware of the risk of haemorrhage in case of surgical interventions, even minor ones (e.g. tooth extraction). In analgesic or antipyretic doses, acetylsalicylic acid inhibits the excretion of uric acid; in doses used in rheumatology (anti-inflammatory doses), acetylsalicylic acid has a uricosuric effect. The use of this medicinal product is not recommended during breastfeeding (see section 4.6). The administration of acetylsalicylic acid is not recommended with: oral anticoagulants with analgesic or antipyretic doses of acetylsalicylic acid (\u0026gt;=500 mg per administration and\/or \u0026lt; 3 g per day) and in patients without a history of gastro-duodenal ulcers (see section 4.5); other nonsteroidal anti-inflammatory drugs (NSAIDs) with anti-inflammatory doses of acetylsalicylic acid (\u0026gt;= 1 g per administration and\/or \u0026gt;=3 g per day) or with analgesic or antipyretic doses of acetylsalicylic acid (\u0026gt;=500 mg per administration and\/or \u0026lt; 3 g per day) (see section 4.5). Low molecular weight heparins (and related molecules) and unfractionated heparins with therapeutic doses or in elderly patients (\u0026gt;65 years) regardless of the heparin dose, and for anti-inflammatory doses of acetylsalicylic acid (\u0026gt;= 1 g per administration and\/or \u0026gt;= 3 g per day) or with analgesic or antipyretic doses of acetylsalicylic acid (\u0026gt;=500 mg per administration and\/or \u0026lt; 3 g per day) (see section 4.5). Clopidogrel (beyond the approved indications for this combination in patients with acute coronary disease) (see section 4.5). Ticlopidine (see section 4.5); uricosurics (see section 4.5); glucocorticoids (except hydrocortisone replacement therapy) for anti-inflammatory doses of acetylsalicylic acid (\u0026gt;= 1g per administration and\/or \u0026gt;= 3g per day) (see section 4.5); pemetrexed in patients with mild to moderately reduced renal function (creatinine clearance between 45 ml\/min and 80 ml\/min) (see section 4.5); anagrelide: increased risk of haemorrhage and decreased antithrombotic effect (see section 4.5). Important information about some of the excipients This medicinal product contains 71.7 mg sodium per dose equivalent to 3.6% of the WHO recommended maximum daily intake of 2 g sodium for an adult.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Aspirin Pain Inflammation 20 Tablets 500 mg - Which medicines or foods can modify the effect of Aspirin Pain Inflammation 20 Tablets 500 mg?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eIn the following text, the following definitions apply: Anti-inflammatory doses of acetylsalicylic acid are defined as \"\"\u0026gt;= 1g per administration and\/or \u0026gt;= 3g per day\"\". Analgesic or antipyretic doses of acetylsalicylic acid are defined as \"\"\u0026gt;=500 mg per administration and\/or \u0026lt; 3 g per day\"\" Several substances give rise to interactions, due to their properties of platelet aggregation inhibitors: abciximab, acetylsalicylic acid, cilostazol, clopidogrel, epoprostenol, eptifibatide, iloprost, iloprost trometamol, prasugrel, ticlopidine, tirofiban, ticagrelor. The risk of bleeding increases with the use of multiple platelet aggregation inhibitors as well as with their use in combination with heparin or related molecules, oral anticoagulants or other thrombolytics, and must be assessed through constant clinical monitoring. Contraindicated combinations (see section 4.3): Methotrexate in doses greater than 15 mg per week, with anti-inflammatory doses of acetylsalicylic acid, or with analgesic or antipyretic doses of acetylsalicylic acid: increased toxicity of methotrexate, in particular haematological toxicity (due to reduced renal elimination of methotrexate caused by acetylsalicylic acid). Oral anticoagulants with anti-inflammatory doses of acetylsalicylic acid, or with analgesic or antipyretic doses of acetylsalicylic acid and in patients with a history of gastroduodenal ulcers: increased risk of haemorrhage. Combinations not recommended: Oral anticoagulants with analgesic or antipyretic doses of acetylsalicylic acid and in patients without a history of gastroduodenal ulcers: increased risk of haemorrhage. Other nonsteroidal anti-inflammatory drugs (NSAIDs) with anti-inflammatory doses of acetylsalicylic acid, or with analgesic or antipyretic doses of acetylsalicylic acid: increased risk of gastrointestinal ulcers and haemorrhage. Low molecular weight heparins (and related molecules) and unfractionated heparins at curative doses, or in elderly patients (\u0026gt;=65 years) regardless of the heparin dose, and for anti-inflammatory doses of acetylsalicylic acid or analgesic or antipyretic doses of acetylsalicylic acid: increased risk of haemorrhage (inhibition of platelet aggregation and aggression of the gastroduodenal mucosa by acetylsalicylic acid). Another anti-inflammatory drug, or another analgesic or antipyretic should be used. Clopidogrel (outside the approved indication for this combination in patients with acute coronary syndrome): increased risk of haemorrhage. If concomitant administration cannot be avoided, clinical monitoring is recommended. Ticlopidine: increased risk of haemorrhage. If concomitant administration cannot be avoided, clinical monitoring is recommended. Uricosurics (benzbromarone, probenecid): decreased uricosuric effect due to competition for uric acid elimination in the renal tubules. Glucocorticoids (excluding hydrocortisone replacement therapy) for anti-inflammatory doses of acetylsalicylic acid: increased risk of haemorrhage. Pemetrexed in patients with mild to moderate renal impairment (creatinine clearance between 45 ml\/min and 80 ml\/min); increased risk of pemetrexed toxicity (due to decreased renal elimination of pemetrexed caused by acetylsalicylic acid) anti-inflammatory doses of acetylsalicylic acid. Anagrelide: Increased risk of haemorrhage and decreased antithrombotic effect. If concomitant administration cannot be avoided, clinical monitoring is recommended. Combinations requiring precautions for use: diuretics, angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor antagonists, with anti-inflammatory doses of acetylsalicylic acid or with analgesic or antipyretic doses of acetylsalicylic acid: Acute renal failure may occur in dehydrated patients due to a reduction in glomerular filtration rate resulting from decreased synthesis of renal prostaglandins. In addition, there may be a reduction in the antihypertensive effect. Ensure that the patient is hydrated and that renal function is monitored at the start of treatment. Methotrexate in doses \u0026lt;= 15 mg per week, with anti-inflammatory doses of acetylsalicylic acid, or with analgesic or antipyretic doses of acetylsalicylic acid: Increased toxicity of methotrexate, particularly haematological toxicity (due to reduced renal elimination of methotrexate caused by acetylsalicylic acid). Blood counts should be monitored weekly during the first weeks of concomitant administration. Patients with reduced renal function (even mild) and elderly patients should be closely monitored. Clopidogrel (in the approved indication for this combination in patients with acute coronary syndrome): Increased risk of haemorrhage. Clinical monitoring is recommended. Gastrointestinal topical treatments, antacids and activated charcoal: Increased renal excretion of acetylsalicylic acid due to alkalinisation of urine. It is recommended that antacids and topical gastrointestinal treatments be administered at least two hours after acetylsalicylic acid. Pemetrexed in patients with normal renal function: increased risk of pemetrexed toxicity (due to decreased renal elimination of pemetrexed caused by acetylsalicylic acid) with anti-inflammatory doses of acetylsalicylic acid. Renal function should be monitored. Combinations that should be considered: glucocorticoids (excluding hydrocortisone replacement therapy) for analgesic and antipyretic doses of acetylsalicylic acid: increased risk of haemorrhage. Deferasirox: with anti-inflammatory doses of acetylsalicylic acid, or with analgesic or antipyretic doses of acetylsalicylic acid: increased risk of gastrointestinal ulcers and haemorrhage.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Aspirin Pain Inflammation 20 Tablets 500 mg can cause side effects - What are the side effects of Aspirin Pain Inflammation 20 Tablets 500 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eFrequencies: Not known (cannot be estimated from the available data). Blood and lymphatic system disorders: Bleeding and tendency to bleed (epistaxis, bleeding gums, purpura, etc.) with increased bleeding time. The risk of bleeding may persist for 4-8 days after stopping acetylsalicylic acid. May cause an increased risk of haemorrhage in case of surgery. Intracranial and gastrointestinal haemorrhages may also occur. Immune system disorders: Hypersensitivity reactions, anaphylactic reactions, asthma, angioedema. Nervous system disorders: Headache, dizziness, sensation of hearing loss, tinnitus, usually indicating an overdose. Intracranial haemorrhage. Gastrointestinal disorders: Abdominal pain. Occult or overt gastrointestinal haemorrhage (haematemesis, melaena, etc.) resulting in iron deficiency anaemia. The risk of bleeding is dose-related. Gastric ulcers and perforations. Intestinal diaphragm disease (especially in long-term treatment). Renal and urinary disorders: renal impairment and acute kidney injury have been reported. Hepatobiliary disorders: elevated liver enzymes usually reversible with discontinuation of treatment, liver damage, mainly hepatocellular in nature. Skin and subcutaneous tissue disorders: urticaria, rash. General disorders: Reye's syndrome (see section 4.4). Reporting of adverse reactions It is important to report adverse reactions after authorisation of the medicinal product. This allows continued monitoring of the risk-benefit ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the website: https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Aspirin Pain Inflammation 20 Tablets 500 mg\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eInflammation 20 Tablets 500 mg Pregnancy: Inhibition of prostaglandin synthesis may adversely affect the course of pregnancy and\/or embryo-foetal development. Data from epidemiological studies suggest an increased risk of miscarriage, cardiac malformations and gastroschisis following the use of prostaglandin synthesis inhibitors in early pregnancy. The absolute risk of cardiovascular malformations is increased from not less than 1% to approximately 1.5%. The risk appears to increase with dose and duration of treatment. In animals, administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post-implantation loss and embryo-foetal mortality. In addition, an increased incidence of various malformations, including cardiovascular, has been reported in animals given a prostaglandin synthesis inhibitor during the organogenetic period of gestation. From the twentieth week of pregnancy onwards, the use of acetylsalicylic acid may cause oligohydramnios resulting from fetal renal dysfunction. This condition may be encountered soon after the start of treatment and is usually reversible upon discontinuation of treatment. In addition, cases of constriction of the ductus arteriosus have been reported following treatment in the second trimester, most of which resolved after discontinuation of treatment. Therefore, during the first 24 weeks of amenorrhea, acetylsalicylic acid should not be administered unless clearly necessary. If acetylsalicylic acid is used by a woman planning a pregnancy, or during the first 24 weeks of amenorrhea, the lowest possible dose should be used for the shortest possible duration. Following exposure to acetylsalicylic acid for several days from the 20th week of gestation onwards, antenatal monitoring for oligohydramnios and constriction of the ductus arteriosus should be considered. If oligohydramnios or constriction of the ductus arteriosus occurs, treatment with acetylsalicylic acid should be discontinued. Beyond the 24th week of amenorrhea, all prostaglandin synthesis inhibitors may expose the fetus to: cardiopulmonary toxicity (premature constriction\/closure of the ductus arteriosus and pulmonary hypertension); renal dysfunction (see above); in the final phase of pregnancy, the mother and the neonate may experience: prolongation of bleeding time, due to inhibition of platelet aggregation which may occur even at very low doses of acetylsalicylic acid; inhibition of uterine contractions resulting in delay or prolongation of labor. Consequently, acetylsalicylic acid is contraindicated after the 5th month of pregnancy (over 24 weeks of amenorrhea) (see section 4.3). Breastfeeding. Acetylsalicylic acid passes into breast milk: therefore the use of acetylsalicylic acid is not recommended during breastfeeding (see section 4.4). Fertility: There is some evidence that drugs that inhibit cyclooxygenase\/prostaglandin synthesis may cause impairment of female fertility due to an effect on ovulation. This effect is reversible upon discontinuation of treatment.\u003c\/span\u003e\u003c\/p\u003e","brand":"BAYER SpA","offers":[{"title":"Default Title","offer_id":40207823208563,"sku":"041962034","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/bayer-spa-aspirina-dolore-infiammazione-20-compresse-500-mg-farmacia-dottor-tili-1213792747.jpg?v=1767125728"},{"product_id":"spray-nasale-physiomer-ipertonico-confezione-135-ml","title":"Physiomer Hypertonic Nasal Spray 135 ml","description":"\u003cp\u003e\u003cstrong\u003ePhysiomer Hypertonic\u003c\/strong\u003e is a nasal spray indicated for decongestion of the nasal passages. Formulated with a hypertonic solution of sea water, Physiomer offers a natural and gentle action, helping to reduce swelling of the nasal mucosa and improving breathing. Thanks to its composition free of chemical additives, Physiomer is suitable for daily use and can also be used by people with sensitivity to traditional decongestant drugs.\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Physiomer Hypertonic?\u003c\/h3\u003e\n\n\u003cp\u003e 1. \u003cstrong\u003eNose cleaning\u003c\/strong\u003e : Gently blow your nose before use.\u003c\/p\u003e\n\n\u003cp\u003e 2. \u003cstrong\u003eApplication\u003c\/strong\u003e : Hold the bottle upright and tilt your head slightly. Insert the spray nozzle into one nostril and gently press to spray the solution. Repeat the process in the other nostril.\u003c\/p\u003e\n\n         \u003cp\u003e3. \u003cstrong\u003eFrequency of use\u003c\/strong\u003e : It is recommended to use Physiomer Hypertonic 1 to 3 times a day, or as needed. After use, wash and dry the nozzle.\u003c\/p\u003e\n\n\n\u003ch2\u003e Package Contents\u003c\/h2\u003e\n\n\u003ch3\u003e What does the Physiomer Hypertonic package contain?\u003c\/h3\u003e\n\n\u003cp\u003e The \u003cstrong\u003ePhysiomer Hypertonic\u003c\/strong\u003e package contains a \u003cstrong\u003e135 ml\u003c\/strong\u003e bottle of hypertonic sea water solution, rich in minerals and natural trace elements. The spray is equipped with an ergonomic nozzle for easy and comfortable application.\u003c\/p\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings of Physiomer Hypertonic?\u003c\/h3\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e Avoid use in case of hypersensitivity to any of the ingredients.\u003c\/li\u003e\n\n\u003cli\u003e Do not use the product if the bottle or nozzle is damaged.\u003c\/li\u003e\n\n\u003cli\u003e Do not use if you have any lesions or acute nasal infections without consulting your doctor.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children.\u003c\/li\u003e\n\n\u003cli\u003e If symptoms persist, consult a doctor.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n         \u003ch2\u003eExpiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration and storage conditions of Physiomer Hypertonic?\u003c\/h3\u003e\n\n\u003cp\u003e Store \u003cstrong\u003ePhysiomer Hypertonic\u003c\/strong\u003e at room temperature, away from heat and direct light. Avoid contact with contaminated surfaces to keep the product hygienic. Do not use after the expiry date shown on the package.\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e Physiomer Hypertonic is available in a \u003cstrong\u003e135 ml\u003c\/strong\u003e spray bottle, easy to use and ideal for precise and hygienic application.\u003c\/p\u003e\n\n","brand":"PERRIGO ITALIA Srl","offers":[{"title":"Default Title","offer_id":40207823339635,"sku":"931340804","price":14.79,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/perrigo-italia-srl-spray-nasale-physiomer-ipertonico-confezione-135-ml-farmacia-dottor-tili-1213792754.jpg?v=1767125808"},{"product_id":"mag-notte-24-bustine-orosolubili","title":"Mag Notte 24 Orosoluble Sachets","description":"\u003cp\u003e\u003cstrong\u003eMag Notte\u003c\/strong\u003e is a food supplement based on \u003cstrong\u003emagnesium\u003c\/strong\u003e , \u003cstrong\u003emelatonin\u003c\/strong\u003e and natural extracts such as \u003cstrong\u003ehawthorn\u003c\/strong\u003e and \u003cstrong\u003epassionflower\u003c\/strong\u003e , specially formulated to promote relaxation and improve the quality of sleep. This supplement helps reduce the time it takes to fall asleep and contributes to a deeper and more restful sleep. The orosoluble sachets are convenient to use and offer rapid intake, without the need for water.\u003c\/p\u003e\n\n\n\u003ch2\u003e Dosage and method of use\u003c\/h2\u003e\n\n\u003ch3\u003e How to take Mag Notte?\u003c\/h3\u003e\n\n\u003cp\u003e It is recommended to take \u003cstrong\u003e1 sachet\u003c\/strong\u003e per day, preferably in the evening, just before bedtime. The orosoluble sachets can be taken directly without water, making the intake practical and fast. It is recommended to follow a treatment cycle for at least 15-30 days to obtain the best results.\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Mag Notte contain?\u003c\/h3\u003e\n\n         \u003cp\u003eMag Notte contains a combination of natural and nutritional ingredients designed to promote relaxation and sleep:\n\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eMagnesium\u003c\/strong\u003e : essential for the normal functioning of the nervous system and to reduce tiredness.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eMelatonin\u003c\/strong\u003e : helps reduce the time it takes to fall asleep.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003ePassionflower\u003c\/strong\u003e : a natural extract with relaxing and anxiolytic properties.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eHawthorn\u003c\/strong\u003e : promotes relaxation and mental well-being, supporting sleep.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eVitamin B6\u003c\/strong\u003e : supports normal psychological function and contributes to the reduction of tiredness and fatigue.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Average analysis\u003c\/h2\u003e\n\n\u003cp\u003e Each sachet of Mag Notte contains:\n\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eMagnesium\u003c\/strong\u003e : 150 mg (40% NRV*)\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eMelatonin\u003c\/strong\u003e : 1 mg\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003ePassionflower dry extract\u003c\/strong\u003e : 100 mg\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eHawthorn dry extract\u003c\/strong\u003e : 100 mg\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eVitamin B6\u003c\/strong\u003e : 1.4 mg (100% VNR*)\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp\u003e *Nutritional Reference Values ​​(NRV)\u003c\/p\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings of Mag Notte?\u003c\/h3\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e Do not exceed the recommended daily dose.\u003c\/li\u003e\n\n\u003cli\u003e Food supplements are not a substitute for a varied and balanced diet.\u003c\/li\u003e\n\n\u003cli\u003e Consult your doctor before use if you are pregnant, breastfeeding or have any medical conditions.\u003c\/li\u003e\n\n\u003cli\u003e Store in a cool, dry place, away from heat sources and direct light.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e Mag Notte is available in a pack of \u003cstrong\u003e24 orosoluble sachets\u003c\/strong\u003e . The sachets are practical to carry with you and allow for rapid intake without the need for water.\u003c\/p\u003e\n\n","brand":"SANOFI SpA","offers":[{"title":"Default Title","offer_id":40207823372403,"sku":"933194728","price":13.86,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/sanofi-spa-mag-notte-24-bustine-orosolubili-farmacia-dottor-tili-1213792756.jpg?v=1767125790"},{"product_id":"durex-natural-gel-100-ml","title":"Durex Natural Gel 100ml","description":"\u003cp\u003e\u003cstrong\u003eDurex Natural Gel\u003c\/strong\u003e is a water-based intimate lubricant designed to improve comfort during sexual intercourse. This gel is formulated to reduce friction and relieve vaginal dryness, providing a smoother and more pleasurable experience. Durex Natural Gel is condom compatible and can be used with both latex and polyurethane, providing protection and safety without compromising the effectiveness of the condom.\u003c\/p\u003e\n\n\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\n\u003ch3\u003e When is Durex Natural Gel indicated?\u003c\/h3\u003e\n\n\u003cp\u003e Durex Natural Gel is indicated for:\n\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eRelieve vaginal dryness\u003c\/strong\u003e and discomfort associated with sexual intercourse.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eImprove comfort\u003c\/strong\u003e during intercourse by reducing friction.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eCompatibility with condoms\u003c\/strong\u003e , ideal for combined use during intercourse.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Durex Natural Gel?\u003c\/h3\u003e\n\n         \u003cp\u003eApply a small amount of gel directly to intimate areas or the outside of the condom. Add more gel during intercourse if necessary. Durex Natural Gel can be used with any type of Durex condom or without a condom. It is easy to rinse and leaves no sticky residue. It is recommended to reapply the gel if the feeling of dryness persists.\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Durex Natural Gel contain?\u003c\/h3\u003e\n\n\u003cp\u003e Durex Natural Gel is formulated with water-based ingredients that are gentle and safe for everyday use. Ingredients include:\n\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e \u003cstrong\u003eWaterfall\u003c\/strong\u003e\n\u003c\/li\u003e\n\n\u003cli\u003e \u003cstrong\u003eGlycerine\u003c\/strong\u003e\n\u003c\/li\u003e\n\n\u003cli\u003e \u003cstrong\u003eCarbomer\u003c\/strong\u003e\n\u003c\/li\u003e\n\n\u003cli\u003e \u003cstrong\u003eSodium hydroxide\u003c\/strong\u003e\n\u003c\/li\u003e\n\n\u003cli\u003e \u003cstrong\u003eSodium benzoate\u003c\/strong\u003e\n\u003c\/li\u003e\n\n\u003cli\u003e \u003cstrong\u003ePotassium sorbate\u003c\/strong\u003e\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Durex Natural Gel?\u003c\/h3\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\n\n         \u003cli\u003eAvoid contact with eyes. If irritation occurs, discontinue use and consult a physician.\u003c\/li\u003e\n\n\u003cli\u003e Do not use if you are allergic to any of the listed ingredients.\u003c\/li\u003e\n\n\u003cli\u003e It is not a contraceptive and does not contain spermicide.\u003c\/li\u003e\n\n\u003cli\u003e Store in a cool, dry place, away from heat sources and direct sunlight.\u003c\/li\u003e\n\n\u003cli\u003e Use within three months of opening the bottle.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Durex Natural Gel?\u003c\/h3\u003e\n\n\u003cp\u003e Store Durex Natural Gel below 25°C. Once opened, use within three months. Do not use after the expiry date shown on the package. Keep out of reach of children.\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e Durex Natural Gel is available in a \u003cstrong\u003e100 ml\u003c\/strong\u003e bottle, equipped with a practical dispenser that allows for easy and precise application.\u003c\/p\u003e\n\n","brand":"RECKITT BENCKISER H.(IT.) SpA","offers":[{"title":"Default Title","offer_id":40207823405171,"sku":"971377561","price":13.95,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/reckitt-benckiser-h-it-spa-durex-natural-gel-100-ml-farmacia-dottor-tili-1213792755.jpg?v=1767125771"},{"product_id":"profilattico-ansell-akuel-skin-elite-6-pezzi","title":"Ansell Akuel Skin Elite Condom 6 Pieces","description":"\u003cp\u003e \u003cstrong\u003eAkuel Skin Elite\u003c\/strong\u003e is an ultra-thin condom, designed to offer a natural sensory experience and a high level of protection. Made of \u003cstrong\u003enatural rubber latex\u003c\/strong\u003e , these condoms are transparent and lubricated, ensuring safety and comfort during sexual intercourse. Thanks to their thinness, Akuel Skin Elite allows for greater sensitivity, without compromising protection against unwanted pregnancies and sexually transmitted diseases (STDs).\u003c\/p\u003e\n\n\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\n\u003ch3\u003e When is the Akuel Skin Elite Condom indicated?\u003c\/h3\u003e\n\n\u003cp\u003e Akuel Skin Elite condoms are indicated for:\n\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003ePrevention of unwanted pregnancies\u003c\/strong\u003e .\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eProtection against sexually transmitted diseases (STDs)\u003c\/strong\u003e .\u003c\/li\u003e\n\n         \u003cli\u003eEnsure a natural sensory experience thanks to their ultra-thin formulation.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use the Akuel Skin Elite Condom?\u003c\/h3\u003e\n\n\u003cp\u003e 1. \u003cstrong\u003eOpening\u003c\/strong\u003e : Open the package carefully to avoid damaging the condom. Do not use scissors or sharp objects.\u003c\/p\u003e\n\n\u003cp\u003e 2. \u003cstrong\u003eApplication\u003c\/strong\u003e : Place the condom on the erect penis and gently unroll to the base. Make sure there are no air bubbles inside the condom.\u003c\/p\u003e\n\n\u003cp\u003e 3. \u003cstrong\u003eRemoval\u003c\/strong\u003e : After intercourse, remove the condom before the penis loses its erection, taking care not to spill any fluids. Dispose of the condom safely, avoiding flushing it down the toilet.\u003c\/p\u003e\n\n\n\u003ch2\u003e Package Contents\u003c\/h2\u003e\n\n\u003ch3\u003e What does the Akuel Skin Elite package contain?\u003c\/h3\u003e\n\n\u003cp\u003e The package contains \u003cstrong\u003e6 Akuel Skin Elite condoms\u003c\/strong\u003e :\n\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e Made of \u003cstrong\u003enatural rubber latex\u003c\/strong\u003e , transparent and lubricated.\u003c\/li\u003e \n\u003cli\u003eUltra-thin design for greater sensitivity and naturalness during intercourse.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings of Akuel Skin Elite?\u003c\/h3\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e Akuel condoms are \u003cstrong\u003edisposable\u003c\/strong\u003e : use a new condom for each sexual intercourse.\u003c\/li\u003e\n\n\u003cli\u003e Store in a cool, dry place, away from heat sources and direct light.\u003c\/li\u003e\n\n\u003cli\u003e Do not use oil or grease based lubricants, as they may damage the latex.\u003c\/li\u003e\n\n\u003cli\u003e Do not use the condom if the packaging is damaged or expired.\u003c\/li\u003e\n\n\u003cli\u003e If you have any allergies to latex, discontinue use and consult a doctor.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Akuel Skin Elite?\u003c\/h3\u003e\n\n\u003cp\u003e Store Akuel Skin Elite condoms at a temperature below 30°C, away from heat sources and direct light. Check the expiry date on the package before use and do not use them beyond the date indicated.\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n         \u003cp\u003eAkuel Skin Elite is available in packs of \u003cstrong\u003e6 condoms\u003c\/strong\u003e , each individually packaged to ensure maximum hygiene and safety.\u003c\/p\u003e\n\n","brand":"NOVA ARGENTIA SpA","offers":[{"title":"Default Title","offer_id":40207823470707,"sku":"934880877","price":12.08,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/nova-argentia-spa-profilattico-ansell-akuel-skin-elite-6-pezzi-farmacia-dottor-tili-1213792751.jpg?v=1767125858"},{"product_id":"pursennid-30-compresse-lassative-12-mg","title":"Pursennid 30 Laxative Tablets 12 mg","description":"\u003cp\u003ePursennid Laxative Tablets is a preparation based on \u003cstrong\u003eactive ingredients extracted from the senna plant\u003c\/strong\u003e with a \u003cstrong\u003elaxative action\u003c\/strong\u003e . Pursennid Laxative Tablets is indicated in cases of \u003cstrong\u003eoccasional constipation, difficulty evacuating and hard stools.\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003cp\u003e Pursennid Laxative Tablets works within 6-12 hours, by stimulating the large intestine, activating the evacuation of feces \u003cstrong\u003eapproximately 8 hours after taking it\u003c\/strong\u003e .\u003cbr\u003e\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Pursennid 30 Laxative Tablets 12 mg - What is the active ingredient in Pursennid 30 Laxative Tablets 12 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eOne coated tablet contains the active substance: sennosides A + B (as calcium salts) 12 mg. Excipients with known effect: lactose monohydrate; glucose anhydrous; sucrose. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eComposition of Pursennid 30 Laxative Tablets 12 mg - What does Pursennid 30 Laxative Tablets 12 mg contain?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eLactose monohydrate; stearic acid; talc; corn starch; anhydrous glucose; sucrose; gum arabic; colloidal anhydrous silica; titanium dioxide; cetyl palmitate.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Pursennid 30 Laxative Tablets 12 mg - Why is Pursennid 30 Laxative Tablets 12 mg used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eShort-term treatment of occasional constipation.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Pursennid 30 Laxative Tablets 12 mg - When should Pursennid 30 Laxative Tablets 12 mg not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eHypersensitivity to the active substance or to any of the excipients listed in section 6.1. Contraindicated in the following medical conditions: inflammatory diseases of the digestive system (i.e. Crohn's disease, ulcerative colitis, liver disease, peritonitis and inflammatory bowel disease); irritation or obstruction of the gastrointestinal tract (i.e. spastic constipation, obstruction of the ileum\/pre-ileum, cramps and pain, nausea, vomiting and colic); abdominal symptoms which may be due to an undiagnosed underlying condition, such as acute intestinal conditions which may require surgery (i.e. acute diverticulitis, appendicitis and massive diarrhoea); states of severe dehydration, with loss of water and electrolytes, especially hypokalaemia. Contraindicated in children under 10 years of age.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eQuantity and method of taking Pursennid 30 Laxative Tablets 12 mg - How to take Pursennid 30 Laxative Tablets 12 mg?\u003c\/span\u003e\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eDosage. Adults and children over 12 years of age: 2-4 coated tablets per day. Children between 10 and 12 years: 1-2 coated tablets per day. After a short period of treatment without appreciable results, consult your doctor. The correct dose is the minimum sufficient to produce easy evacuation of soft stools. It is advisable to initially use the minimum doses indicated. When necessary, the dose can then be increased, but without ever exceeding the maximum indicated. Paediatric population: contraindicated in children under 10 years of age. Method of administration: preferably take in the evening. Pursennid's action occurs after 6-12 hours. Administered in the evening, Pursennid appears the following morning. Laxatives should be used as infrequently as possible and for no more than seven days. Use for longer periods of time requires a doctor's prescription after adequate evaluation of the individual case. Swallow together with an adequate quantity of water (a large glass). A diet rich in liquids favors the use of the medicine.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Pursennid 30 Laxative Tablets 12 mg - How to store Pursennid 30 Laxative Tablets 12 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThis medicinal product does not require any special storage conditions.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Pursennid 30 Laxative Tablets 12 mg - About Pursennid 30 Laxative Tablets 12 mg it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe established dose should not be exceeded. Prolonged indiscriminate use of laxatives may lead to habituation and deterioration of intestinal function. The lowest effective dosage for the restoration of normal intestinal function should be used. If no intestinal improvement has been achieved, the dosage may be increased under medical supervision. Products containing senna and sennosides should only be used if a therapeutic effect cannot be achieved by changing the diet or administering bulking agents. The use of these drugs requires medical supervision: if no positive effects are achieved following treatment; if use is prolonged beyond one week of treatment; if symptoms persist or worsen; after laparotomy or abdominal surgery; if a skin rash is present, as this may be a sign of hypersensitivity; if nausea and vomiting are present, as these symptoms may be signs of a potential or existing intestinal blockage (ileus); in children between 10 and 12 years. Information on excipients. Lactose: Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. Glucose: Patients with rare hereditary problems of glucose-galactose malabsorption should not take this medicine. Sucrose: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Pursennid 30 Laxative Tablets 12 mg - Which medicines or foods can modify the effect of Pursennid 30 Laxative Tablets 12 mg?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eConcomitant use of other drugs that induce hypokalemia (hydiuretics, adrenocorticosteroids and liquorice) may increase electrolyte imbalance. Hypokalemia (resulting from abuse of laxatives taken for a long time) potentiates the action of cardiac glycosides and interferes with antiarrhythmic drugs, with other drugs that induce a return to sinus rhythm (quinidine) and with drugs that induce QT interval prolongation.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Pursennid 30 Laxative Tablets 12 mg can cause side effects - What are the side effects of Pursennid 30 Laxative Tablets 12 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThis medicine may cause mild abdominal discomfort such as abdominal pain, cramps, irritation of the colonic and gastric mucosa. Other effects such as dehydration, hypotension, fatigue, myopathies, stomach pain, hyponatremia, renal disorders, secondary hyperaldosteronism, hypocalcemia and hypomagnesemia have also been reported. These adverse reactions are usually reversible once the laxative is stopped. Prolonged use or overdose of this medicine may cause nausea, diarrhea with excessive loss of electrolytes, especially potassium (hypokalaemia). There is also the possibility of developing megacolon. During treatment, a yellow-brownish (pH-dependent) coloration of the urine due to metabolites may occur, which has no clinical significance. Habituation has been reported after prolonged treatment. The adverse reactions are listed below by system organ class and frequency. The frequencies are defined as: very common (\u0026gt;= 1\/10); common (\u0026gt;= 1\/100, \u0026lt; 1\/10); uncommon (\u0026gt;= 1\/1,000, \u0026lt; 1\/100); rare (\u0026gt;= 1\/10,000; \u0026lt; 1\/1,000); very rare (\u0026lt; 1\/10,000); or not known (frequency cannot be estimated from the available data). Undesirable effects in post-marketing experience. Immune system disorders. Not known: hypersensitivity reactions (pruritus, urticaria, local or generalized rash). Gastrointestinal disorders. Not known: megacolon, abdominal pain, diarrhoea, nausea, abdominal discomfort. General disorders and administration site conditions. Not known: fatigue, drug tolerance. Musculoskeletal and connective tissue disorders. Not known: myopathy. Renal and urinary disorders. Not known: kidney problems, chromaturia. Metabolism and nutrition disorders. Not known: hyperaldosteronism, hypocalcemia, hypomagnesemia, dehydration, hypokalaemia, hyponatremia, decreased blood electrolytes. Vascular disorders. Not known: hypotension. The adverse events listed above are based on spontaneous post-marketing reports and are a less precise estimate of the incidence that would be obtained in clinical trials. Paediatric population: the same frequency, type and severity of adverse events are expected in children and adults. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Pursennid 30 Laxative Tablets 12 mg.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003ePregnancy: There are no adequate data on the use of sennosides in pregnant women. Studies in animals have not shown reproductive toxicity. The potential risk for humans is unknown. Pregnant women should consult their doctor before taking this medicine. Breastfeeding: Use during breastfeeding is not recommended as there are insufficient data on the excretion of metabolites in breast milk. Small amounts of metabolites (rhein) are excreted in breast milk. No laxative effect on breast-fed infants has been reported. Fertility: Preclinical studies with sennosides do not indicate any particular risk for fertility at therapeutically relevant doses.\u003c\/span\u003e\u003c\/p\u003e","brand":"GLAXOSMITHKLINE C.HEALTH.SpA","offers":[{"title":"Default Title","offer_id":40207823732851,"sku":"004758025","price":12.28,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/glaxosmithkline-c-health-spa-pursennid-30-compresse-lassative-12-mg-farmacia-dottor-tili-1213792748.jpg?v=1767125872"},{"product_id":"enterogermina-4-miliardi-5-ml-20-flaconcini","title":"Enterogermina 4 Billion\/5 Ml 20 Vials","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eEnterogermina 4 Billion\/5 Ml 20 Vials\u003c\/span\u003e \u003cspan\u003elactic ferments with probiotic action\u003c\/span\u003e \u003cspan\u003efor the\u003c\/span\u003e \u003cspan\u003etreatment and prophylaxis of intestinal dysbiosis.\u003c\/span\u003e \u003cspan\u003eHelps\u003c\/span\u003e \u003cspan\u003erestore intestinal balance\u003c\/span\u003e \u003cspan\u003ethanks to the spores of Bacillus clausii polyantibiotic resistant.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eEnterogermina 4 Billion\/5 Ml 20 Vials is indicated for:\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003ePrevention\u003c\/span\u003e \u003cspan\u003eand treatment of alterations in the normal balance of intestinal bacterial flora\u003c\/span\u003e \u003cspan\u003e(intestinal dysbiosis) and vitamin deficiencies in the body resulting from an imbalance in intestinal bacterial flora (endogenous dysvitaminosis).\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eAdjuvant therapy for the\u003c\/span\u003e \u003cspan\u003erestoration of the intestinal microbial flora\u003c\/span\u003e \u003cspan\u003e, altered during antibiotic or chemotherapy treatments.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n \u003cp role=\"presentation\" dir=\"ltr\"\u003e\u003cspan\u003eTreatment\u003c\/span\u003e \u003cspan\u003eof acute and chronic gastrointestinal diseases\u003c\/span\u003e \u003cspan\u003eof infants caused by intoxication or alterations in the normal balance of intestinal bacterial flora (intestinal dysmicrobism) or vitamin deficiencies in the body (dysvitaminosis).\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Enterogermina 4 Billion\/5 Ml 20 Vials - What is the active ingredient in Enterogermina 4 Billion\/5 Ml 20 Vials?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eOne vial contains, active substance: spores of polyantibiotic-resistant Bacillus clausii (strains SIN, O\/C, T, N\/R) 4 billion. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Enterogermina 4 Billion\/5 Ml 20 Vials - What does Enterogermina 4 Billion\/5 Ml 20 Vials contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eVials: purified water.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eTherapeutic indications Enterogermina 4 Billion\/5 Ml 20 Vials - Why is Enterogermina 4 Billion\/5 Ml 20 Vials used? What is it used for?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eTreatment and prophylaxis of intestinal dysmicrobism and consequent endogenous dysvitaminosis. Adjuvant therapy for the restoration of intestinal microbial flora, altered during antibiotic or chemotherapy treatments. Acute and chronic gastro-intestinal disorders in infants, attributable to intoxications or intestinal dysmicrobism and dysvitaminosis.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Enterogermina 4 Billion\/5 Ml 20 Vials - When should Enterogermina 4 Billion\/5 Ml 20 Vials not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eQuantity and method of taking Enterogermina 4 Billion\/5 Ml 20 Vials - How is Enterogermina 4 Billion\/5 Ml 20 Vials taken?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eDosage. Adults: 1 vial per day. Infants and children: 1 vial per day. Method of administration: take the contents of the vial as is or diluted in water or other drinks (e.g. milk, tea, orange juice). This medicine is for oral use only. Do not inject or administer in any other way (see section 4.4).\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Enterogermina 4 Billion\/5 Ml 20 Vials - How is Enterogermina 4 Billion\/5 Ml 20 Vials stored?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eStore below 30 degrees C.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Enterogermina 4 Billion\/5 Ml 20 Vials - It is important to know that about Enterogermina 4 Billion\/5 Ml 20 Vials:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eSpecial warnings. Bacteremia\/sepsis: Cases of bacteremia, septicaemia and sepsis have been reported in immunocompromised or critically ill patients and in preterm infants since the introduction into the market. In some critically ill patients, the outcome was fatal. Enterogermina should be avoided in these groups of patients (see section 4.8). This medicinal product is for oral use only. Do not inject or administer by other routes. Incorrect use of the medicinal product has caused serious anaphylactic reactions such as anaphylactic shock. Precautions for use: during antibiotic therapy, it is advisable to administer the preparation in the interval between one and the other antibiotic administration. Any visible corpuscles in the vials of Enterogermina are due to aggregates of Bacillus clausii spores; therefore, they do not indicate an altered product. Shake the vial before use.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eInteractions Enterogermina 4 Billion\/5 Ml 20 Vials - Which medicines or foods can modify the effect of Enterogermina 4 Billion\/5 Ml 20 Vials?'\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eNo interaction studies have been performed.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Enterogermina 4 Billion\/5 Ml 20 Vials can cause side effects - What are the side effects of Enterogermina 4 Billion\/5 Ml 20 Vials?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe following undesirable effects have been observed during treatment with this medicinal product, classified according to the MedDRA organ class and frequency categories: very common (\u0026gt;=1\/10); common (\u0026gt;=1\/100, \u0026lt;1\/10); uncommon (\u0026gt;=1\/1,000, \u0026lt;1\/100); rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000); very rare \u0026lt;1\/10,000); not known (frequency cannot be estimated from the available data). Infections and infestations. Not known: bacteraemia, septicaemia and sepsis (in immunocompromised or severely ill patients) (see section 4.4). Skin and subcutaneous tissue disorders. Not known: hypersensitivity reactions, including rash, urticaria and angioedema. Reporting of suspected adverse reactions. Reporting of suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Enterogermina 4 Billion\/5 Ml 20 Vials.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePregnancy: There are no data available on the use of Enterogermina in pregnant women; therefore, it is not possible to draw conclusions on the safety of using Enterogermina during pregnancy. Enterogermina should be used during pregnancy only if the potential benefits for the mother outweigh the potential risks, including those for the fetus. Breastfeeding: There are no data available on the use of Enterogermina during breastfeeding regarding the composition of breast milk and the effects on the child. It is not possible to draw conclusions on the safety of using Enterogermina during breastfeeding. Enterogermina should be used during breastfeeding only if the potential benefits for the mother outweigh the potential risks, including those for the breastfed child. Fertility: There are no data available on the effect of Enterogermina on human fertility.\u003c\/span\u003e\u003c\/p\u003e","brand":"SANOFI SpA","offers":[{"title":"Default Title","offer_id":40207823798387,"sku":"013046089","price":25.02,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/sanofi-spa-enterogermina-4-miliardi-5-ml-20-flaconcini-farmacia-dottor-tili-1213792750.webp?v=1767125928"},{"product_id":"froben-gola-spray-mucosa-orale-15-ml-flurbiprofene-0-25","title":"Froben Throat Oral Mucosa Spray 15 ml Flurbiprofen 0.25%","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eFroben Gola Spray is an over-the-counter drug based on Flurbiprofen indicated for the\u003c\/span\u003e \u003cspan\u003esymptomatic treatment of irritative-inflammatory conditions associated with pain\u003c\/span\u003e \u003cspan\u003ein the oropharyngeal cavity.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eFlurbiprofen belongs to a group of medicines called nonsteroidal anti-inflammatory drugs (NSAIDs), used to relieve pain, redness, heat and swelling in the presence of inflammatory processes. For this reason, Froben Gola Spray is used to\u003c\/span\u003e \u003cspan\u003ereduce burning, redness, pain and inflammation of the mouth and throat\u003c\/span\u003e \u003cspan\u003e, due to\u003c\/span\u003e \u003cspan\u003egingivitis, stomatitis, pharyngitis\u003c\/span\u003e \u003cspan\u003eand as a consequence of\u003c\/span\u003e \u003cspan\u003econservative or extractive dental therapy\u003c\/span\u003e \u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Froben Gola Spray Oral Mucosa 15 ml Flurbiprofen 0.25% - What is the active ingredient of Froben Gola Spray Oral Mucosa 15 ml Flurbiprofen 0.25%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eFroben Gola 250 mg\/100 ml Mouthwash, 100 ml of solution contain, active ingredient: flurbiprofen 0.25 g. Excipients with known effect: 40-polyoxyethylened hydrogenated castor oil, ethanol, mint essence flavour (containing limonene). Froben Gola 250 mg\/100 ml Oral mucosa spray, 100 ml of solution contain, active ingredient: flurbiprofen 0.25 g. Excipients with known effect: 40-polyoxyethylened hydrogenated castor oil, ethanol, mint essence flavour (containing limonene). For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Froben Throat Spray Oral Mucosa 15 ml Flurbiprofen 0.25% - What does Froben Throat Spray Oral Mucosa 15 ml Flurbiprofen 0.25% contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003ePurified water, ethanol, patent blue V (E131), glycerol, mint essence flavouring (containing limonene), 40-polyoxyethylened hydrogenated castor oil, potassium bicarbonate, sodium saccharinate, sorbitol.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eTherapeutic indications Froben Gola Spray Oral Mucosa 15 ml Flurbiprofen 0.25% - Why is Froben Gola Spray Oral Mucosa 15 ml Flurbiprofen 0.25% used? What is it used for?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eFroben Gola is indicated for the symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Froben Gola Spray Oral Mucosa 15 ml Flurbiprofen 0.25% - When should Froben Gola Spray Oral Mucosa 15 ml Flurbiprofen 0.25% not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eHypersensitivity to flurbiprofen or to any of the excipients listed in section 6.1. Froben Gola is also contraindicated in: patients who have previously shown hypersensitivity reactions (e.g. asthma, urticaria) after taking aspirin or other NSAIDs; patients with a history of gastrointestinal bleeding or perforation related to previous NSAID therapy; patients with active or history of ulcerative colitis, Crohn's disease, recurrent peptic ulcer or gastrointestinal bleeding (defined as two or more distinct episodes of proven ulceration or bleeding); patients with severe cardiac, renal or hepatic insufficiency (see section 4.4). Froben Gola is contraindicated during the third trimester of pregnancy.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Froben Gola Spray Mucosa Orale 15 ml Flurbiprofene 0.25% - How do you take Froben Gola Spray Mucosa Orale 15 ml Flurbiprofene 0.25%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe lowest effective dose should be used for the shortest duration necessary to relieve symptoms (see section 4.4). It is recommended to use this medicine for a maximum of three days. Dosage. Mouthwash: the recommended dose is two or three rinses or gargles per day with 10 ml of mouthwash. It can be diluted in water. Spray for oral mucosa: the recommended dose is 2 sprays 3 times a day directed directly at the affected area. Paediatric population: there are no adequate data available on the paediatric population; therefore, the use of the medicine is not recommended. Method of administration: the use of Froben Gola is exclusively for local oral use and must not be swallowed.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Froben Throat Spray Oral Mucosa 15 ml Flurbiprofen 0.25% - How is Froben Throat Spray Oral Mucosa 15 ml Flurbiprofen 0.25% stored?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eMouthwash: This medicine should not be stored above 25 degrees C. Oral mucosa spray: This medicine should not be stored above 25 degrees C. Keep the bottle in the outer carton in order to protect from light.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Froben Gola Spray Oral Mucosa 15 ml Flurbiprofen 0.25% - About Froben Gola Spray Oral Mucosa 15 ml Flurbiprofen 0.25% it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eAt the recommended doses, any swallowing of FROBEN GOLA does not cause any harm to the patient as these doses are much lower than those of the single dosage of the product for systemic use. The use of Froben Gola, especially if prolonged, may give rise to phenomena of sensitization or local irritation; in such cases the treatment should be interrupted and, if necessary, appropriate therapy should be instituted. General precautions: flurbiprofen should not be used for prolonged treatments. It is necessary to inform patients to seek medical advice if after short periods of treatment there are no appreciable results. Undesirable effects can be minimised by using the lowest effective dose for the shortest duration of treatment necessary to control symptoms (see section 4.2 and the sections below on gastrointestinal and cardiovascular risks). Use in elderly patients: elderly patients have an increased frequency of adverse reactions to NSAIDs, especially gastrointestinal bleeding and perforation, which may be fatal. Gastrointestinal effects: Flurbiprofen should be administered with caution to patients with a history of peptic ulcer and other gastrointestinal disease as these conditions may be exacerbated. Gastrointestinal bleeding, ulceration or perforation have been reported with all NSAIDs at any time during treatment. These adverse events can be fatal and may occur with or without warning symptoms or with a previous history of serious gastrointestinal events. The risk of gastrointestinal bleeding, ulceration or perforation is higher with increasing flurbiprofen dosage in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation and in the elderly. These patients should start treatment on the lowest available dose. Concomitant use of protective agents (misoprostol or proton pump inhibitors) should be considered for these patients and also for patients taking low dose aspirin or other drugs likely to increase the risk of gastrointestinal events (see section below and section 4.5). Patients with a history of gastrointestinal disease, particularly when elderly, should report any unusual abdominal symptoms (especially gastrointestinal bleeding) in the initial stages of treatment. When gastrointestinal bleeding or ulceration occurs in patients receiving Froben Gola, the treatment should be withdrawn. Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin reuptake inhibitors or anti-platelet agents such as acetylsalicylic acid (see section 4.5). In case of concomitant intake of alcohol, the undesirable effects related to the active substance, particularly those involving the gastrointestinal tract or the central nervous system, may be increased with the use of NSAIDs. Respiratory disorders: cases of bronchospasm have been reported with flurbiprofen in patients with a history of bronchial asthma. Cardiac, renal and hepatic impairment: Particular caution should be exercised when treating patients with severely impaired renal, cardiac or hepatic function, as the use of NSAIDs may result in deterioration of renal function. In such patients the dosage should be kept as low as possible and renal function should be monitored. Administration of an NSAID may cause a dose-dependent reduction in prostaglandin formation, precipitating renal failure. Patients at highest risk of developing this reaction are those with impaired renal function, cardiac insufficiency and hepatic dysfunction, those taking diuretics and the elderly. Renal function should be monitored in these patients (see also section 4.3). Flurbiprofen should be administered with caution in patients with a history of cardiac insufficiency or hypertension since cases of oedema have been reported in association with flurbiprofen administration. Central nervous system effects: Headache may occur with prolonged use of any analgesic and should not be treated by increasing the dosage of the medicinal product. Cardiovascular and cerebrovascular effects: Appropriate monitoring and advice are necessary in patients with a history of hypertension and\/or mild to moderate congestive heart failure since fluid retention and oedema have been reported in association with flurbiprofen administration and NSAID treatment. Froben Gola should be used with caution in these patients. Clinical trial and epidemiological data suggest that the use of some NSAIDs, particularly at high doses and in long-term treatment, may be associated with a small increased risk of arterial thrombotic events, such as myocardial infarction or stroke. There are insufficient data to exclude a similar risk for flurbiprofen. Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease and\/or cerebrovascular disease should only be treated with flurbiprofen after careful consideration. Similar consideration should be made before initiating long-term treatment in patients with risk factors for cardiovascular disease (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking). Skin reactions: Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs. Patients appear to be at highest risk early in the course of therapy: the onset of the reaction occurring in the majority of cases within the first month of treatment. Flurbiprofen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity. Renal effects: Caution should be exercised when initiating treatment with NSAIDs such as flurbiprofen in patients with considerable dehydration.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Froben Gola Spray Mucosa Orale 15 ml Flurbiprofene 0.25% - Which medicines or foods can modify the effect of Froben Gola Spray Mucosa Orale 15 ml Flurbiprofene 0.25%?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eCaution should be exercised in patients treated with any of the following medicinal products, as interactions have been reported in some patients. Diuretics, ACE inhibitors and angiotensin II antagonists: NSAIDs may reduce the effect of diuretics and other antihypertensive drugs. Diuretics may also increase the risk of nephrotoxicity of NSAIDs. In some patients with compromised renal function (e.g. dehydrated patients or elderly patients with compromised renal function) the co-administration of an ACE inhibitor or an angiotensin II antagonist and agents that inhibit the cyclo-oxygenase system may lead to further deterioration of renal function, including possible acute renal failure, which is usually reversible. These interactions should be considered in patients taking flurbiprofen concomitantly with ACE inhibitors or angiotensin II antagonists. Therefore, the combination should be administered with caution, especially in elderly patients. Patients should be adequately hydrated and consideration should be given to monitoring renal function after initiation of concomitant therapy and periodically thereafter. Lithium salts: decreased lithium elimination. Methotrexate: caution is advised when co-administering flurbiprofen and methotrexate since NSAIDs may increase methotrexate levels and thus its toxic effects. Anticoagulants, such as warfarin: increased anticoagulant. Anti-platelet agents: increased risk of gastrointestinal bleeding (see section 4.4). Selective serotonin reuptake inhibitors (SSRIS): increased risk of gastrointestinal bleeding. Acetylsalicylic acid (Aspirin): as with other NSAID-containing medicinal products, concomitant administration of flurbiprofen and aspirin is generally not recommended due to the potential for increased adverse effects (see section 4.4). Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce glomerular filtration rate and increase plasma levels of cardiac glycosides. Ciclosporins: Increased risk of nephrotoxicity with NSAIDs. Corticosteroids: Increased risk of gastrointestinal ulceration or haemorrhage with NSAIDs. Cox-2 inhibitors and other NSAIDs: Concomitant use of other NSAIDs, including cyclooxygenase-2 selective inhibitors, should be avoided due to potential additive effects. Mifepristone: NSAIDs should not be taken for 8-12 days after mifepristone administration since NSAIDs may reduce the effects of mifepristone. Quinolone antibiotics: Results from animal studies suggest that NSAIDs may increase the risk of convulsions associated with the use of quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions. Tacrolimus: possible increased risk of nephrotoxicity in case of co-administration with NSAIDs. Zidovudine: increased risk of haematotoxicity in case of co-administration with NSAIDs. There is evidence of an increased risk of haemarthrosis and haematoma in haemophiliac patients affected by HIV in concomitant treatment with Zidovudine and other NSAIDs. The interactions reported above have been reported in particular after the administration of flurbiprofen-based formulations for systemic use. At the recommended doses of Froben Gola no interactions with other medicinal products or other types have been reported. In any case, inform your doctor if you are taking other medicines.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Froben Gola Spray Mucosa Orale 15 ml Flurbiprofene 0.25% can cause side effects - What are the side effects of Froben Gola Spray Mucosa Orale 15 ml Flurbiprofene 0.25%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe following adverse reactions, reported in particular after administration of systemic formulations, are reported according to the MedDRA classification. Frequency groupings are classified according to the following convention: very common (\u0026gt;= 1\/10), common (\u0026gt;= 1\/100, \u0026lt;1\/10), uncommon (\u0026gt;= 1\/1000, \u0026lt;1\/100), rare (\u0026gt;= 1\/10 000, \u0026lt;1\/1 000), very rare (\u0026lt;1\/10 000) and not known (frequency cannot be estimated from the available data). Blood and lymphatic system disorders: Uncommon: anaemia; very rare: leucopenia, agranulocytosis, aplastic anaemia, neutropenia, thrombocytopenia, haemolytic anaemia. Immune system disorders: Uncommon: hypersensitivity; rare: anaphylactic reaction. Psychiatric disorders: Rare: depression, confusional state; very rare: hallucination. Nervous system disorders. Common: migraine, dizziness; uncommon: paraesthesia; rare: somnolence, insomnia; not known: optic neuritis, cerebrovascular accident, aseptic meningitis, headache. Eye disorders. Uncommon: visual disturbances. Ear and labyrinth disorders. Uncommon: tinnitus, vertigo. Respiratory, thoracic and mediastinal disorders. Uncommon: asthma, dyspnoea; rare: bronchospasm. Gastrointestinal disorders. Common: dyspepsia, diarrhoea, nausea, vomiting, abdominal pain, flatulence, constipation, melaena, haematemesis, gastrointestinal haemorrhage; uncommon: gastritis, duodenal ulcer, gastric ulcer, mouth ulcer, gastrointestinal perforation; very rare: pancreatitis; not known: colitis and Crohn's disease. Hepatobiliary disorders. Very rare: jaundice, cholestatic jaundice, abnormal liver function; not known: hepatitis. Skin and subcutaneous tissue disorders. Uncommon: rash, urticaria, pruritus, purpura, angioedema, photosensitivity reactions; very rare: severe forms of bullous skin reactions (e.g. erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis). Renal and urinary disorders. Rare: nephrotoxicity in various forms. Interstitial nephritis, nephrotic syndrome, renal failure and acute renal failure (see section 4.4); not known: glomerulonephritis. General disorders and administration site conditions. Common: fatigue, malaise, oedema. Cardiac disorders. Uncommon: cardiac failure. Vascular disorders. Uncommon: hypertension. Investigations. Common: liver function test abnormal, prolonged bleeding time. Metabolism and nutrition disorders. Common: fluid retention. Immune system disorders. Hypersensitivity reactions have been reported following treatment with flurbiprofen. These consist of: a) non-specific allergic reactions and anaphylaxis; b) respiratory tract reactions including asthma, including severe asthma, bronchospasm or dyspnoea, or c) various skin disorders, such as rashes of various types, pruritus, urticaria, purpura, angioedema and, very rarely, exfoliative and bullous dermatitis (including toxic epidermal necrolysis and erythema multiforme). Cardiac and vascular disorders: Cases of oedema, hypertension and cardiac failure have been reported in association with treatment with NSAIDs. Clinical trial and epidemiological data suggest that the intake of some NSAIDs (particularly at high doses and in case of long-term treatment) may be associated with an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) (see section 4.4). Nervous System Disorders: aseptic meningitis (especially in patients with existing autoimmune disorders such as systemic lupus erythematosus and connective tissue disorders) with symptoms such as stiff neck, headache, nausea, vomiting, fever or disorientation (see section 4.4). Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Froben Gola Spray Mucosa Orale 15 ml Flurbiprofen 0.25%\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eFertility: The use of Froben Gola may adversely affect fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of fertility, discontinuation of Froben Gola should be considered. Pregnancy: Inhibition of prostaglandin synthesis may adversely affect pregnancy and\/or embryo\/foetal development. Results of epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk of cardiac malformations increases from less than 1%, up to approximately 1.5%. The risk was believed to increase with dose and duration of therapy. In animals, administration of prostaglandin synthesis inhibitors has been shown to cause an increase in pre- and post-implantation loss and embryo-foetal mortality. Furthermore, an increased incidence of various malformations, including cardiovascular, has been reported in animals administered prostaglandin synthesis inhibitors during the organogenetic period. There are no clinical data on the use of Froben Gola during pregnancy. Although systemic exposure is lower than with oral administration, it is not known whether systemic exposure of Froben Gola achieved after topical administration can be harmful to an embryo\/fetus. During the first and second trimester of pregnancy, flurbiprofen should not be administered unless clearly necessary. If administered, the dose should be the lowest possible and the duration of treatment as short as possible. During the third trimester of pregnancy, systemic use of prostaglandin synthetase inhibitors, including Froben Gola, may induce cardiopulmonary and renal toxicity in the fetus. At the end of pregnancy, prolonged bleeding time may occur in both mother and child and labor may take longer. Therefore, Froben Gola is contraindicated during the third trimester of pregnancy (see section 4.3). Breastfeeding: in the few studies available to date, NSAIDs may appear in breast milk in very low concentrations. If possible, NSAIDs should be avoided during breastfeeding. See section 4.4 Special warnings and precautions for use, regarding fertility in women.\u003c\/span\u003e\u003c\/p\u003e","brand":"MYLAN ITALIA Srl","offers":[{"title":"Default Title","offer_id":40207824158835,"sku":"042822027","price":11.44,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/mylan-italia-srl-froben-gola-spray-mucosa-orale-15-ml-flurbiprofene-0-25-farmacia-dottor-tili-1213792740.jpg?v=1767126746"},{"product_id":"proctolyn-crema-rettale-30-g","title":"Proctolyn Rectal Cream 30 g","description":"\u003cp\u003e \u003cstrong\u003eProctolyn Rectal Cream 30 g\u003c\/strong\u003e is a drug indicated for the treatment of anal and perianal conditions such as hemorrhoids, fissures and dermatitis. Its active ingredient, fluocinolone acetonide, belongs to the class of corticosteroids and has a local anti-inflammatory action, reducing inflammation, itching and pain. The cream also contains \u003cstrong\u003ebenzocaine\u003c\/strong\u003e , a local anesthetic that quickly relieves pain and discomfort, providing rapid relief of symptoms.\u003c\/p\u003e\n\n\u003cp\u003e Proctolyn Rectal Cream is indicated for:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eSymptomatic treatment of external and internal hemorrhoids\u003c\/strong\u003e .\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eTreatment of anal fissures\u003c\/strong\u003e .\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDermatitis and itching\u003c\/strong\u003e in the anal and perianal area.\u003c\/li\u003e\n\n\u003cli\u003e Reduction of inflammation and pain associated with rectal conditions.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Proctolyn Rectal Cream 30 g - What is the active ingredient of Proctolyn Rectal Cream 30 g?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eFluocinolone acetonide and ketocaine hydrochloride.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Proctolyn Rectal Cream 30 g - What does Proctolyn Rectal Cream 30 g contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eRectal cream: citric acid, menthol methyl parahydroxybenzoate, propyl parahydroxybenzoate, propylene glycol, stearyl alcohol, cetyl alcohol, vaseline oil, sorbitan monostearate, polysorbate 60, purified water. Suppositories: citric acid, menthol, propylene glycol, polysorbate 60, sorbitan monostearate, colloidal silica, semi-synthetic glycerides.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n \u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Proctolyn Rectal Cream 30 g - Why is Proctolyn Rectal Cream 30 g used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eInternal and external hemorrhoids; anal and perianal eczema and erythema; anal fissures; anal and perianal itching and burning; pre- and post-operative treatment in ano-rectal surgery.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Proctolyn Rectal Cream 30 g - When should Proctolyn Rectal Cream 30 g not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eHypersensitivity to the active substances or to any of the excipients. Tbc, mycosis, Herpes Symplex, viral diseases with cutaneous localization.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Proctolyn Rectal Cream 30 g - How to take Proctolyn Rectal Cream 30 g?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eRectal cream: enough to cover the affected area, massaging lightly and repeating the application 2-3 times a day. For internal application, use the special cannula inserted into the tube. Suppositories: 1 suppository in the morning and 1 in the evening. Rectal cream and suppositories can be used for combined treatments. The use of the drug is not recommended in children under 12 years of age, due to the lack of data on safety and efficacy.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Proctolyn Rectal Cream 30 g - How to store Proctolyn Rectal Cream 30 g?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThis medicinal product does not require any special storage conditions.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Proctolyn Rectal Cream 30 g - About Proctolyn Rectal Cream 30 g it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eTopical application of corticosteroids in excessive doses and for prolonged periods may cause systemic absorption. Use, especially if prolonged, of topical products may give rise to sensitization phenomena. In the presence of a skin infection, appropriate cover therapy should be instituted. Visual disturbances may be reported with the use of systemic and topical corticosteroids. If a patient presents with symptoms such as blurred vision or other visual disturbances, it is necessary to consider referral to an ophthalmologist for evaluation of possible causes which may include cataracts, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR), which have been reported after the use of systemic and topical corticosteroids. The rectal cream contains methyl parahydroxybenzoate and propyl parahydroxybenzoate which may cause allergic reactions; stearyl alcohol and cetyl alcohol which may cause localized skin reactions.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n \u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Proctolyn Rectal Cream 30 g - Which medicines or foods can modify the effect of Proctolyn Rectal Cream 30 g?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eConcomitant treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to increase the risk of systemic side effects. The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side effects, in which case patients should be monitored for systemic corticosteroid side effects.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Proctolyn Rectal Cream 30 g can cause side effects - What are the side effects of Proctolyn Rectal Cream 30 g?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eDuring topical cortisone therapy, especially for intense and prolonged treatments, the following side effects may occur: burning sensation, itching, irritation. Blurred vision may occur, with an unknown frequency.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Proctolyn Rectal Cream 30 g.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThe medicine should be used during pregnancy only if necessary, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus. Topical corticosteroids should be used with caution during breastfeeding.\u003c\/span\u003e\u003c\/p\u003e","brand":"RECORDATI SpA","offers":[{"title":"Default Title","offer_id":40207824289907,"sku":"021925060","price":12.74,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/recordati-spa-proctolyn-crema-rettale-30-g-farmacia-dottor-tili-1213792737.jpg?v=1767126730"},{"product_id":"imodium-12-capsule-2-mg","title":"Imodium 12 Capsules 2mg","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eImodium 12 Capsules 2 mg is an antidiarrheal drug indicated for the treatment of\u003c\/span\u003e \u003cspan\u003eacute and chronic diarrhea\u003c\/span\u003e \u003cspan\u003e. Each capsule contains 2 mg of loperamide hydrochloride, the active ingredient that works by slowing down intestinal movements, thus promoting\u003c\/span\u003e \u003cspan\u003egreater absorption of liquids and reducing the frequency of bowel movements\u003c\/span\u003e \u003cspan\u003e. Imodium is indicated for adults and children aged 12 years and over, and is effective in\u003c\/span\u003e \u003cspan\u003erapidly reducing the symptoms of diarrhea\u003c\/span\u003e \u003cspan\u003e, improving stool consistency and reducing fluid loss.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eImodium is indicated for:\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\n\n\u003cp dir=\"ltr\" role=\"presentation\"\u003e \u003cspan\u003eSymptomatic treatment of acute diarrhoea in adults and children over 12 years.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\n\n\u003cp dir=\"ltr\" role=\"presentation\"\u003e \u003cspan\u003eTreatment of chronic diarrhea associated with specific pathological conditions.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\n\n\u003cp dir=\"ltr\" role=\"presentation\"\u003e \u003cspan\u003eRegulation of stool consistency in patients with ileostomy.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eActive ingredients contained in Imodium 12 Capsules 2 mg - What is the active ingredient in Imodium 12 Capsules 2 mg?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eOne hard capsule contains the active substance: loperamide hydrochloride 2 mg. One orodispersible tablet contains the active substance: loperamide hydrochloride 2 mg. One soft capsule contains the active substance: loperamide hydrochloride 2 mg. Excipients with known effect. Imodium 2 mg hard capsules: lactose 127 mg. Imodium 2 mg orodispersible tablets: each tablet contains 750 micrograms of aspartame; the mint flavour contains traces of sulphites. Imodium 2 mg soft capsules: each soft capsule contains 115.31 mg of propylene glycol. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Imodium 12 Capsules 2 mg - What does Imodium 12 Capsules 2 mg contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eImodium mg hard capsules: lactose, corn starch, talc, magnesium stearate. A green-grey hard capsule consists of: erythrosine (E 127); indigo carmine (E 132); yellow iron oxide (E 172); black iron oxide (E 172); titanium dioxide and gelatin. Imodium 2 mg orodispersible tablets: gelatin, mannitol, aspartame, mint flavour, sodium bicarbonate. Imodium 2 mg soft capsules: propylene glycol monocaprylate, propylene glycol, distilled water. A capsule consists of: gelatin, glycerol 99%, propylene glycol, FD\u0026amp;C blue n.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Imodium 12 Capsules 2 mg - Why is Imodium 12 Capsules 2 mg used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eImodium is indicated for the symptomatic treatment of acute diarrhea.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Imodium 12 Capsules 2 mg - When should Imodium 12 Capsules 2 mg not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eHypersensitivity to the active substance or to any of the excipients listed in section 6.1; children under 6 years of age; Pregnancy and lactation (see section 4.6 \"Pregnancy and lactation\"). Imodium should not be used as primary therapy: in acute dysentery characterised by blood in the stool and high fever; in patients with acute ulcerative colitis or pseudomembranous colitis due to the use of broad-spectrum antibiotics; in patients with bacterial enterocolitis caused by invasive organisms including Salmonella, Shigella and Campylobacter. In general, the use of loperamide HCl is contraindicated in all cases where inhibition of peristalsis is to be initiated because of the possible risk of significant sequelae such as ileus, megacolon and toxic megacolon.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Imodium 12 Capsules 2 mg - How to take Imodium 12 Capsules 2 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eDosage. Adults: the initial dose is 2 hard capsules or 2 soft capsules or 2 orodispersible tablets (4 mg). Continue treatment with 1 capsule or 1 tablet (2 mg), after each subsequent evacuation of loose (soft) stools. The maximum daily dose is 8 capsules or tablets per day (16 mg). Special populations. Children aged 6 to 17 years (see section 4.3): the initial dose is 1 hard capsule or 1 soft capsule or 1 orodispersible tablet (2 mg). Continue treatment with 1 capsule or 1 tablet (2 mg), after each subsequent evacuation of loose (soft) stools. The maximum daily dose in children must be established according to body weight (3 capsules or tablets\/20 kg), but must not exceed the maximum of 8 capsules or tablets per day (16 mg). There are limited data available on the use of loperamide HCl in children under 12 years of age (see section 4.8 \"Undesirable effects\"). Elderly: No dose adjustment is necessary in the elderly. Renal impairment: No dose adjustment is necessary in patients with renal impairment. Hepatic impairment: Although no data are available in patients with hepatic impairment, loperamide HCl should be used with caution in these patients due to reduced first-pass metabolism (see section 4.4 \"Special warnings and precautions for use\"). Method of administration. Imodium 2 mg hard capsules\/2 mg soft capsules: take by mouth with a little water. Imodium 2 mg orodispersible tablets: leave the tablet to dissolve on the tongue for a few seconds; the tablet will dissolve rapidly in saliva. No water is required. Caution: do not use for more than 2 days. In any case, discontinue treatment when stools return to normal, or if you have not had bowel movements for 12 hours, or if constipation occurs. In episodes of acute diarrhea, loperamide HCl is generally able to stop the symptoms within 48 hours. If this period elapses without appreciable results, discontinue treatment and consult your doctor.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Imodium 12 Capsules 2 mg - How is Imodium 12 Capsules 2 mg stored?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eStore the medicine at a temperature not exceeding 25 degrees C.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Imodium 12 Capsules 2 mg - About Imodium 12 Capsules 2 mg it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eTreatment of diarrhea with loperamide HCl is only symptomatic. Therefore, where possible, it is also advisable to treat the causes of the disorder. In acute diarrhea, loperamide HCl is usually able to arrest the symptoms within 48 hours; if this period elapses without appreciable results, treatment should be stopped and the patient should be advised to consult a doctor. Patients with diarrhea, especially children, may experience significant fluid and electrolyte loss. In such cases, appropriate fluid and electrolyte replacement may be very important. Although no pharmacokinetic data are available in patients with hepatic dysfunction, loperamide HCl should be used with caution in these patients due to extensive first-pass metabolism. The drug should be used with caution in patients with hepatic insufficiency as it may lead to relative overdose with CNS toxicity. AIDS patients treated with loperamide HCl for diarrhea should discontinue therapy at the first signs of abdominal distension. In these patients with infectious colitis of bacterial or viral origin, treated with loperamide HCl, isolated cases of intestinal obstruction with an increased risk of toxic megacolon have been observed. If constipation or abdominal or ileal distension occurs, treatment should be discontinued immediately. Cases of abuse and misuse of loperamide, used as an opioid substitute, in individuals with opioid dependence have been reported (see section 4.9). Cardiac events including QT and QRS prolongation and torsade de pointes have been reported in association with overdose. Some cases have had a fatal outcome (see section 4.9). Overdose may unmask the presence of Brugada syndrome. Patients should not exceed the recommended dose and\/or prolong the duration of therapy. Paediatric population: In children between 6 and 12 years of age, Imodium should be used only under medical supervision. There are limited data available on the use of loperamide HCl in children under 12 years of age (see section 4.8 \"Undesirable effects\"). Important information about some of the excipients: Imodium 2 mg hard capsules contain lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine. Imodium 2 mg orodispersible tablets contain: traces of sulphites. Sulphites may rarely cause severe hypersensitivity reactions and bronchospasm; 0.750 mg of aspartame per single dose which is equivalent to 0.011 mg\/kg for a 70 kg adult and 0.038 mg\/kg for a 20 kg child. Aspartame is hydrolysed in the gastrointestinal tract when taken orally. One of the major products of its hydrolysis is phenylalanine. There are no clinical or non-clinical data available to evaluate the use of aspartame in infants less than 12 weeks of age; less than 1 mmol (23 mg) sodium per single dose. It can therefore be considered essentially sodium-free; 0.00066 mg benzyl alcohol per single tablet. Benzyl alcohol may cause allergic reactions. It is possible that accumulation of large amounts of benzyl alcohol may cause metabolic acidosis; use with caution and only if necessary, especially in patients with hepatic or renal insufficiency; 0.00003 mg alcohol (ethanol) in each tablet. The amount of ethanol in this medicinal product is equivalent to less than 0.00000075 ml of beer or 0.0000003 of wine. This medicinal product contains enough ethanol to produce no relevant effects. Imodium 2 mg soft capsules contain: 115.31 mg propylene glycol. 115.31 mg propylene glycol per single dose, equivalent to 1.65 mg\/kg for a 70 kg adult and 5.77 mg\/kg for a 20 kg child; less than 1 mmol (23 mg) sodium per single dose. It can therefore be considered essentially sodium-free.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Imodium 12 Capsules 2 mg - Which medicines or foods can modify the effect of Imodium 12 Capsules 2 mg?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eNon-clinical data have shown that loperamide is a substrate of P-glycoprotein. Co-administration of loperamide (single dose of 16 mg) with quinidine or ritonavir (both inhibitors of P-glycoprotein) has been shown to increase the plasma levels of loperamide by 2 to 3-fold. The clinical relevance of this pharmacokinetic interaction with P-glycoprotein inhibitors when loperamide is administered at the recommended doses (2 to a maximum of 16 mg daily) is unknown. Co-administration of loperamide (single dose of 4 mg) with itraconazole, an inhibitor of CYP3A4, and P-glycoprotein, has been shown to increase the plasma levels of loperamide by 34-fold. In the same study, gemfibrozil, an inhibitor of CYP2C8, has been shown to increase the plasma levels of loperamide by 2-fold. The combination of itraconazole and gemfibrozil showed a 4-fold increase in peak plasma levels of loperamide and a 13-fold increase in total plasma exposure. These increases were not associated with central nervous system (CNS) effects as measured by psychomotor tests (e.g. subjective dizziness and Digit Symbol Substitution Test). Concomitant administration of loperamide (single dose of 16 mg) and ketoconazole, an inhibitor of CYP3A4, and P-glycoprotein, showed a 5-fold increase in plasma levels of loperamide. This increase was not associated with an increase in pharmacodynamic effects as measured by pupillometry. Concomitant treatment with oral desmopressin resulted in a 3-fold increase in plasma desmopressin concentrations, presumably due to slowed gastrointestinal motility. Concomitant use of CYP450 inhibitors is not recommended. Substances that accelerate gastrointestinal transit may decrease Imodium. Drugs with pharmacological properties similar to those of loperamide or drugs that can slow intestinal peristalsis (e.g. anticholinergics) may increase Imodium.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Imodium 12 Capsules 2 mg can cause side effects - What are the side effects of Imodium 12 Capsules 2 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eAdults and children aged ≥12 years Adverse reactions reported in clinical trials with loperamide HCl The safety of Loperamide HCl has been evaluated in 3076 adult and child subjects aged ≥12 years who participated in 31 controlled and uncontrolled clinical trials with loperamide HCl used for the treatment of diarrhoea. Of these, 26 trials were for acute diarrhoea (N=2755) and 5 for chronic diarrhoea (N=321). The most commonly reported adverse drug reactions (ADRs) (i.e. with an incidence of ≥1%) in clinical trials with Loperamide HCl for the treatment of acute diarrhoea were: constipation (2.7%), flatulence (1.7%), headache (1.2%) and nausea (1.1%). In clinical trials for the treatment of chronic diarrhoea, the most commonly reported ADRs (i.e. \u0026gt;=1% incidence) were: flatulence (2.8%), constipation (2.2%), nausea (1.2%) and dizziness (1.2%). The following list shows the ADRs that have been reported with the use of loperamide HCl in clinical trials (in acute or chronic diarrhoea) in adults and children aged ≥12 years. The frequency of adverse reactions presented below is defined using the following convention: very common (\u0026gt;=1\/10); common (\u0026gt;=1\/100 to \u0026lt;1\/10); uncommon (\u0026gt;=1\/1,000 to \u0026lt;1\/100); rare (\u0026gt;=1\/10,000 to \u0026lt;1\/1,000); very rare (\u0026lt;1\/10,000); not known (cannot be estimated from the available data). Adverse reactions reported with the use of loperamide HCl in clinical trials in adults and children aged ≥ 12 years. Nervous system disorders. Headache. Acute diarrhoea: common; chronic diarrhoea: uncommon. Dizziness. Acute diarrhoea: uncommon; chronic diarrhoea: common. Gastrointestinal disorders. Constipation, nausea, flatulence. Acute diarrhoea: common; chronic diarrhoea: common. Abdominal pain, abdominal discomfort, dry mouth. Acute diarrhoea: uncommon; chronic diarrhoea: uncommon. Upper abdominal pain, vomiting. Acute diarrhoea: uncommon. Dyspepsia. Chronic diarrhoea: uncommon. Abdominal distension. Acute diarrhoea: rare. Skin and subcutaneous tissue disorders. Rash. Acute diarrhoea: uncommon. Adverse reactions reported in post-marketing experience with loperamide HCl: The determination of adverse reactions via post-marketing experience for loperamide HCl does not distinguish between the indications acute and chronic diarrhoea or the populations adults and children; the data collected therefore represent the combination of the indications (acute and chronic diarrhoea) and the populations in question (adults and children). Adverse reactions observed during post-marketing experience for loperamide HCl are listed below by System Organ Class, using MedDRA terminology. Adverse reactions reported with the use of loperamide HCl in post-marketing experience in adults and children. Immune system disorders: hypersensitivity reaction, anaphylactic reaction (including anaphylactic shock), anaphylactic reaction. Nervous system disorders: somnolence, loss of consciousness, drowsiness, depressed level of consciousness, hypertonia, coordination disorders. Eye disorders: miosis. Gastrointestinal disorders: ileus (including paralytic ileus), megacolon (including toxic megacolon), glossodynia, acute pancreatitis (frequency not known). Skin and subcutaneous tissue disorders: bullous eruption (including Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme), angioedema, urticaria, pruritus. Renal and urinary disorders: urinary retention. General disorders and administration site conditions: fatigue. Paediatric population: the safety of loperamide HCl has been evaluated in 607 patients aged 10 days to 13 years, who participated in 13 controlled and uncontrolled clinical trials with loperamide HCl used for the treatment of acute diarrhoea. In general, the ADR profile in this patient population was similar to that observed in clinical trials with loperamide HCl used in adults and children aged 12 years and above. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at http:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-unasospe tta-reazione-avversa.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Imodium 12 Capsules 2 mg.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThe administration of Imodium is contraindicated during pregnancy and breastfeeding. Pregnant or breastfeeding women should therefore be advised to consult their doctor for the most appropriate treatment.\u003c\/span\u003e\u003c\/p\u003e","brand":"JOHNSON \u0026 JOHNSON SpA","offers":[{"title":"Default Title","offer_id":40207824355443,"sku":"023673128","price":12.92,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/johnson-johnson-spa-imodium-12-capsule-2-mg-farmacia-dottor-tili-1213792735.jpg?v=1767126790"},{"product_id":"verolax-ad-rettale-6-clismi-6-75g","title":"Verolax AD Rectal 6 Enemas 6.75g","description":"\u003cp\u003e\u003cstrong\u003eVerolax AD\u003c\/strong\u003e is a drug used to treat occasional constipation. Thanks to its \u003cstrong\u003eglycerol\u003c\/strong\u003e -based formulation, Verolax works by softening the stool and facilitating its expulsion. This rectal enema is indicated for a rapid and delicate action, with local effects that help stimulate intestinal transit without causing irritation or cramps. The package contains \u003cstrong\u003e6 ready-to-use enemas\u003c\/strong\u003e , 6.75g, for rapid and safe relief.\u003c\/p\u003e\n\n\u003cp\u003e Verolax AD is indicated for the treatment of \u003cstrong\u003eoccasional constipation\u003c\/strong\u003e in adults. It is particularly useful in situations where rapid evacuation is necessary, such as before medical or surgical examinations. It can also be used in case of temporary constipation caused by changes in diet, stress or a sedentary lifestyle.\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eActive ingredients contained in Verolax AD Rettale 6 Clismi 6 - What is the active ingredient of Verolax AD Rettale 6 Clismi 6?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eAdults Rectal Solution. 6 single-dose containers 9G: glycerin 6.75 g. Children Rectal Solution. 6 Single-dose Containers 3 G: glycerin 2.25 g. Adults Suppositories: glycerin 2.25 g. Children Suppositories: glycerin 1.375 g. Infants Suppositories: glycerin 0.675 g.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Verolax AD Rectal 6 Enemas 6 - What does Verolax AD Rectal 6 Enemas 6 contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eRectal solution. Adults and Children: mallow fluid extract; chamomile fluid extract; wheat starch; purified water. Suppositories Adults, Children, Infants: sodium stearate, sodium carbonate.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Verolax AD Rectal 6 Enemas 6 - Why is Verolax AD Rectal 6 Enemas 6 used? What is it for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eConstipation.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eContraindications Verolax AD Rectal 6 Enemas 6 - When should Verolax AD Rectal 6 Enemas 6 not be used?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eKnown individual hypersensitivity to the product. Anorectal affections, hemorrhagic rectocolitis and inflammation of hemorrhoids.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Verolax AD Rectal 6 Enemas 6 - How do you take Verolax AD Rectal 6 Enemas 6?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eRectal solution: 1 or 2 single-dose containers in 24 hours. In case of obstinate constipation, no more than 2 doses can be introduced into the rectum at the same time. Suppositories: 1 suppository as needed. Do not exceed the recommended doses.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Verolax AD Rectal 6 Enemas 6 - How do you store Verolax AD Rectal 6 Enemas 6?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eNo special storage precautions.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eWarnings Verolax AD Rectal 6 Enemas 6 - About Verolax AD Rectal 6 Enemas 6 it is important to know that:\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eContinuous use of laxatives can cause addiction or harm of various kinds. Do not use laxatives if you have abdominal pain, nausea and vomiting. If constipation is persistent, consult your doctor.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Verolax AD Rettale 6 Clismi 6 - Which medicines or foods can modify the effect of Verolax AD Rettale 6 Clismi 6?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eNo interactions with other drugs have been found.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Verolax AD Rettale 6 Clismi 6 can cause side effects - What are the side effects of Verolax AD Rettale 6 Clismi 6?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThe only effects that may be encountered are of an irritative nature, at the level of the rectal area. These are usually mild forms, which do not require medical intervention.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n \u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Verolax AD Rettale 6 Clismi 6\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eBased on its chemical-physical properties, rectal glycerin can be usefully used during pregnancy or the puerperium.\u003c\/span\u003e\u003c\/p\u003e","brand":"ANGELINI SpA","offers":[{"title":"Default Title","offer_id":40207824453747,"sku":"026525055","price":5.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/angelini-spa-verolax-ad-rettale-6-clismi-6-75g-farmacia-dottor-tili-1213792736.jpg?v=1767126868"},{"product_id":"benactiv-gola-arancia-16-pastiglie","title":"Benactiv Throat Orange 16 Lozenges","description":"\u003cp dir=\"\"\u003e\u003cspan\u003eBenactiv Gola Arancia is an\u003c\/span\u003e \u003cspan\u003eover-the-counter analgesic medicine\u003c\/span\u003e \u003cspan\u003ebased on \u003cstrong\u003eflurbiprofen\u003c\/strong\u003e indicated to\u003c\/span\u003e \u003cspan\u003e\u003cstrong\u003erelieve sore throat and associated cough\u003c\/strong\u003e ,\u003c\/span\u003e \u003cspan\u003eproviding long-lasting relief for up to 6 hours.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"\"\u003e \u003cspan\u003eBenactiv Gola Arancia combines flurbiprofen, an active \u003cstrong\u003eanalgesic\u003c\/strong\u003e and \u003cstrong\u003eanti-inflammatory\u003c\/strong\u003e ingredient, with the emollient action of a lozenge. It penetrates from the surface to the deepest layers of the throat tissue and\u003c\/span\u003e \u003cspan\u003e\u003cstrong\u003efights irritative-inflammatory conditions of the oropharyngeal cavity\u003c\/strong\u003e , also associated with \u003cstrong\u003epain\u003c\/strong\u003e , such as \u003cstrong\u003egingivitis\u003c\/strong\u003e , \u003cstrong\u003epharyngitis\u003c\/strong\u003e and \u003cstrong\u003estomatitis\u003c\/strong\u003e .\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"\"\u003e \u003cspan\u003eBenactiv Gola Arancia does not contain gluten and can also be taken by celiac subjects.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"\"\u003e\u003cspan\u003eActive ingredients contained in Benactiv Gola Arancia 16 Pastiglie - What is the active ingredient in Benactiv Gola Arancia 16 Pastiglie?\u003c\/span\u003e\u003c\/h3\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003eBenactiv Gola Mouthwash. 100 ml of mouthwash contain the active ingredient: flurbiprofen 250 mg. Excipients with known effects: hydrogenated castor oil-40-polyoxyethylene, methyl parahydroxybenzoate, propyl parahydroxybenzoate, mint essence (containing d-limonene). Benactiv Gola Spray for oral mucosa. 100 ml of solution contain the active ingredient: flurbiprofen 250 mg. Excipients with known effects: hydrogenated castor oil-40-polyoxyethylene, methyl parahydroxybenzoate, propyl parahydroxybenzoate, mint essence (containing d-limonene). Benactiv Gola Lemon and Honey flavour lozenges. One lozenge contains the active ingredient: flurbiprofen 8.75 mg. Excipients with known effects: liquid glucose (containing sulphites and wheat starch), liquid sucrose, honey, lemon flavouring and levomenthol (containing butylated hydroxyanisole, citral, citronellol, d-limonene, farnesol, geraniol, linalool). Benactiv Gola Sugar Free Lozenges Orange flavour. One lozenge contains the active ingredient: flurbiprofen 8.75mg. Excipients with known effects: liquid maltitol (E965), isomalt (E953), orange flavouring and levomenthol (containing citral, citronellol, d-limonene, geraniol, linalool). Benactiv Gola Sugar Free Lozenges Eucalyptus and Manuka Honey flavour. One lozenge contains the active ingredient: flurbiprofen 8.75mg. Excipients with known effect: liquid maltitol (E965), isomalt (E953), eucalyptus flavour and Manuka honey (containing anisilicate alcohol, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, cinnamal, cinnamyl alcohol, citral, geraniol, d-limonene, linalool). For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"\"\u003e \u003cspan\u003eComposition of Benactiv Gola Arancia 16 Pastilles - What does Benactiv Gola Arancia 16 Pastilles contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003eBenactiv Gola Mouthwash: glycerol, ethanol (96 percent), sorbitol 70, hydrogenated castor oil-40-polyoxyethylene, sodium hydroxide, sodium saccharin, methyl parahydroxybenzoate, propyl parahydroxybenzoate, mint essence (containing d-limonene), patent blue V (E131), purified water. Benactiv Gola Spray for oral mucosa: glycerol, ethanol (96 percent), sorbitol 70, hydrogenated castor oil-40-polyoxyethylene, sodium hydroxide, sodium saccharin, methyl parahydroxybenzoate, propyl parahydroxybenzoate, mint essence (containing d-limonene), patent blue V (E131), purified water. Benactiv Gola Lemon and Honey Flavour Pastilles: liquid sucrose, liquid glucose (containing sulphites and wheat starch), macrogol 300, potassium hydroxide, lemon flavouring and levomenthol (containing butylated hydroxyanisole, citral, citronellol, d-limonene, farnesol, geraniol, linalool), honey. Benactiv Gola Sugar Free Pastilles Orange Flavour: macrogol 300, potassium hydroxide, orange flavouring and levomenthol (containing citral, citronellol, d-limonene, geraniol, linalool), acesulfame potassium (E950), liquid maltitol (E965), isomalt (E953). Benactiv Gola Sugar Free Lozenges Eucalyptus and Manuka Honey Flavour: macrogol 300, potassium hydroxide, ammonia caramel (E150c), curcumin (E100), eucalyptus and Manuka honey flavouring (containing anisyl alcohol, benzyl alcohol, benzyl benzoate, benzyl cinnamate, benzyl salicylate, cinnamal, cinnamyl alcohol, citral, geraniol, d-limonene, linalool), acesulfame potassium (E950), liquid maltitol (E965), isomalt (E953).\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"\"\u003e \u003cspan\u003eTherapeutic indications Benactiv Gola Arancia 16 Pastiglie - Why is Benactiv Gola Arancia 16 Pastiglie used? What is it for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"\"\u003e \u003cspan\u003eBenactiv Gola Mouthwash; Benactiv Gola Spray for oral mucosa: symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis), also as a consequence of conservative or extractive dental therapy. Benactiv Gola Lemon and Honey flavour lozenges; Benactiv Gola Sugar-Free Lozenges Orange flavour; Benactiv Gola Sugar-Free Lozenges Eucalyptus and Manuka Honey flavour: symptomatic treatment of irritative-inflammatory conditions also associated with pain in the oropharyngeal cavity (e.g. gingivitis, stomatitis, pharyngitis).\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"\"\u003e \u003cspan\u003eContraindications Benactiv Gola Arancia 16 Pastilles - When should Benactiv Gola Arancia 16 Pastilles not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003eDo not use the medicinal product in children under 12 years of age. Flurbiprofen is contraindicated in patients with known hypersensitivity to flurbiprofen or to any of the excipients listed in section 6.1. Patients who have previously shown hypersensitivity reactions (e.g. asthma, urticaria, allergy, rhinitis, angioedema, bronchospasm) to ibuprofen, acetylsalicylic acid (aspirin) or other nonsteroidal anti-inflammatory drugs (NSAIDs). Flurbiprofen is also contraindicated in patients with a history of gastrointestinal bleeding or perforation related to previous NSAID treatment. Flurbiprofen should not be taken by patients with active or history of ulcerative colitis, Crohn's disease, recurrent peptic ulcer or gastrointestinal bleeding (defined as two or more distinct episodes of proven ulceration or bleeding). Flurbiprofen is contraindicated in patients with severe heart failure, severe hepatic failure and renal failure (see section 4.4). Third trimester of pregnancy.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"\"\u003e \u003cspan\u003eQuantity and method of taking Benactiv Gola Arancia 16 Pastiglie - How to take Benactiv Gola Arancia 16 Pastiglie?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003eThe lowest effective dose should be used for the shortest duration necessary to relieve symptoms (see section 4.4). Benactiv Gola Mouthwash. Dosage. Adults: 2-3 rinses or gargles per day with 10 ml (1 measuring spoon) of mouthwash. Paediatric population. Children over 12 years of age: as for adults. Children under 12 years of age: do not administer to children under 12 years of age (see section 4.3). Special populations. Elderly: the clinical data currently available are limited, therefore no recommendation on posology can be made. The elderly are at increased risk of serious consequences in case of adverse reactions (see section 4.4). Patients with hepatic insufficiency: a dosage reduction is not necessary in patients with mild to moderate hepatic insufficiency. Flurbiprofen is contraindicated in patients with severe hepatic insufficiency (see section 4.3). Patients with renal insufficiency: no dosage reduction is necessary in patients with mild to moderate renal insufficiency. Flurbiprofen is contraindicated in patients with severe hepatic insufficiency (see section 4.3). Method of administration: for oropharyngeal use. Rinse or hold in the mouth during gargling for up to 1 minute. Do not swallow. The mouthwash can be used pure or diluted in half a glass of water. Benactiv Gola Spray for oral mucosa. Dosage. Adults: apply one dose (2 sprays) 3 times a day, directed directly at the affected area. Each spray delivers 0.2 ml of solution, equivalent to 0.5 mg of active ingredient. Paediatric population. Children Over 12 years of age: as for adults. Children under 12 years of age: do not administer to children under 12 years of age (see section 4.3). Special populations. Elderly: The clinical data currently available are limited, therefore no recommendation on dosage can be made. Elderly people are at increased risk of serious consequences in case of adverse reactions (see section 4.4). Patients with hepatic impairment: no dosage reduction is necessary in patients with mild to moderate hepatic impairment. Flurbiprofen is contraindicated in patients with severe hepatic impairment (see section 4.3). Patients with renal impairment: no dosage reduction is necessary in patients with mild to moderate renal impairment. Flurbiprofen is contraindicated in patients with severe hepatic impairment (see section 4.3). Method of administration: for oropharyngeal use. Aim the dispenser towards the back of the throat and spray on the affected area. Benactiv Gola Lemon and Honey flavoured Lozenges; Benactiv Gola Sugar Free Lozenges Orange flavoured; Benactiv Gola Sugar Free Lozenges Eucalyptus and Manuka Honey flavoured. Dosage. Adults: 1 lozenge every 3-6 hours, as needed. Do not exceed 8 lozenges in 24 hours. Paediatric population. Children over 12 years of age: as for adults. Children under 12 years of age: do not administer to children under 12 years of age (see section 4.3). Special populations. Elderly: Currently available clinical data are limited, therefore no recommendation on posology can be made. Elderly are at increased risk of serious consequences in case of adverse reactions (see section 4.4). Patients with hepatic impairment: no dosage reduction is necessary in patients with mild to moderate hepatic impairment. Flurbiprofen is contraindicated in patients with severe hepatic impairment (see section 4.3). Patients with renal impairment: no dosage reduction is necessary in patients with mild to moderate renal impairment. Flurbiprofen is contraindicated in patients with severe hepatic impairment (see section 4.3). Method of administration: For oropharyngeal use. Dissolve slowly in the mouth. As with all lozenges, flurbiprofen lozenges should be moved around the mouth during administration to avoid local irritation. If mouth irritation occurs, treatment should be discontinued.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"\"\u003e \u003cspan\u003eStorage Benactiv Gola Arancia 16 Pastilles - How do you store Benactiv Gola Arancia 16 Pastilles?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"\"\u003e \u003cspan\u003eBenactiv Gola Sugar-Free Lozenges Orange Flavour\/Lemon and Honey Flavour Lozenges\/Sugar-Free Lozenges Eucalyptus and Manuka Honey Flavour: store below 25 degrees C.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"\"\u003e \u003cspan\u003eWarnings Benactiv Gola Arancia 16 Pastiglie - About Benactiv Gola Arancia 16 Pastiglie it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003eAt the recommended doses, when using the medicinal product in its various pharmaceutical forms, any swallowing does not cause any harm to the patient, as the dose of flurbiprofen is much lower than that commonly used in systemic treatments. Elderly: elderly patients have an increased frequency of adverse reactions to NSAIDs, especially gastrointestinal bleeding and perforation, which may be fatal. Respiratory disorders: cases of bronchospasm have been reported with flurbiprofen in patients with a history of bronchial asthma or allergies. Flurbiprofen should be used with caution in these patients. Other NSAIDs: it is advisable not to combine the medicinal product with other NSAIDs (see section 4.5). Systemic lupus erythematosus (SLE) and mixed connective tissue disease: Patients with systemic lupus erythematosus and mixed connective tissue disease may be at increased risk of aseptic meningitis (see section 4.8), however, this effect is not usually seen with products intended for limited and short-term use such as flurbiprofen. Cardiac, hepatic and renal impairment: The medicinal product should be used with caution in patients with cardiac, renal or hepatic insufficiency. NSAIDs have been reported to cause various forms of nephrotoxicity, including interstitial nephritis, nephrotic syndrome and renal failure. Administration of an NSAID may cause a dose-dependent reduction in prostaglandin formation and precipitate renal failure. Patients at greatest risk of developing this reaction are those with impaired renal function, cardiac impairment, hepatic dysfunction, those on diuretic therapy and the elderly; however, this effect is not usually seen with products intended for limited and short-term use such as flurbiprofen. Cardiovascular and cerebrovascular effects: Caution is advised before initiating treatment in patients with a history of hypertension and\/or heart failure (discuss with your doctor or pharmacist), since fluid retention, hypertension and oedema have been reported in association with NSAID treatment. Clinical trial and epidemiological data suggest that use of some NSAIDs, particularly at high doses and in long-term treatment, may be associated with a small increased risk of arterial thrombotic events such as myocardial infarction or stroke. There are insufficient data to exclude a similar risk for flurbiprofen. Patients with uncontrolled hypertension, congestive heart failure, established ischaemic heart disease, peripheral arterial disease and\/or cerebrovascular disease should only be treated with flurbiprofen after careful consideration. Similar consideration should be made before initiating long-term treatment in patients with risk factors for cardiovascular disease (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking). Central nervous system effects: Analgesic-induced headache. Headache may occur with prolonged or inappropriate use of analgesics, which should not be treated by increasing the dose of the medicinal product. Gastrointestinal effects: Flurbiprofen should be administered with caution to patients with a history of peptic ulcer and other gastrointestinal diseases as these conditions may be exacerbated. The risk of gastrointestinal bleeding, ulceration or perforation is higher with increasing flurbiprofen dosage in patients with a history of ulcer, particularly if complicated with haemorrhage and perforation and in the elderly. These patients should start treatment on the lowest available dose. Gastrointestinal bleeding, ulceration or perforation have been reported with all NSAIDs at any time during treatment. These adverse reactions can be fatal and may occur with or without warning symptoms or in case of a previous history of serious gastrointestinal reactions. Patients with a history of gastrointestinal disease, particularly when elderly, should report any unusual abdominal symptoms (especially gastrointestinal bleeding) in the early stages of treatment. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2). Caution should be advised in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin reuptake inhibitors or anti-platelet agents such as acetylsalicylic acid (see section 4.5). When gastrointestinal bleeding or ulceration occurs in patients receiving flurbiprofen, the treatment should be withdrawn. Dermatological effects: Use of the medicinal product, especially if prolonged, may give rise to sensitisation or local irritation phenomena. In such cases, treatment should be discontinued and a doctor should be consulted to institute, if necessary, an appropriate therapy. Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). Flurbiprofen should be discontinued at the first appearance of skin rash, mucosal lesions, or any other sign of hypersensitivity. Infections: Since isolated cases of exacerbation of infection-related inflammation (e.g. development of necrotising fasciitis) have been described in temporal association with the systematic use of NSAIDs, patients are advised to seek medical advice immediately if signs of bacterial infection appear or worsen during flurbiprofen therapy. The possibility of initiating antibiotic therapy should be considered. If mouth irritation develops, treatment should be discontinued. Masking of symptoms of underlying infections: Epidemiological studies suggest that systemic nonsteroidal anti-inflammatory drugs (NSAIDs) may mask the symptoms of infection, which may lead to delays in initiating appropriate treatment and thus worsen the outcome of the infection. This has been observed in community-acquired bacterial pneumonia and in bacterial complications of chickenpox.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"\"\u003e \u003cspan\u003eInteractions Benactiv Gola Arancia 16 Pastiglie - Which medicines or foods can modify the effect of Benactiv Gola Arancia 16 Pastiglie?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003eCaution should be exercised in patients treated with any of the following medicinal products, as interactions have been reported in some patients. Inform your doctor if you are taking other medicinal products. Flurbiprofen should be avoided in combination with aspirin: unless low dose aspirin (not exceeding 100 mg\/day or local prophylactic doses for cardiovascular protection) has been recommended by your doctor; as with other NSAID-containing medicinal products, concomitant administration of flurbiprofen and aspirin is generally not recommended due to the potential for increased adverse effects (see section 4.4). Cox-2 inhibitors and other NSAIDs: Concomitant use of other NSAIDs, including cyclooxygenase-2 selective inhibitors, should be avoided due to the potential for additive effects and an increased risk of adverse reactions (see section 4.4). Flurbiprofen should be used with caution in combination with anticoagulants: NSAIDs may enhance the effects of anticoagulants such as warfarin (see section 4.4). Antiplatelet agents: increased risk of gastrointestinal bleeding. Selective serotonin reuptake inhibitors (SSRIs): increased risk of gastrointestinal bleeding. Antihypertensives (diuretics, ACE inhibitors and angiotensin II antagonists): NSAIDs may reduce the effect of diuretics. Other antihypertensive drugs may enhance nephrotoxicity caused by inhibition of cyclooxygenase, especially in patients with impaired renal function (these patients must be adequately hydrated). Alcohol: may increase the risk of adverse reactions, especially bleeding in the gastrointestinal tract. Cardiac glycosides: NSAIDs may exacerbate cardiac failure, reduce GFR (glomerular filtration rate) and increase plasma glycoside levels. Ciclosporin: Increased risk of nephrotoxicity. Corticosteroids: Increased risk of gastrointestinal ulceration or haemorrhage with NSAIDs (see section 4.4). Lithium: There is evidence of a possible increase in lithium plasma levels. Methotrexate: There may be an increase in methotrexate plasma levels. Mifepristone: NSAIDs should not be used for 8-12 days after mifepristone administration, as NSAIDs may reduce the effect of mifepristone. Quinolone antibiotics: Animal data indicate that NSAIDs may increase the risk of convulsions associated with quinolone antibiotics. Patients taking NSAIDs and quinolones may have an increased risk of developing convulsions. Tacrolimus: Possible increased risk of nephrotoxicity when NSAIDs are administered with tacrolimus. Zidovudine: Increased risk of haematological toxicity when NSAIDs are administered with zidovudine.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"\"\u003e \u003cspan\u003eLike all medicines, Benactiv Gola Arancia 16 Pastiglie can cause side effects - What are the side effects of Benactiv Gola Arancia 16 Pastiglie?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003eHypersensitivity reactions to NSAIDs have been reported and may consist of: (a) non-specific allergic reactions and anaphylaxis; (b) respiratory tract reactivity, e.g. asthma, aggravated asthma, bronchospasm, dyspnoea; (c) various skin disorders, including e.g. rashes of various types, pruritus, urticaria, purpura, angioedema and, more rarely, exfoliative and bullous dermatoses (including epidermal necrolysis and erythema multiforme). The most commonly observed adverse reactions are gastrointestinal in nature. Local use of the medicinal product, especially if prolonged, may give rise to sensitization or local irritation phenomena. Dissolution of the medicinal product in the oral cavity in tablet form may be accompanied by sensations of heat or tingling in the oropharynx. In such cases, treatment should be discontinued and, if necessary, appropriate therapy instituted. The following undesirable effects have been reported, particularly after administration of systemic formulations. They refer to those observed with the use of flurbiprofen used short-term and at doses compatible with the classification of over-the-counter medicines. In case of treatment of chronic conditions and for long periods of time, additional undesirable effects may occur. The undesirable effects associated with the use of flurbiprofen are divided below according to the system organ class and frequency. The frequency is defined as: very common (\u0026gt;= 1\/10), common (\u0026gt;=1\/100, \u0026lt;1\/10), uncommon (\u0026gt;=1\/1,000, \u0026lt;1\/100), rare (\u0026gt;=1\/10,000, \u0026lt;1\/1,000), very rare (\u0026lt;1\/10,000) and not known (the frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Blood and lymphatic system disorders. Not known: anaemia, thrombocytopenia, aplastic anaemia and agranulocytosis. Nervous system disorders. Common: dizziness, headache, paraesthesia; uncommon: somnolence; not known: cerebrovascular accident, optic neuritis, migraine, confusional states, vertigo. Immune system disorders. Rare: anaphylactic reaction; not known: angioedema, hypersensitivity. Eye disorders. Not known: visual impairment. Ear and labyrinth disorders. Not known: tinnitus. Cardiac disorders. Not known: cardiac failure, oedema. Vascular disorders. Not known: hypertension. Respiratory, thoracic and mediastinal disorders. Common: throat irritation; uncommon: asthma, bronchospasm and dyspnoea, oropharyngeal vesicular eruption, oropharyngeal hypoaesthesia. Gastrointestinal disorders. Common: diarrhoea, mouth ulceration, nausea, oral pain, oral paraesthesia, oropharyngeal pain, oral discomfort (warm or burning sensation, tingling of the mouth); uncommon: abdominal distension, abdominal pain, constipation, dry mouth, dyspepsia, flatulence, glossodynia, dysgeusia, oral dysaesthesia, vomiting; not known: melaena, haematemesis, gastrointestinal haemorrhage, colitis, exacerbation of Crohn's disease, gastritis, peptic ulcer, gastric perforation, ulcer haemorrhage. Skin and subcutaneous tissue disorders. Uncommon: rash, pruritus; not known: urticaria, purpura, bullous dermatitis (including Stevens-Johnson syndrome, toxic epidermal necrolysis and erythema multiforme). Renal and urinary disorders. Not known: toxic nephropathy, tubulointerstitial nephritis and nephrotic syndrome, renal failure (as with other NSAIDs). General disorders and administration site conditions. Uncommon: pyrexia, pain; not known: discomfort, fatigue. Hepatobiliary disorders. Not known: hepatitis. Psychiatric disorders. Uncommon: insomnia; not known: depression, hallucination. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Benactiv Gola Arancia 16 Pastiglie.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"\"\u003e\u003cspan\u003ePregnancy: There are no clinical data on the use of Benactiv Gola during pregnancy. Although systemic exposure is lower than with oral administration, it is not known whether the systemic exposure of Benactiv Gola reached after topical administration can be harmful to an embryo\/fetus. During the first and second trimester of pregnancy Benactiv Gola should not be administered unless strictly necessary. If administered, the dose should be the lowest possible and the duration of treatment as short as possible. During the third trimester of pregnancy, systemic use of prostaglandin synthase inhibitors, including Benactiv Gola, may induce cardiopulmonary and renal toxicity in the fetus. At the end of pregnancy, prolonged bleeding time may occur in both the mother and the child and labor may take longer. Therefore, Benactiv Gola is contraindicated during the last trimester of pregnancy (see section 4.3). Breastfeeding: In a limited number of studies, flurbiprofen appears in breast milk at very low concentrations and is unlikely to have any adverse effects on the breast-fed infant. However, administration of flurbiprofen is not recommended in nursing mothers. Fertility: There is evidence that cyclooxygenase\/prostaglandin synthesis inhibitors may cause impairment of female fertility by an effect on ovulation. This is reversible upon discontinuation of treatment.\u003c\/span\u003e\u003c\/p\u003e","brand":"RECKITT BENCKISER H.(IT.) SpA","offers":[{"title":"Default Title","offer_id":40207824552051,"sku":"033262078","price":12.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/reckitt-benckiser-h-it-spa-benactiv-gola-arancia-16-pastiglie-farmacia-dottor-tili-1213792732.webp?v=1767126886"},{"product_id":"fexallegra-10-compresse-rivestite-120-mg","title":"Fexallegra 10 Coated Tablets 120 mg","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eFexallegra 10 Coated Tablets 120 mg\u003c\/span\u003e \u003cspan\u003eis a drug indicated for the symptomatic treatment of seasonal and chronic allergies, such as allergic rhinitis and urticaria. The active ingredient, fexofenadine hydrochloride, belongs to the category of second-generation antihistamines, known for their ability to effectively reduce allergic symptoms without causing marked drowsiness. Thanks to its 120 mg formulation, Fexallegra acts quickly, with a prolonged effect that lasts up to 24 hours, improving the quality of life during allergy seasons.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eFexallegra is indicated for:\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\n\n\u003cp dir=\"ltr\" role=\"presentation\"\u003e \u003cspan\u003eSymptomatic treatment of\u003c\/span\u003e \u003cspan\u003eseasonal allergic rhinitis\u003c\/span\u003e \u003cspan\u003ein adults and adolescents aged 12 years and above.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli dir=\"ltr\" aria-level=\"1\"\u003e\n\n\u003cp dir=\"ltr\" role=\"presentation\"\u003e \u003cspan\u003eChronic idiopathic urticaria\u003c\/span\u003e \u003cspan\u003e, reducing symptoms such as itching and the appearance of wheals.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eActive ingredients contained in Fexallegra 10 Coated Tablets 120 mg - What is the active ingredient of Fexallegra 10 Coated Tablets 120 mg?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eOne tablet contains: active substance: 120 mg fexofenadine hydrochloride, equivalent to 112 mg fexofenadine. For a full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Fexallegra 10 Coated Tablets 120 mg - What does Fexallegra 10 Coated Tablets 120 mg contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eTablet core: microcrystalline cellulose; pregelatinized maize starch; croscarmellose sodium; magnesium stearate. Film coating: hypromellose; povidone K30; titanium dioxide (E171); colloidal anhydrous silica; macrogol 400; red iron oxide (E172), yellow iron oxide (E172).\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Fexallegra 10 Coated Tablets 120 mg - Why is Fexallegra 10 Coated Tablets 120 mg used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eFexallegra is indicated in adults and children aged 12 years and above for the symptomatic treatment of allergic rhinitis.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Fexallegra 10 Coated Tablets 120 mg - When should Fexallegra 10 Coated Tablets 120 mg not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThe medicinal product is contraindicated in patients with hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Fexallegra 10 Coated Tablets 120 mg - How to take Fexallegra 10 Coated Tablets 120 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eDosage. Adults: The recommended dose of fexofenadine hydrochloride for adults is 120 mg once daily, before meals. Fexofenadine is a pharmacologically active metabolite of terfenadine. Paediatric population. Children aged 12 years and above: The recommended dose of fexofenadine hydrochloride for children aged 12 years and above is 120 mg once daily, before meals. Children under 12 years of age: The efficacy and safety of fexofenadine hydrochloride 120 mg have not been studied in children under 12 years of age. In children aged 6 to 11 years: fexofenadine hydrochloride 30 mg tablets is the appropriate formulation for administration and dosing in this population. Special populations: Studies performed in groups of patients at risk (elderly, patients with renal or hepatic insufficiency) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n \u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Fexallegra 10 Coated Tablets 120 mg - How to store Fexallegra 10 Coated Tablets 120 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThis medicinal product does not require any special storage conditions.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Fexallegra 10 Coated Tablets 120 mg - About Fexallegra 10 Coated Tablets 120 mg it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eData in elderly subjects and in patients with impaired renal or hepatic function are limited. Fexofenadine hydrochloride should be administered with caution to these groups of subjects (see section 4.2). Patients with pre-existing or existing cardiovascular disease should be informed that antihistamines, as a class of medicinal products, have been associated with adverse reactions such as tachycardia and palpitations (see section 4.8). Fexallegra contains sodium: this medicinal product contains less than 1 mmol sodium (23 mg) per tablet, i.e. essentially \"sodium-free\".\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Fexallegra 10 Coated Tablets 120 mg - Which medicines or foods can modify the effect of Fexallegra 10 Coated Tablets 120 mg?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eFexofenadine does not undergo hepatic biotransformation and therefore does not interact with other medicinal products at the level of hepatic mechanisms. Fexofenadine is a substrate of P-glycoprotein (P-gp) and organic anion transporting polypeptide (OATP). Concomitant use of fexofenadine with inhibitors or inducers of P-gp may influence the exposure to fexofenadine; co-administration of fexofenadine hydrochloride with the P-gp inhibitors, erythromycin or ketoconazole has been found to increase the plasma levels of fexofenadine by 2-3 fold. These alterations were not accompanied by any effect on the QT interval and were not associated with any increase in adverse reactions compared to those observed with the same medicinal products administered alone. A clinical drug-drug interaction study demonstrated that co-administration of apalutamide (a weak P-gp inducer) and a single oral dose of 30 mg fexofenadine resulted in a 30% decrease in fexofenadine AUC. No interaction was observed between fexofenadine and omeprazole. However, administration of an antacid containing aluminium and magnesium hydroxide 15 minutes prior to administration of fexofenadine hydrochloride resulted in a reduction in bioavailability, most likely due to binding in the gastrointestinal tract. A 2-hour interval between administration of fexofenadine hydrochloride and antacids containing aluminium and magnesium hydroxide is recommended.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Fexallegra 10 Coated Tablets 120 mg can cause side effects - What are the side effects of Fexallegra 10 Coated Tablets 120 mg?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe following frequency category has been used, where applicable: very common (\u0026gt;= 1\/10); common (\u0026gt;= 1\/100 and \u0026lt; 1\/10); uncommon (\u0026gt;= 1\/1,000 and \u0026lt; 1\/100); rare (\u0026gt;= 1\/10,000 and \u0026lt; 1\/1,000); very rare (\u0026lt; 1\/10,000) and not known (frequency cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. In adults, the following undesirable effects have been reported in clinical trials with an incidence similar to that observed with placebo. Nervous system disorders. Common: headache, somnolence, dizziness. Gastrointestinal disorders. Common: nausea. Systemic disorders and administration site conditions. Uncommon: fatigue. In adults, the following undesirable effects have been reported in post-marketing surveillance. The frequency with which they occur is not known (cannot be estimated from the available data). Immune system disorders: hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnoea, hot flushes and systemic anaphylaxis. Psychiatric disorders: insomnia, nervousness, sleep disturbances or nightmares\/excessive dreaming (paroniria). Cardiac disorders: tachycardia, palpitations. Gastrointestinal disorders: diarrhoea. Skin and subcutaneous tissue disorders: rash, urticaria and pruritus. Eye disorders: Not known: blurred vision. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Fexallegra 10 Coated Tablets 120 mg.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePregnancy: There are no adequate data from the use of fexofenadine hydrochloride in pregnant women. Limited animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal\/foetal development, parturition or postnatal development (see section 5.3). Fexofenadine hydrochloride should not be used during pregnancy unless clearly necessary. Breastfeeding: There are no data on the concentration in breast milk after administration of fexofenadine hydrochloride. However, when terfenadine was administered to nursing mothers, fexofenadine was found to pass into breast milk. Therefore, the use of fexofenadine hydrochloride is not recommended during breastfeeding. Fertility: There are no data on the consumption of fexofenadine hydrochloride on human fertility. In mice, treatment with fexofenadine hydrochloride showed no effect on fertility (see section 5.3).\u003c\/span\u003e\u003c\/p\u003e","brand":"SANOFI SpA","offers":[{"title":"Default Title","offer_id":40207824584819,"sku":"042554042","price":12.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/sanofi-spa-fexallegra-10-compresse-rivestite-120-mg-farmacia-dottor-tili-1213792731.jpg?v=1767126850"},{"product_id":"enterogermina-gonfiore-probiotici-10-bustine-bipartite","title":"Enterogermina Swelling Probiotics 10 Bipartite Sachets","description":"\u003cp\u003eEnterogermina Gonfiore Probiotici 10 Bipartite Sachets \u003cstrong\u003elactic ferments with probiotic action\u003c\/strong\u003e with a specific formulation based on \u003cstrong\u003eenzymes, probiotics and plant extracts\u003c\/strong\u003e . The action of probiotics \u003cstrong\u003epromotes the balance of the intestinal bacterial flora\u003c\/strong\u003e . Digestive enzymes are protein molecules present in all living organisms, including the human body. They play a fundamental role in the digestion of food, because \u003cstrong\u003ethey accelerate and catalyze chemical reactions\u003c\/strong\u003e . Plant extracts (mint leaves and coriander fruits) help digestive functions and \u003cstrong\u003eregular gastrointestinal motility\u003c\/strong\u003e , promoting the \u003cstrong\u003eelimination of gas\u003c\/strong\u003e at the origin of abdominal swelling.\u003c\/p\u003e\n\n\u003cp\u003e Enterogermina gonfia is a \u003cstrong\u003egluten-free and lactose-free\u003c\/strong\u003e product.\u003c\/p\u003e\n\n\u003cp\u003e Enterogermina Gonfiore works thanks to its triple action:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eRebalances the intestinal bacterial flora\u003c\/strong\u003e thanks to the administration of probiotics;\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eReduces bacterial fermentation\u003c\/strong\u003e ;\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eIt helps intestinal motility\u003c\/strong\u003e to expel gas accumulated inside the stomach.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp\u003e Enterogermina Gonfiore Probiotici 10 Bipartite Sachets is presented in the format of double sachets to be taken together in half a glass of water. The first group of sachets contains:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eProbiotics\u003c\/strong\u003e , such as Bifidobacterium Animalis subsp. Lactis and Lactobacillius acidophilus, which perform the function of rebalancing the intestinal flora highly compromised by various factors.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp\u003e In the other group of sachets there are:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eFOS\u003c\/strong\u003e (fructooligosaccharides), prebiotics essential for the development and nourishment of intestinal bacteria;\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDry extract of mint leaves\u003c\/strong\u003e , highly appreciated for their spasmolytic and anti-flatulence properties, essential for restored gastrointestinal motility;\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eDry coriander extract\u003c\/strong\u003e , which works by reducing the symptoms of aerophagia;\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eα-galactosidase\u003c\/strong\u003e , a digestive enzyme that prevents the accumulation of intestinal gas. \u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\n\u003cdiv align=\"justify\"\u003e\n\n\u003ch3 data-mce-fragment=\"1\"\u003e Dosage and method of use Enterogermina Gonfiore Probiotics 10 Bipartite Sachets\u003c\/h3\u003e\n\n Cut both sachets of Enterogermina Gonfiore along the dotted line and drop the contents into half a glass of water. Stir to dissolve the powder. Drink the resulting suspension preferably before the main meal. \u003c\/div\u003e\n\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\n\u003ch3 align=\"justify\"\u003eActive ingredients and Excipients Enterogermina Gonfiore Probiotics 10 Bipartite Sachets\u003c\/h3\u003e\n\n\u003cdiv align=\"justify\"\u003e Average analysis per daily dose (1 paired sachet)\u003cbr\u003e\u003cbr\u003e Bifidobacterium animalis subsp. Lactis (BB-12) 2 billion UFC\u003cbr\u003e\u003cbr\u003e Lactobacillus acidophilus (LA-5) 1 billion CFU\u003cbr\u003e\u003cbr\u003e Fructo-oligosaccharides 1,750 mg\u003cbr\u003e\u003cbr\u003e Dry extract of mint leaves 200 mg\u003cbr\u003e\u003cbr\u003e Coriander fruit es 50 mg\u003cbr\u003e\u003cbr\u003e Fermented maltodextrin 40 mg\u003cbr\u003e\u003cbr\u003e Alpha-galactosidase 20 mg\u003c\/div\u003e\n\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\n\u003cdiv align=\"justify\"\u003e \n\u003cstrong\u003eProbiotic ingredients\u003c\/strong\u003e : fructo-oligosaccharides, fructose, Bifidobacterium Animalis subsp. Lactis (BB-12) DSM 15954 (maltodextrin), Lactobacillus Acidophilus (LA-5) DMS 13241 (maltodextrin), anti-caking agent: silicon dioxide, flavouring.\u003c\/div\u003e\n\n\u003cdiv align=\"justify\"\u003e\n\n\u003cbr\u003e \u003cstrong\u003eIngredients: enzymes\u003c\/strong\u003e : fructose, fructo-oligosaccharides, Mint (Mentha piperita L., maltodextrin, silicon dioxide) leaves dry extract 0.5% rosmarinic acid, Coriander (Coriandrum sativum L., corn maltodextrin) fruit dry extract, Enzymix – fermented maltodextrins (rice dextrins), flavourings, alpha-galactosidase from Aspergillus niger (maltodextrins) 1% thousands of GAL, anti-caking agent: silicon dioxide, acidifier: citric acid. \u003c\/div\u003e\n\n\u003cdiv align=\"justify\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\n\u003cdiv align=\"justify\"\u003e\n\u003cbr\u003e\n\n\u003c\/div\u003e\n\n\u003cdiv align=\"justify\"\u003e\n\n\u003ch3\u003e Special warnings Enterogermina Gonfiore Probiotics 10 Bipartite Sachets\u003c\/h3\u003e\n\n \u003cp\u003eProbiotics and enzymes are very delicate elements that must be stored with the utmost care to preserve their functionality. This is why Enterogermina gonfia is composed of coupled sachets that allow the separate storage of the two nutrients until the moment of intake.\u003cbr\u003e Do not exceed the recommended dose. Food supplements should not be considered as a substitute for a varied and balanced diet and a healthy lifestyle. Keep out of reach of children under 3 years of age.\u003c\/p\u003e\n\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\n\u003ch3\u003e Expiry and storage Enterogermina Gonfiore Probiotics 10 Bipartite Sachets\u003c\/h3\u003e\n\n Store the product at a temperature below 30°C. The expiry date refers to the product correctly stored in an intact package. Do not dispose of in the environment.\u003cbr\u003e\n\n\u003c\/div\u003e","brand":"SANOFI SpA","offers":[{"title":"Default Title","offer_id":40207824650355,"sku":"935190393","price":15.72,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/sanofi-spa-enterogermina-gonfiore-probiotici-10-bustine-bipartite-farmacia-dottor-tili-1213792713.jpg?v=1767126929"},{"product_id":"tachifludec-limone-polvere-10-bustine","title":"Tachifludec Lemon Powder 10 Sachets","description":"\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eTachifludec Lemon Powder 10 Sachets is an\u003c\/span\u003e \u003cb\u003eover-the-counter analgesic and antipyretic\u003c\/b\u003e \u003cspan style=\"font-weight: 400;\"\u003epowder based on Paracetamol, Ascorbic Acid and Phenylephrine hydrochloride. Tachifludec Lemon Powder is indicated for the\u003c\/span\u003e \u003cb\u003esymptomatic treatment of influenza, colds and feverish and painful conditions\u003c\/b\u003e \u003cspan style=\"font-weight: 400;\"\u003erelated to them. The decongestant action of Tachifludec on the upper airways\u003c\/span\u003e \u003cb\u003efluidifies and frees from mucus and phlegm\u003c\/b\u003e \u003cspan style=\"font-weight: 400;\"\u003ein case of cough and cold.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp\u003e Tachifludec Lemon Flavor 10 Sachets is a preparation formulated with:\u003c\/p\u003e\n\n\u003cp\u003e • \u003cstrong\u003eParacetamol\u003c\/strong\u003e : active ingredient with antipyretic and analgesic action which makes the medicine particularly suitable in cases of: pain and spasms in the stomach and intestines, pain caused by obstacles in the flow of the urinary tract and biliary tract and menstrual pain.\u003c\/p\u003e\n\n \u003cp\u003e• \u003cstrong\u003eVitamin C\u003c\/strong\u003e (Ascorbic Acid): active ingredient that participates in the body's defense system.\u003c\/p\u003e\n\n\u003cp\u003e • \u003cstrong\u003ePhenylephrine Hydrochloride\u003c\/strong\u003e : sympathomimetic active ingredient that acts by causing vasoconstriction of the local vascular bed, improving the symptoms of nasal obstruction.\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Tachifludec Lemon Powder 10 Sachets - What is the active ingredient of Tachifludec Lemon Powder 10 Sachets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eEach sachet contains active ingredients: paracetamol 600 mg, ascorbic acid 40 mg and phenylephrine hydrochloride 10 mg (equivalent to phenylephrine 8.2 mg). Excipients with known effects: Tachifludec lemon flavour contains: 1.817 g of sucrose, 112.86 mg of sodium, 6.65 mg of glucose. Tachifludec lemon and honey flavour contains: 1.892 g of sucrose, 135.79 mg of sodium. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eComposition of Tachifludec Lemon Powder 10 Sachets - What does Tachifludec Lemon Powder 10 Sachets contain?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eTachifludec powder for oral solution lemon flavour: sucrose, anhydrous citric acid, sodium citrate, corn starch, sodium cyclamate, sodium saccharin, anhydrous colloidal silica, lemon flavouring, curcumin (E100), dried glucose syrup. Tachifludec powder for oral solution lemon and honey flavour: sucrose, anhydrous citric acid, sodium citrate, corn starch, sodium cyclamate, sodium saccharin, lemon flavouring, honey flavouring, caramel (E150), anhydrous colloidal silica.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Tachifludec Lemon Powder 10 Sachets - Why is Tachifludec Lemon Powder 10 Sachets used? What is it for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eShort-term treatment of cold and flu symptoms, including mild to moderate pain and fever, when associated with nasal congestion.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n \u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Tachifludec Lemon Powder 10 Sachets - When should Tachifludec Lemon Powder 10 Sachets not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eChildren under 12 years of age; hypersensitivity to the active substances or to any of the excipients (listed in section 6.1); patients taking beta-blockers; patients taking tricyclic antidepressants and those taking or who have taken in the last 2 weeks monoamine oxidase inhibitors; patients with bronchial asthma, pheochromocytoma, narrow-angle glaucoma, or who are taking other sympathomimetic medicinal products (such as decongestants, appetite suppressants and amphetamine-like psychostimulants); patients with hepatic or renal insufficiency, diabetes, hyperthyroidism, hypertension and cardiovascular disease; paracetamol-based products are contraindicated in patients with manifest glucose-6-phosphate dehydrogenase insufficiency and in those with severe haemolytic anaemia; severe hepatocellular insufficiency.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eQuantity and method of taking Tachifludec Lemon Powder 10 Sachets - How to take Tachifludec Lemon Powder 10 Sachets?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eDosage. Adults and children over 12 years: 1 sachet every 4-6 hours and up to a maximum of 3 sachets in 24 hours. The medicine should not be used for more than 3 consecutive days without consulting your doctor. Paediatric population. Children under 12 years: Tachifludec lemon, lemon and honey flavour is contraindicated in children under 12 years of age (see section 4.3). Method of administration: dissolve the contents of 1 sachet in half a glass of very hot water and, if desired, dilute with cold water to cool and sweeten as desired.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Tachifludec Lemon Powder 10 Sachets - How do you store Tachifludec Lemon Powder 10 Sachets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eStore below 25 degrees C. Store in the original container in order to protect from moisture and light.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Tachifludec Lemon Powder 10 Sachets - About Tachifludec Lemon Powder 10 Sachets it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePatients should be advised not to take other paracetamol-containing medicinal products while taking Tachifludec as high doses of paracetamol may cause serious adverse reactions. Avoid alcohol consumption during treatment with Tachifludec. The risk of overdose is greater in patients with liver problems. Invite the patient to contact the doctor before combining warfarin or any other drug (see also section 4.5). The use of the product is not recommended if the patient is being treated with anti-inflammatory drugs. Caution is advised if paracetamol is administered concomitantly with flucloxacillin due to the increased risk of high anion gap metabolic acidosis (HAGMA), particularly in patients with severe renal impairment, sepsis, malnutrition and other sources of glutathione deficiency (e.g. chronic alcoholism), as well as in those using maximum daily doses of paracetamol. Careful monitoring is recommended, including measurement of urinary 5-oxoproline. Consult your doctor before using the product in patients with enlarged prostate gland or occlusive vascular diseases (e.g. Raynaud's syndrome). Do not exceed the recommended dose and do not administer for more than 3 consecutive days. Tachifludec lemon flavor contains; sodium: this medicine contains 112.86 mg of sodium per sachet equivalent to 5.64% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult, to be taken into consideration in patients with reduced kidney function or who follow a low-sodium diet; sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. Patients with diabetes should take into account the sucrose content within Tachifludec when taking more than 2 sachets per day (sucrose\u0026gt; 5g); glucose: patients with rare glucose-galactose malabsorption problems should not take this medicine. Tachifludec lemon and honey flavour contains: sodium: 135.79 mg of sodium per sachet equivalent to 6.79% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult, to be taken into consideration in patients with reduced renal function or who follow a low-sodium diet; sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. The sucrose content in Tachifludec should be taken into consideration in people with diabetes mellitus in case of taking more than 2 sachets per day (sucrose\u0026gt; 5g).\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTachifludec Lemon Powder 10 Sachets Interactions - Which medicines or foods can modify the effect of Tachifludec Lemon Powder 10 Sachets?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eParacetamol: hepatotoxicity of paracetamol can be enhanced by the intake of other drugs active on the liver such as zidovudine and isoniazid which can produce an inhibition of the metabolism of paracetamol. The administration of probenecid before paracetamol decreases the clearance of paracetamol and the urinary elimination of paracetamol sulphate and paracetamol-glucuronide, and increases the half-life of paracetamol itself. Use with extreme caution and under strict control during chronic treatment with drugs that can determine the induction of hepatic monooxygenases or in case of exposure to substances that can have this effect (for example rifampicin, cimetidine, antiepileptics such as glutethimide, phenobarbital, carbamazepine). Paracetamol increases the half-life of chloramphenicol. The product taken in high doses can enhance coumarin anticoagulants (warfarin). Metoclopramide and domperidone may increase the absorption of paracetamol, while it is reduced or delayed by cholestyramine and anticholinergics, respectively. Caution should be exercised when paracetamol is used concomitantly with flucloxacillin since concomitant intake has been associated with high anion gap metabolic acidosis, especially in patients with risk factors (see section 4.4). Phenylephrine: phenylephrine may antagonise beta-blocking and antihypertensive drugs (including debrisoquine, guanethidine, reserpine and methyldopa) and may potentiate the action of monoamine oxidase inhibitors (see section 4.3). Concomitant use of phenylephrine with tricyclic antidepressants or sympathomimetic amines may increase the risk of cardiovascular effects. Phenylephrine may interact with digoxin and cardiac glycosides, increasing the risk of arrhythmia or infarction, and with alkaloids (ergotamine and methylsergide), increasing the risk of ergotism. Ascorbic acid: Ascorbic acid may increase the absorption of iron and estrogens. Ascorbic acid is metabolized to oxalate, and may potentially cause hyperoxaluria and kidney stones in patients through the crystallization of calcium oxalate in patients who tend to form calcium stones. Interference with some laboratory tests: Paracetamol administration may interfere with the determination of uric acid (by the phosphotungstic acid method) and blood glucose (by the glucose-oxidase-peroxidase method). Ascorbic acid may interfere with the measurement of blood and urine parameters (e.g. urate, glucose, bilirubin, hemoglobin).\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Tachifludec Lemon Powder 10 Sachets can cause side effects - What are the side effects of Tachifludec Lemon Powder 10 Sachets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe following adverse reactions are listed below, organised according to the MedDRA System Organ Class. Frequency is defined as follows: very common (\u0026gt;=1\/10), common (from \u0026gt;=1\/100 to \u0026lt;1\/10), uncommon (from \u0026gt;=1\/1000 to \u0026lt;1\/100), rare (from \u0026gt;=1\/10,000 to \u0026lt;1\/1000), very rare (\u0026lt;1\/10,000), not known (frequency cannot be estimated from the available data). Blood and lymphatic system disorders. Rare: agranulocytosis1, leucopenia1, thrombocytopenia1; not known: anaemia1. Immune system disorders. Rare: allergic reactions1,2, hypersensitivity reactions1,2, anaphylaxis1,2; not known: anaphylactic shock1,2. Metabolism and nutrition disorders. Common: anorexia2. Psychiatric disorders. Very rare: insomnia2, nervousness2, anxiety2, restlessness2, confusion2, irritability2. Nervous system disorders. Very rare: tremor2, dizziness2, headache2. Eye disorders. Not known: mydriasis2, acute angle-closure glaucoma2. Cardiac disorders. Rare: tachycardia2, palpitations2. Vascular disorders. Not known: hypertension2. Respiratory, thoracic and mediastinal disorders. Rare: bronchospasm1,2; not known: laryngeal oedema1. Gastrointestinal disorders. Common: nausea2, vomiting2; not known: diarrhoea1, gastrointestinal disorder1. Hepatobiliary disorders. Rare: liver function abnormal1; not known: liver disorder1, hepatitis1. Skin and subcutaneous tissue disorders. Rare: rash1,2, angioedema2; not known: toxic epidermal necrolysis1, Steven Johnson syndrome1, erythema multiforme or polymorphic1. Renal and urinary disorders. Very rare: tubulointerstitial nephritis (after prolonged use of paracetamol at high doses)1; not known: aggravated renal failure1, haematuria1, anuria1 urinary retention2. Very rare cases of serious skin reactions have been reported. ^1 Undesirable effects associated with paracetamol. ^2 Undesirable effects associated with phenylephrine. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Tachifludec Lemon Powder 10 Sachets.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePregnancy; paracetamol: a large amount of data on pregnant women indicate neither malformative nor fetal\/neonatal toxicity. Epidemiological studies on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. If clinically necessary, paracetamol can be used during pregnancy, however it should be used at the lowest effective dose for the shortest possible duration and with the lowest possible frequency. Epidemiological studies in pregnant women have shown that there are no contraindications to the use of paracetamol when used in the recommended doses, but the administration of the preparation during pregnancy and breastfeeding should take place under the direct supervision of a doctor. Phenylephrine: data on the use of phenylephrine during pregnancy are limited. Vasoconstriction of the uterine vessels and reduction of blood flow to the uterus associated with the use of phenylephrine may result in fetal hypoxia. The use of phenylephrine during pregnancy should be avoided as further information is needed. Ascorbic acid: There are no controlled data on use during pregnancy. The use of ascorbic acid during pregnancy is recommended only when the benefit outweighs the risk. Breastfeeding; paracetamol: Paracetamol is excreted in breast milk but in clinically insignificant quantities. Available published data do not contraindicate its use during breastfeeding. Phenylephrine: There are no data on the excretion of phenylephrine in breast milk nor are there any information on the effects of phenylephrine on breast-fed children. In the absence of available data, the use of phenylephrine should be avoided during breastfeeding. Ascorbic acid: Ascorbic acid is excreted in breast milk. The effects on breast-fed children are unknown. In summary, the use of Tachifludec is not recommended during pregnancy and breastfeeding. Fertility: There is no evidence in non-clinical studies to indicate effects of paracetamol on male and female fertility at doses commonly used in clinic. Phenylephrine has not been studied on male and female fertility. There is sufficient evidence to indicate the importance of ascorbic acid at different levels in the reproductive process. However, no definitive data in humans are available on the clinical potential of vitamin C.\u003c\/span\u003e\u003c\/p\u003e","brand":"ANGELINI SpA","offers":[{"title":"Default Title","offer_id":40207824814195,"sku":"034358010","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/angelini-spa-tachifludec-limone-polvere-10-bustine-farmacia-dottor-tili-1213792728.webp?v=1767127487"},{"product_id":"tachifludec-limone-e-miele-polvere-10-bustine","title":"Tachifludec Lemon and Honey Powder 10 Sachets","description":"\u003cp\u003eTachifludec Lemon and Honey Powder 10 Sachets is an \u003cstrong\u003eover-the-counter analgesic and antipyretic\u003c\/strong\u003e powder based on Paracetamol, Ascorbic Acid and Phenylephrine hydrochloride. Tachifludec Lemon and Honey Powder is indicated for the \u003cstrong\u003esymptomatic treatment of influenza, colds and feverish and painful conditions\u003c\/strong\u003e related to them. The decongestant action of Tachifludec on the upper airways \u003cstrong\u003efluidifies and frees from mucus and phlegm\u003c\/strong\u003e in case of cough and cold.\u003c\/p\u003e\n\n\u003cp\u003e Tachifludec Lemon and Honey Flavor 10 Sachets is a preparation formulated with:\u003c\/p\u003e\n\n\u003cp\u003e •\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eParacetamol\u003c\/strong\u003e : active ingredient with antipyretic and analgesic action which makes the medicine particularly suitable in cases of: pain and spasms in the stomach and intestines, pain caused by obstacles in the flow of the urinary tract and biliary tract and menstrual pain.\u003c\/p\u003e\n\n \u003cp\u003e•\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eVitamin C\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e(Ascorbic Acid): active ingredient that participates in the body's defense system.\u003c\/p\u003e\n\n\u003cp\u003e •\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ePhenylephrine Hydrochloride\u003c\/strong\u003e : sympathomimetic active ingredient that acts by causing vasoconstriction of the local vascular bed, improving the symptoms of nasal obstruction.\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Tachifludec Lemon and Honey Powder 10 Sachets - What is the active ingredient in Tachifludec Lemon and Honey Powder 10 Sachets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eEach sachet contains active ingredients: paracetamol 600 mg, ascorbic acid 40 mg and phenylephrine hydrochloride 10 mg (equivalent to phenylephrine 8.2 mg). Excipients with known effects: Tachifludec lemon flavour contains: 1.817 g of sucrose, 112.86 mg of sodium, 6.65 mg of glucose. Tachifludec lemon and honey flavour contains: 1.892 g of sucrose, 135.79 mg of sodium. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eComposition of Tachifludec Lemon and Honey Powder 10 Sachets - What does Tachifludec Lemon and Honey Powder 10 Sachets contain?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eTachifludec powder for oral solution lemon flavour: sucrose, anhydrous citric acid, sodium citrate, corn starch, sodium cyclamate, sodium saccharin, anhydrous colloidal silica, lemon flavouring, curcumin (E100), dried glucose syrup. Tachifludec powder for oral solution lemon and honey flavour: sucrose, anhydrous citric acid, sodium citrate, corn starch, sodium cyclamate, sodium saccharin, lemon flavouring, honey flavouring, caramel (E150), anhydrous colloidal silica.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Tachifludec Lemon and Honey Powder 10 Sachets - Why is Tachifludec Lemon and Honey Powder 10 Sachets used? What is it for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eShort-term treatment of cold and flu symptoms, including mild to moderate pain and fever, when associated with nasal congestion.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n \u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Tachifludec Lemon and Honey Powder 10 Sachets - When should Tachifludec Lemon and Honey Powder 10 Sachets not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eChildren under 12 years of age; hypersensitivity to the active substances or to any of the excipients (listed in section 6.1); patients taking beta-blockers; patients taking tricyclic antidepressants and those taking or who have taken in the last 2 weeks monoamine oxidase inhibitors; patients with bronchial asthma, pheochromocytoma, narrow-angle glaucoma, or who are taking other sympathomimetic medicinal products (such as decongestants, appetite suppressants and amphetamine-like psychostimulants); patients with hepatic or renal insufficiency, diabetes, hyperthyroidism, hypertension and cardiovascular disease; paracetamol-based products are contraindicated in patients with manifest glucose-6-phosphate dehydrogenase insufficiency and in those with severe haemolytic anaemia; severe hepatocellular insufficiency.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eQuantity and method of taking Tachifludec Lemon and Honey Powder 10 Sachets - How do you take Tachifludec Lemon and Honey Powder 10 Sachets?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eDosage. Adults and children over 12 years: 1 sachet every 4-6 hours and up to a maximum of 3 sachets in 24 hours. The medicine should not be used for more than 3 consecutive days without consulting your doctor. Paediatric population. Children under 12 years: Tachifludec lemon, lemon and honey flavour is contraindicated in children under 12 years of age (see section 4.3). Method of administration: dissolve the contents of 1 sachet in half a glass of very hot water and, if desired, dilute with cold water to cool and sweeten as desired.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Tachifludec Lemon and Honey Powder 10 Sachets - How do you store Tachifludec Lemon and Honey Powder 10 Sachets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eStore below 25 degrees C. Store in the original container in order to protect from moisture and light.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Tachifludec Lemon and Honey Powder 10 Sachets - About Tachifludec Lemon and Honey Powder 10 Sachets it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePatients should be advised not to take other paracetamol-containing medicinal products while taking Tachifludec as high doses of paracetamol may cause serious adverse reactions. Avoid alcohol consumption during treatment with Tachifludec. The risk of overdose is greater in patients with liver problems. Invite the patient to contact the doctor before combining warfarin or any other drug (see also section 4.5). The use of the product is not recommended if the patient is being treated with anti-inflammatory drugs. Caution is advised if paracetamol is administered concomitantly with flucloxacillin due to the increased risk of high anion gap metabolic acidosis (HAGMA), particularly in patients with severe renal impairment, sepsis, malnutrition and other sources of glutathione deficiency (e.g. chronic alcoholism), as well as in those using maximum daily doses of paracetamol. Careful monitoring is recommended, including measurement of urinary 5-oxoproline. Consult your doctor before using the product in patients with enlarged prostate gland or occlusive vascular diseases (e.g. Raynaud's syndrome). Do not exceed the recommended dose and do not administer for more than 3 consecutive days. Tachifludec lemon flavor contains; sodium: this medicine contains 112.86 mg of sodium per sachet equivalent to 5.64% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult, to be taken into consideration in patients with reduced kidney function or who follow a low-sodium diet; sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. Patients with diabetes should take into account the sucrose content within Tachifludec when taking more than 2 sachets per day (sucrose\u0026gt; 5g); glucose: patients with rare glucose-galactose malabsorption problems should not take this medicine. Tachifludec lemon and honey flavour contains: sodium: 135.79 mg of sodium per sachet equivalent to 6.79% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult, to be taken into consideration in patients with reduced renal function or who follow a low-sodium diet; sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. The sucrose content in Tachifludec should be taken into consideration in people with diabetes mellitus in case of taking more than 2 sachets per day (sucrose\u0026gt; 5g).\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Tachifludec Lemon and Honey Powder 10 Sachets - Which medicines or foods can modify the effect of Tachifludec Lemon and Honey Powder 10 Sachets?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eParacetamol: hepatotoxicity of paracetamol can be enhanced by the intake of other drugs active on the liver such as zidovudine and isoniazid which can produce an inhibition of the metabolism of paracetamol. The administration of probenecid before paracetamol decreases the clearance of paracetamol and the urinary elimination of paracetamol sulphate and paracetamol-glucuronide, and increases the half-life of paracetamol itself. Use with extreme caution and under strict control during chronic treatment with drugs that can determine the induction of hepatic monooxygenases or in case of exposure to substances that can have this effect (for example rifampicin, cimetidine, antiepileptics such as glutethimide, phenobarbital, carbamazepine). Paracetamol increases the half-life of chloramphenicol. The product taken in high doses can enhance coumarin anticoagulants (warfarin). Metoclopramide and domperidone may increase the absorption of paracetamol, while it is reduced or delayed by cholestyramine and anticholinergics, respectively. Caution should be exercised when paracetamol is used concomitantly with flucloxacillin since concomitant intake has been associated with high anion gap metabolic acidosis, especially in patients with risk factors (see section 4.4). Phenylephrine: phenylephrine may antagonise beta-blocking and antihypertensive drugs (including debrisoquine, guanethidine, reserpine and methyldopa) and may potentiate the action of monoamine oxidase inhibitors (see section 4.3). Concomitant use of phenylephrine with tricyclic antidepressants or sympathomimetic amines may increase the risk of cardiovascular effects. Phenylephrine may interact with digoxin and cardiac glycosides, increasing the risk of arrhythmia or infarction, and with alkaloids (ergotamine and methylsergide), increasing the risk of ergotism. Ascorbic acid: Ascorbic acid may increase the absorption of iron and estrogens. Ascorbic acid is metabolized to oxalate, and may potentially cause hyperoxaluria and kidney stones in patients through the crystallization of calcium oxalate in patients who tend to form calcium stones. Interference with some laboratory tests: Paracetamol administration may interfere with the determination of uric acid (by the phosphotungstic acid method) and blood glucose (by the glucose-oxidase-peroxidase method). Ascorbic acid may interfere with the measurement of blood and urine parameters (e.g. urate, glucose, bilirubin, hemoglobin).\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Tachifludec Lemon and Honey Powder 10 Sachets can cause side effects - What are the side effects of Tachifludec Lemon and Honey Powder 10 Sachets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe following adverse reactions are listed below, organised according to the MedDRA System Organ Class. Frequency is defined as follows: very common (\u0026gt;=1\/10), common (from \u0026gt;=1\/100 to \u0026lt;1\/10), uncommon (from \u0026gt;=1\/1000 to \u0026lt;1\/100), rare (from \u0026gt;=1\/10,000 to \u0026lt;1\/1000), very rare (\u0026lt;1\/10,000), not known (frequency cannot be estimated from the available data). Blood and lymphatic system disorders. Rare: agranulocytosis1, leucopenia1, thrombocytopenia1; not known: anaemia1. Immune system disorders. Rare: allergic reactions1,2, hypersensitivity reactions1,2, anaphylaxis1,2; not known: anaphylactic shock1,2. Metabolism and nutrition disorders. Common: anorexia2. Psychiatric disorders. Very rare: insomnia2, nervousness2, anxiety2, restlessness2, confusion2, irritability2. Nervous system disorders. Very rare: tremor2, dizziness2, headache2. Eye disorders. Not known: mydriasis2, acute angle-closure glaucoma2. Cardiac disorders. Rare: tachycardia2, palpitations2. Vascular disorders. Not known: hypertension2. Respiratory, thoracic and mediastinal disorders. Rare: bronchospasm1,2; not known: laryngeal oedema1. Gastrointestinal disorders. Common: nausea2, vomiting2; not known: diarrhoea1, gastrointestinal disorder1. Hepatobiliary disorders. Rare: liver function abnormal1; not known: liver disorder1, hepatitis1. Skin and subcutaneous tissue disorders. Rare: rash1,2, angioedema2; not known: toxic epidermal necrolysis1, Steven Johnson syndrome1, erythema multiforme or polymorphic1. Renal and urinary disorders. Very rare: tubulointerstitial nephritis (after prolonged use of paracetamol at high doses)1; not known: aggravated renal failure1, haematuria1, anuria1 urinary retention2. Very rare cases of serious skin reactions have been reported. ^1 Undesirable effects associated with paracetamol. ^2 Undesirable effects associated with phenylephrine. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Tachifludec Lemon and Honey Powder 10 Sachets.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePregnancy; paracetamol: a large amount of data on pregnant women indicate neither malformative nor fetal\/neonatal toxicity. Epidemiological studies on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. If clinically necessary, paracetamol can be used during pregnancy, however it should be used at the lowest effective dose for the shortest possible duration and with the lowest possible frequency. Epidemiological studies in pregnant women have shown that there are no contraindications to the use of paracetamol when used in the recommended doses, but the administration of the preparation during pregnancy and breastfeeding should take place under the direct supervision of a doctor. Phenylephrine: data on the use of phenylephrine during pregnancy are limited. Vasoconstriction of the uterine vessels and reduction of blood flow to the uterus associated with the use of phenylephrine may result in fetal hypoxia. The use of phenylephrine during pregnancy should be avoided as further information is needed. Ascorbic acid: There are no controlled data on use during pregnancy. The use of ascorbic acid during pregnancy is recommended only when the benefit outweighs the risk. Breastfeeding; paracetamol: Paracetamol is excreted in breast milk but in clinically insignificant quantities. Available published data do not contraindicate its use during breastfeeding. Phenylephrine: There are no data on the excretion of phenylephrine in breast milk nor are there any information on the effects of phenylephrine on breast-fed children. In the absence of available data, the use of phenylephrine should be avoided during breastfeeding. Ascorbic acid: Ascorbic acid is excreted in breast milk. The effects on breast-fed children are unknown. In summary, the use of Tachifludec is not recommended during pregnancy and breastfeeding. Fertility: There is no evidence in non-clinical studies to indicate effects of paracetamol on male and female fertility at doses commonly used in clinic. Phenylephrine has not been studied on male and female fertility. There is sufficient evidence to indicate the importance of ascorbic acid at different levels in the reproductive process. However, no definitive data in humans are available on the clinical potential of vitamin C.\u003c\/span\u003e\u003c\/p\u003e","brand":"ANGELINI SpA","offers":[{"title":"Default Title","offer_id":40207824879731,"sku":"034358022","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/angelini-spa-tachifludec-limone-e-miele-polvere-10-bustine-farmacia-dottor-tili-1213792714.jpg?v=1767127548"},{"product_id":"tachifludec-arancia-polvere-10-bustine","title":"Tachifludec Orange Powder 10 Sachets","description":"\u003cp\u003e\u003cspan style=\"font-weight: 400;\"\u003eTachifludec Orange Powder 10 Sachets is an\u003c\/span\u003e \u003cb\u003eover-the-counter analgesic and antipyretic\u003c\/b\u003e \u003cspan style=\"font-weight: 400;\"\u003epowder based on Paracetamol, Ascorbic Acid and Phenylephrine hydrochloride. Tachifludec Orange Powder is indicated for the\u003c\/span\u003e \u003cb\u003esymptomatic treatment of influenza, colds and feverish and painful conditions\u003c\/b\u003e \u003cspan style=\"font-weight: 400;\"\u003erelated to them. The decongestant action of Tachifludec on the upper airways\u003c\/span\u003e \u003cb\u003efluidifies and frees from mucus and phlegm\u003c\/b\u003e \u003cspan style=\"font-weight: 400;\"\u003ein case of cough and cold.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp\u003e Tachifludec Orange Flavor 10 Sachets is a preparation formulated with:\u003c\/p\u003e\n\n\u003cp\u003e •\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eParacetamol\u003c\/strong\u003e : active ingredient with antipyretic and analgesic action which makes the medicine particularly suitable in cases of: pain and spasms in the stomach and intestines, pain caused by obstacles in the flow of the urinary tract and biliary tract and menstrual pain.\u003c\/p\u003e\n\n \u003cp\u003e•\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eVitamin C\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003e(Ascorbic Acid): active ingredient that participates in the body's defense system.\u003c\/p\u003e\n\n\u003cp\u003e •\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ePhenylephrine Hydrochloride\u003c\/strong\u003e : sympathomimetic active ingredient that acts by causing vasoconstriction of the local vascular bed, improving the symptoms of nasal obstruction.\u003c\/p\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Tachifludec Orange Powder 10 Sachets - What is the active ingredient of Tachifludec Orange Powder 10 Sachets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eEach sachet contains active ingredients: paracetamol 600 mg, ascorbic acid 40 mg and phenylephrine hydrochloride 10 mg (equivalent to phenylephrine 8.2 mg). Excipients with known effect: 2 g of sucrose; 135.82 mg of sodium; 33.25 mg of glucose. For the full list of excipients, see section 6.1.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Tachifludec Orange Powder 10 Sachets - What does Tachifludec Orange Powder 10 Sachets contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eSucrose, anhydrous citric acid, sodium citrate, corn starch, sodium cyclamate, sodium saccharin, colloidal anhydrous silica, red orange flavouring, curcumin (E100), dried glucose syrup.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Tachifludec Orange Powder 10 Sachets - Why is Tachifludec Orange Powder 10 Sachets used? What is it for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eShort-term treatment of cold and flu symptoms, including mild to moderate pain and fever, when associated with nasal congestion.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Tachifludec Orange Powder 10 Sachets - When should Tachifludec Orange Powder 10 Sachets not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eChildren under 12 years of age; hypersensitivity to the active substances or to any of the excipients (listed in section 6.1); patients taking beta-blockers; patients taking tricyclic antidepressants and those taking or who have taken in the last 2 weeks monoamine oxidase inhibitors; patients with bronchial asthma, pheochromocytoma, narrow-angle glaucoma, or who are taking other sympathomimetic medicinal products (such as decongestants, appetite suppressants and amphetamine-like psychostimulants); patients with hepatic or renal insufficiency, diabetes, hyperthyroidism, hypertension and cardiovascular disease. Paracetamol-based products are contraindicated in patients with manifest glucose-6-phosphate dehydrogenase insufficiency and in those with severe haemolytic anaemia; severe hepatocellular insufficiency.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eQuantity and method of taking Tachifludec Orange Powder 10 Sachets - How to take Tachifludec Orange Powder 10 Sachets?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eDosage; adults and children over 12 years: 1 sachet every 4-6 hours and up to a maximum of 3 sachets in 24 hours. The medicine should not be used for more than 3 consecutive days without consulting your doctor. Paediatric population; children under 12 years: Tachifludec orange flavour is contraindicated in children under 12 years of age (see section 4.3). Method of administration: dissolve the contents of one sachet in a glass of hot or cold water and sweeten to taste. Once dissolved, the medicine gives rise to a yellow opalescent solution, free of foreign particles and with an orange flavour.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Tachifludec Orange Powder 10 Sachets - How do you store Tachifludec Orange Powder 10 Sachets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eStore below 25 degrees C. Store in the original container in order to protect from moisture and light.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Tachifludec Orange Powder 10 Sachets - About Tachifludec Orange Powder 10 Sachets it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePatients should be advised not to take other paracetamol-containing medicinal products while taking Tachifludec as high doses of paracetamol may cause serious adverse reactions. Avoid alcohol consumption during treatment with Tachifludec. The risk of overdose is greater in patients with liver problems. Instruct the patient to contact the doctor before combining warfarin or any other drug (see also section 4.5). The use of the product is not recommended if the patient is being treated with anti-inflammatory drugs. Caution is advised if paracetamol is administered concomitantly with flucloxacillin due to the increased risk of high anion gap metabolic acidosis (HAGMA), particularly in patients with severe renal impairment, sepsis, malnutrition and other sources of glutathione deficiency (e.g. chronic alcoholism), as well as in those using maximum daily doses of paracetamol. Careful monitoring is recommended, including measurement of urinary 5-oxoproline. Consult your doctor before using the product in patients with enlarged prostate gland or occlusive vascular diseases (e.g. Raynaud's syndrome). Do not exceed the recommended dose and do not administer for more than 3 consecutive days. Tachifludec orange flavor contains, sodium: this medicine contains 135.82 mg of sodium per sachet, equivalent to 6.79% of the maximum daily intake recommended by the WHO which corresponds to 2 g of sodium for an adult, to be taken into consideration in patients with reduced kidney function or who follow a low-sodium diet. Sucrose: patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. Patients with diabetes should take into account the sucrose content within Tachifludec when taking more than 2 sachets per day (sucrose\u0026gt; 5g). Glucose: Patients with rare glucose-galactose malabsorption problems should not take this medicine.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTachifludec Orange Powder 10 Sachets Interactions - Which medicines or foods can modify the effect of Tachifludec Orange Powder 10 Sachets?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eParacetamol: hepatotoxicity of paracetamol can be enhanced by the intake of other drugs active on the liver, such as zidovudine and isoniazid which can produce an inhibition of the metabolism of paracetamol. The administration of probenecid before paracetamol decreases the clearance of paracetamol and the urinary elimination of paracetamol sulphate and paracetamol-glucuronide, and increases the half-life of paracetamol itself. Use with extreme caution and under strict control during chronic treatment with drugs that can determine the induction of hepatic monooxygenases or in case of exposure to substances that can have this effect (for example rifampicin, cimetidine, antiepileptics such as glutethimide, phenobarbital, carbamazepine). Paracetamol increases the half-life of chloramphenicol. The product taken in high doses can enhance coumarin anticoagulants (warfarin). Metoclopramide and domperidone may increase the absorption of paracetamol, while it is reduced or delayed by cholestyramine and anticholinergics, respectively. Caution should be exercised when paracetamol is used concomitantly with flucloxacillin since concomitant intake has been associated with high anion gap metabolic acidosis, especially in patients with risk factors (see section 4.4). Phenylephrine: phenylephrine may antagonise beta-blocking and antihypertensive drugs (including debrisoquine, guanethidine, reserpine and methyldopa) and may potentiate the action of monoamine oxidase inhibitors (see section 4.3). Concomitant use of phenylephrine with tricyclic antidepressants or sympathomimetic amines may increase the risk of cardiovascular effects. Phenylephrine may interact with digoxin and cardiac glycosides, increasing the risk of arrhythmia or heart attack, and with alkaloids (ergotamine and methylsergide), increasing the risk of ergotism. Ascorbic Acid: Ascorbic acid may increase the absorption of iron and estrogens. Ascorbic acid is metabolized to oxalate, and may potentially cause hyperoxaluria and kidney stones in patients through the crystallization of calcium oxalate in patients who tend to form calcium stones. Interference with some laboratory tests: Paracetamol administration may interfere with the determination of uric acid (by the phosphotungstic acid method) and blood sugar (by the glucose-oxidase-peroxidase method). Ascorbic acid may interfere with the measurement of blood and urine parameters (e.g. urate, glucose, bilirubin, hemoglobin).\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Tachifludec Orange Powder 10 Sachets can cause side effects - What are the side effects of Tachifludec Orange Powder 10 Sachets?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe following adverse reactions are listed below, organised according to the MedDRA System Organ Class. Frequency is defined as follows: very common (\u0026gt;=1\/10), common (\u0026gt;=1\/100 to \u0026lt;1\/10), uncommon (\u0026gt;=1\/1000 to \u0026lt;1\/100), rare (\u0026gt;=1\/10,000 to \u0026lt;1\/1000), very rare (\u0026lt;1\/10,000), not known (frequency cannot be estimated from the available data). Blood and lymphatic system disorders. Rare: agranulocytosis1, leukopenia1, thrombocytopenia1; not known: anaemia1. Immune system disorders. Rare: allergic reactions1,2, hypersensitivity reactions1,2, anaphylaxis1,2; not known: anaphylactic shock1, 2. Metabolism and nutrition disorders. Common: anorexia2. Psychiatric disorders very rare: insomnia2, nervousness2, anxiety2, restlessness2, confusion2, irritability2. Nervous system disorders. Very rare: tremor2, dizziness2, headache2. Eye disorders. Not known: mydriasis2, acute angle-closure glaucoma2. Cardiac disorders. Rare: tachycardia2, palpitations2. Vascular disorders. Not known: hypertension2. Respiratory, thoracic and mediastinal disorders. Rare: bronchospasm1,2; not known: laryngeal oedema1. Gastrointestinal disorders. Common: nausea2, vomiting2; not known: diarrhoea1, gastrointestinal disorder1. Hepatobiliary disorders. Rare: liver function abnormal1; not known: liver disorder1, hepatitis1. Skin and subcutaneous tissue disorders. Rare: rash1,2, angioedema2; not known: toxic epidermal necrolysis1, Steven Johnson syndrome1, erythema multiforme or polymorphic1. Renal and urinary disorders. Very rare: tubulointerstitial nephritis (after prolonged use of paracetamol at high doses)1; not known: aggravated renal failure1, haematuria1, anuria1 urinary retention2. Very rare cases of serious skin reactions have been reported. ^1 Undesirable effects associated with paracetamol ^2 Undesirable effects associated with phenylephrine. Reporting of suspected adverse reactions. Reporting suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit\/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Tachifludec Orange Powder 10 Sachets.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003ePregnancy; paracetamol: a large amount of data on pregnant women indicate neither malformative nor fetal\/neonatal toxicity. Epidemiological studies on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. If clinically necessary, paracetamol can be used during pregnancy, however it should be used at the lowest effective dose for the shortest possible duration and with the lowest possible frequency. Epidemiological studies in pregnant women have shown that there are no contraindications to the use of paracetamol when used in the recommended doses, but the administration of the preparation during pregnancy and breastfeeding should take place under the direct supervision of a doctor. Phenylephrine: data on the use of phenylephrine during pregnancy are limited. Vasoconstriction of the uterine vessels and reduction of blood flow to the uterus associated with the use of phenylephrine may result in fetal hypoxia. The use of phenylephrine during pregnancy should be avoided as further information is needed. Ascorbic acid: There are no controlled data on use during pregnancy. The use of ascorbic acid during pregnancy is recommended only when the benefit outweighs the risk. Breastfeeding; paracetamol: Paracetamol is excreted in breast milk but in clinically insignificant quantities. Available published data do not contraindicate its use during breastfeeding. Phenylephrine: There are no data on the excretion of phenylephrine in breast milk nor are there any information on the effects of phenylephrine on breast-fed children. In the absence of available data, the use of phenylephrine should be avoided during breastfeeding. Ascorbic acid: Ascorbic acid is excreted in breast milk. The effects on breast-fed children are unknown. In summary, the use of Tachifludec is not recommended during pregnancy and breastfeeding. Fertility: There is no evidence in non-clinical studies to indicate effects of paracetamol on male and female fertility at doses commonly used in clinic. Phenylephrine has not been studied on male and female fertility. There is sufficient evidence to indicate the importance of ascorbic acid at different levels in the reproductive process. However, no definitive data in humans are available on the clinical potential of vitamin C.\u003c\/span\u003e\u003c\/p\u003e","brand":"ANGELINI SpA","offers":[{"title":"Default Title","offer_id":40207824912499,"sku":"034358034","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/angelini-spa-tachifludec-arancia-polvere-10-bustine-farmacia-dottor-tili-1213792726.jpg?v=1767127528"},{"product_id":"eumill-protection-gocce-oculari-10-flaconcini-monodose-0-5-ml","title":"Eumill Protection Eye Drops 10 Single-Dose Vials 0.5 ml","description":"\u003cp\u003e\u003cstrong\u003eEumill Protection Eye Drops\u003c\/strong\u003e is a natural ophthalmic solution, designed to protect and soothe dry and irritated eyes. This product contains natural ingredients such as chamomile, witch hazel and aloe vera, known for their soothing and hydrating properties. It is particularly suitable for daily use in case of prolonged exposure to irritating environmental factors such as wind, dust, smoke or electronic devices. Thanks to the single-dose vial format, Eumill Protection guarantees maximum hygiene and ease of use.\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Eumill Protection Eye Drops?\u003c\/h3\u003e\n\n     \u003cp\u003eApply \u003cstrong\u003e1-2 drops of Eumill Protection Eye Drops\u003c\/strong\u003e in each eye, 2-3 times a day, or as needed. To apply, separate a single-dose vial from the blister and open it. Wash your hands before use, gently pull the lower eyelid and instill the drop without touching the eye with the tip of the vial. Use immediately after opening and discard the vial after use.\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Eumill Protection Eye Drops contain?\u003c\/h3\u003e\n\n\u003cp\u003e The formula of \u003cstrong\u003eEumill Protection Eye Drops\u003c\/strong\u003e includes:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eChamomile\u003c\/strong\u003e : known for its soothing and calming properties, it reduces eye irritation.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eHamamelis\u003c\/strong\u003e : with astringent properties, it protects the eyes from external agents.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eAloe vera\u003c\/strong\u003e : known for its hydrating and regenerating properties, it helps maintain eye lubrication.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eWithout preservatives\u003c\/strong\u003e : to ensure maximum safety even in case of frequent use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Eumill Protection Eye Drops?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSingle use\u003c\/strong\u003e : Each single-dose vial is intended for a single use. Discard after use.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDo not use if allergic\u003c\/strong\u003e to any of the ingredients.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eConsult a doctor\u003c\/strong\u003e if symptoms persist or worsen.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eUse with caution during pregnancy and breastfeeding\u003c\/strong\u003e , after consulting your doctor.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Eumill Protection Eye Drops?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eExpiry\u003c\/strong\u003e : The expiry date is shown on the package. Do not use the product beyond this date.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eStorage\u003c\/strong\u003e : Store in a cool, dry place, away from direct light and heat sources. Do not refrigerate.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e \u003cstrong\u003eEumill Protection Eye Drops\u003c\/strong\u003e is available in packs of \u003cstrong\u003e10 single-dose 0.5 ml bottles\u003c\/strong\u003e , ideal for hygienic and practical use.\u003c\/p\u003e\n\n","brand":"RECORDATI SpA","offers":[{"title":"Default Title","offer_id":40207825109107,"sku":"905351387","price":11.35,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/recordati-spa-eumill-protection-gocce-oculari-10-flaconcini-monodose-0-5-ml-farmacia-dottor-tili-1213793096.jpg?v=1767127608"},{"product_id":"eumill-gocce-oculari-10-flaconcini-monodose-0-5-ml","title":"Eumill Eye Drops 10 Single Dose Vials 0.5 ml","description":"\u003cp\u003e\u003cstrong\u003eEumill Eye Drops\u003c\/strong\u003e is a natural ophthalmic solution indicated to provide relief and protect irritated or tired eyes. Formulated with plant-based ingredients, such as chamomile, witch hazel and eyebright, it is suitable for hydrating and soothing the eyes, reducing sensations of discomfort and redness caused by external agents such as wind, smoke or prolonged use of electronic devices. Thanks to the single-dose format, the drops offer hygiene and practicality in every situation.\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Eumill Eye Drops?\u003c\/h3\u003e\n\n\u003cp\u003e Apply \u003cstrong\u003e1-2 drops of Eumill Eye Drops\u003c\/strong\u003e in each eye, 2-3 times a day, or as needed. To apply, separate a single-dose vial from the blister and open it. Wash your hands thoroughly, gently pull the lower eyelid and instill the drop without touching the eye with the tip of the vial. Use immediately after opening and discard the vial after use.\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n     \u003ch3\u003eWhat ingredients does Eumill Eye Drops contain?\u003c\/h3\u003e\n\n\u003cp\u003e The formula of \u003cstrong\u003eEumill Eye Drops\u003c\/strong\u003e includes:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eChamomile\u003c\/strong\u003e : Known for its soothing and calming properties, it helps reduce inflammation.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eHamamelis\u003c\/strong\u003e : with astringent properties, it helps protect the eyes from irritation and external agents.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eEyebright\u003c\/strong\u003e : An ingredient traditionally used to relieve redness and tired eyes.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eWithout preservatives\u003c\/strong\u003e : to ensure maximum safety and tolerability of use even in case of frequent use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Eumill Eye Drops?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSingle use\u003c\/strong\u003e : Each single-dose vial is intended for a single use. Discard after use.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDo not use if allergic\u003c\/strong\u003e to any of the ingredients.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eConsult a doctor\u003c\/strong\u003e if symptoms persist or worsen.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eUse with caution during pregnancy and breastfeeding\u003c\/strong\u003e , after consulting your doctor.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Eumill Eye Drops?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eExpiry\u003c\/strong\u003e : The expiry date is shown on the package. Do not use the product beyond this date.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eStorage\u003c\/strong\u003e : Store in a cool, dry place, away from light and heat sources. Do not refrigerate.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e \u003cstrong\u003eEumill Eye Drops\u003c\/strong\u003e is available in packs of \u003cstrong\u003e10 single-dose 0.5 ml bottles\u003c\/strong\u003e , ideal for hygienic and practical use.\u003c\/p\u003e\n\n","brand":"RECORDATI SpA","offers":[{"title":"Default Title","offer_id":40207825141875,"sku":"906175827","price":11.35,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/recordati-spa-eumill-gocce-oculari-10-flaconcini-monodose-0-5-ml-farmacia-dottor-tili-1213793095.jpg?v=1767127589"},{"product_id":"imidazyl-collirio-flacone-10-ml-0-1","title":"Imidazyl Eye Drops Bottle 10 ml 0.1%","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eImidazyl Eye Drops\u003c\/span\u003e \u003cspan\u003eis a decongestant medicine for ocular use indicated for the treatment of redness and eye irritation caused by environmental factors such as dust, smoke, wind, allergies or visual fatigue. The active ingredient\u003c\/span\u003e \u003cspan\u003etetrizoline\u003c\/span\u003e \u003cspan\u003eacts as a vasoconstrictor, reducing swelling and inflammation of the ocular tissues. Thanks to its 10 ml bottle format,\u003c\/span\u003e \u003cspan\u003eImidazyl\u003c\/span\u003e \u003cspan\u003eis ideal for more frequent use, ensuring rapid and long-lasting relief.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eImidazyl Eye Drops\u003c\/span\u003e \u003cspan\u003eare indicated for:\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eRelieve redness and eye irritation caused by external agents such as dust, smoke, wind.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eTreat mild eye symptoms due to allergies or eye strain.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Imidazyl Eye Drops Bottle 10 ml 0.1% - What is the active ingredient in Imidazyl Eye Drops Bottle 10 ml 0.1%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eNaphazoline nitrate.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Imidazyl Eye Drops Bottle 10 ml 0.1% - What does Imidazyl Eye Drops Bottle 10 ml 0.1% contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003e10 ml bottle: benzalkonium chloride; sodium chloride; disodium edetate; sodium phosphate monobasic dihydrate; sodium phosphate dibasic dihydrate; purified water. Single-dose container: sodium phosphate monobasic; sodium chloride; water for injections.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Imidazyl Eye Drops Bottle 10 ml 0.1% - Why is Imidazyl Eye Drops Bottle 10 ml 0.1% used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eIn allergic and inflammatory conditions of the conjunctiva characterized by a burning sensation, even from external agents, associated with excessive tearing, photophobia, hyperemia.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eContraindications Imidazyl Eye Drops Bottle 10 ml 0.1% - When should Imidazyl Eye Drops Bottle 10 ml 0.1% not be used?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eHypersensitivity to the active substance or to any of the excipients listed or to other closely related substances from a chemical point of view; in particular to xylometazoline, oxymetazoline, tetryzoline; narrow-angle glaucoma or other serious eye diseases; children under 12 years; concomitant treatment with monoamine oxidase inhibitor drugs.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Imidazyl Eye Drops Bottle 10 ml 0.1% - How to take Imidazyl Eye Drops Bottle 10 ml 0.1%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eInstill 1-2 drops in the affected eye, 1-2 times a day. Do not exceed the recommended doses. In any case, the product should not be used for more than 4 consecutive days unless otherwise prescribed by a doctor, given the possibility that undesirable effects may otherwise occur. Strictly adhere to the recommended doses. A higher dosage of the product, even if taken topically and for a short period of time, may give rise to serious systemic effects.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Imidazyl Eye Drops Bottle 10 ml 0.1% - How is Imidazyl Eye Drops Bottle 10 ml 0.1% stored?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eStore in original packaging.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Imidazyl Eye Drops Bottle 10 ml 0.1% - About Imidazyl Eye Drops Bottle 10 ml 0.1% it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe product, although having very low systemic absorption, must be used with caution in subjects suffering from hypertension, hyperthyroidism, cardiac disorders, bronchial asthma and hyperglycemia (diabetes). The product must be kept out of the reach of children since accidental ingestion can cause CNS depression (marked sedation and hypotonia), coma. In these cases, immediate medical assistance is always necessary. The product is not suitable for the treatment of infections, mechanical (trauma), chemical or heat damage or to eliminate foreign bodies in the eye. These situations require medical attention. The 10 ml bottle contains benzalkonium chloride. It can cause eye irritation during treatment, soft contact lenses should not be worn. Since benzalkonium chloride is not present in the single-dose package, this can be used by contact lens wearers, or by those who show hypersensitivity to benzalkonium chloride.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Imidazyl Eye Drops Bottle 10 ml 0.1% - Which medicines or foods can modify the effect of Imidazyl Eye Drops Bottle 10 ml 0.1%?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThe medicine should not be used if you are taking monoamine oxidase inhibitor drugs or if less than two weeks have passed since the last administration of these drugs as serious hypertensive crises may occur.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Imidazyl Eye Drops Bottle 10 ml 0.1% can cause side effects - What are the side effects of Imidazyl Eye Drops Bottle 10 ml 0.1%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe use of the product can sometimes cause pupillary dilation, systemic effects from absorption (hypertension, cardiac disorders, hyperglycemia), increased intraocular pressure, nausea, headache. Hypersensitivity phenomena may rarely occur. In this case, treatment should be stopped and appropriate therapy instituted. Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Imidazyl Eye Drops Bottle 10 ml 0.1%.\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThere are no known teratogenic and embryotoxic effects of the component of the specialty, in topical use. However, in women who are pregnant or breastfeeding, the product should be used only in case of real need.\u003c\/span\u003e\u003c\/p\u003e","brand":"RECORDATI SpA","offers":[{"title":"Default Title","offer_id":40207825240179,"sku":"003410026","price":8.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/recordati-spa-imidazyl-collirio-flacone-10-ml-0-1-farmacia-dottor-tili-1213793093.jpg?v=1767127667"},{"product_id":"imidazyl-collirio-10-flaconcini-monodose-1-mg-ml","title":"Imidazyl Eye Drops 10 Single Dose Vials 1 mg\/ml","description":"\u003cp dir=\"ltr\"\u003e \u003cspan\u003eImidazyl Eye Drops\u003c\/span\u003e \u003cspan\u003eis an ocular decongestant indicated to relieve redness and irritation of the eyes caused by dust, smoke, wind, allergies or visual fatigue. The active ingredient,\u003c\/span\u003e \u003cspan\u003etetrizoline\u003c\/span\u003e \u003cspan\u003e, acts as a vasoconstrictor, reducing swelling and inflammation of the ocular tissues. Thanks to its formulation in single-dose vials, Imidazyl offers practicality and hygiene, ideal for occasional or sporadic use in situations of ocular irritation.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eImidazyl Eye Drops\u003c\/span\u003e \u003cspan\u003eare indicated for:\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eRelieve redness and eye irritation caused by external agents such as dust, smoke or wind.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n \u003cp role=\"presentation\" dir=\"ltr\"\u003e\u003cspan\u003eTreat mild eye symptoms due to allergies or eye strain.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml - What is the active ingredient in Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eNaphazoline nitrate.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml - What does Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003e10 ml bottle: benzalkonium chloride; sodium chloride; disodium edetate; sodium phosphate monobasic dihydrate; sodium phosphate dibasic dihydrate; purified water. Single-dose container: sodium phosphate monobasic; sodium chloride; water for injections.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml - Why is Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eIn allergic and inflammatory conditions of the conjunctiva characterized by a burning sensation, even from external agents, associated with excessive tearing, photophobia, hyperemia.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml - When should Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eHypersensitivity to the active substance or to any of the excipients listed or to other closely related substances from a chemical point of view; in particular to xylometazoline, oxymetazoline, tetryzoline; narrow-angle glaucoma or other serious eye diseases; children under 12 years; concomitant treatment with monoamine oxidase inhibitor drugs.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml - How do you take Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eInstill 1-2 drops in the affected eye, 1-2 times a day. Do not exceed the recommended doses. In any case, the product should not be used for more than 4 consecutive days unless otherwise prescribed by a doctor, given the possibility that undesirable effects may otherwise occur. Strictly adhere to the recommended doses. A higher dosage of the product, even if taken topically and for a short period of time, may give rise to serious systemic effects.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml - How is Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml stored?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eStore in original packaging.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml - About Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe product, although having very low systemic absorption, must be used with caution in subjects suffering from hypertension, hyperthyroidism, cardiac disorders, bronchial asthma and hyperglycemia (diabetes). The product must be kept out of the reach of children since accidental ingestion can cause CNS depression (marked sedation and hypotonia), coma. In these cases, immediate medical assistance is always necessary. The product is not suitable for the treatment of infections, mechanical (trauma), chemical or heat damage or to eliminate foreign bodies in the eye. These situations require medical attention. The 10 ml bottle contains benzalkonium chloride. It can cause eye irritation during treatment, soft contact lenses should not be worn. Since benzalkonium chloride is not present in the single-dose package, this can be used by contact lens wearers, or by those who show hypersensitivity to benzalkonium chloride.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml - Which medicines or foods can modify the effect of Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThe medicine should not be used if you are taking monoamine oxidase inhibitor drugs or if less than two weeks have passed since the last administration of these drugs as serious hypertensive crises may occur.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml can cause side effects - What are the side effects of Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThe use of the product can sometimes cause pupillary dilation, systemic effects from absorption (hypertension, cardiac disorders, hyperglycemia), increased intraocular pressure, nausea, headache. Hypersensitivity phenomena may rarely occur. In this case, treatment should be stopped and appropriate therapy instituted. Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit\/risk balance of the medicinal product.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Imidazyl Eye Drops 10 Single-Dose Vials 1 mg\/ml\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThere are no known teratogenic and embryotoxic effects of the component of the specialty, in topical use. However, in women who are pregnant or breastfeeding, the product should be used only in case of real need.\u003c\/span\u003e\u003c\/p\u003e","brand":"RECORDATI SpA","offers":[{"title":"Default Title","offer_id":40207825272947,"sku":"003410065","price":9.49,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/recordati-spa-imidazyl-collirio-10-flaconcini-monodose-1-mg-ml-farmacia-dottor-tili-1213793089.jpg?v=1767127648"},{"product_id":"levoreact-ofta-collirio-4-ml-0-5-mg-ml","title":"Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml","description":"\u003cp dir=\"ltr\"\u003e\u003cspan\u003eLevoreact Ofta Eye Drops\u003c\/span\u003e \u003cspan\u003eis an antihistamine eye drop specifically formulated to treat the ocular symptoms of seasonal and chronic allergies, such as redness, itching and excessive tearing. Its active ingredient,\u003c\/span\u003e \u003cspan\u003elevocabastine\u003c\/span\u003e \u003cspan\u003e, works by blocking the action of histamine, a substance that the body produces during allergic reactions, thus helping to reduce the associated symptoms. Levoreact Ofta provides fast and long-lasting relief from allergic eye disorders.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eLevoreact Ofta Eye Drops\u003c\/span\u003e \u003cspan\u003eare indicated for:\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eSymptomatic treatment of seasonal and perennial allergic conjunctivitis.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\u003cli aria-level=\"1\" dir=\"ltr\"\u003e\n\n\u003cp role=\"presentation\" dir=\"ltr\"\u003e \u003cspan\u003eRelieve eye symptoms such as redness, itching and tearing associated with allergies.\u003c\/span\u003e\u003c\/p\u003e\n\n\n\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml - What is the active ingredient in Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eOne ml of eye drops, suspension contains: levocabastine hydrochloride 0.54 mg (equivalent to 0.5 mg of levocabastine).\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml - What does Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml contain?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003ePropylene glycol, sodium dihydrogen phosphate monohydrate, disodium hydrogen phosphate anhydrous, hydroxypropyl methylcellulose 2910, polysorbate 80, benzalkonium chloride, disodium edetate, water for injections.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDIRECTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml - Why is Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml used? What is it used for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eAllergic conjunctivitis.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONTRAINDICATIONS SIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eContraindications Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml - When should Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml not be used?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eHypersensitivity to the active substance or to any of the excipients.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eDOSAGE\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml - How to take Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eAdults and children: The usual dose is 1 drop in each eye, 2 times a day. The dose may be increased to 1 drop up to 3 or 4 times a day. Treatment should be continued for as long as symptoms resolve. Method of administration: Ophthalmic use.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml - How is Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml stored?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eDo not store above 25 degrees C.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eWARNINGS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml - It is important to know that Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eAs with all ophthalmic preparations containing benzalkonium chloride, propylene glycol and esters, patients should be advised not to wear soft (hydrophilic) contact lenses whilst taking the suspension eye drops as they may cause eye irritation. Contact lenses should be removed prior to application of the medicinal product and should wait at least 15 minutes before putting them back in. The medicinal product discolours soft contact lenses.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eINTERACTIONS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml - Which medicines or foods can modify the effect of Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eNo interaction studies have been performed.\u003c\/span\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml can cause side effects - What are the side effects of Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eFrequency of adverse reactions: very common \u0026gt;=1\/10, common \u0026gt;=1\/100 and \u0026lt;1\/10, uncommon \u0026gt;=1\/1,000 and \u0026lt;1\/100, rare \u0026gt;=1\/10,000 and \u0026lt;1\/1,000, very rare \u0026lt;1\/10,000, not known. Cardiac disorders. Not known: palpitations. Eye disorders. Common: eye pain, blurred vision; uncommon: eyelid oedema; not known: conjunctivitis, eye swelling, blepharitis, ocular hyperaemia. General disorders and administration site conditions. Common: application site reaction, including burning sensation\/irritation in the eyes, eye irritation; very rare: application site reaction, such as eye redness, eye itching; not known: application site reaction, such as tearing. Immune system disorders. Not known: angioedema, hypersensitivity, anaphylactic reaction. Skin and subcutaneous tissue disorders. Not known: contact dermatitis, urticaria. Nervous system disorders. Common: headache. Report any suspected adverse reactions via the national reporting system.\u003c\/span\u003e\u003c\/p\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Levoreact Ofta Eye Drops 4 ml 0.5 mg\/ml\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eStudies in animals have not shown any embryotoxic or teratogenic effects. Postmarketing data on the use of levocabastine eye drops, suspension in pregnant women are limited; the risk for humans is unknown, therefore it should not be used during pregnancy unless the potential benefit for the woman justifies the potential risk to the fetus. Based on determinations of levocabastine concentrations in saliva and breast milk, of a nursing woman administered a single oral dose of 0.5 mg levocabastine, it is expected that approximately 0.3% of the total ophthalmologically administered levocabastine dose may be transmitted to the infant. However, due to the limited availability of clinical and experimental data, caution is recommended when administering the drug to nursing women. Animal data have shown no effect on male or female fertility.\u003c\/span\u003e\u003c\/p\u003e","brand":"JOHNSON \u0026 JOHNSON SpA","offers":[{"title":"Default Title","offer_id":40207825338483,"sku":"027699026","price":12.87,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/johnson-johnson-spa-levoreact-ofta-collirio-4-ml-0-5-mg-ml-farmacia-dottor-tili-1213793091.jpg?v=1767127726"},{"product_id":"regobasic-polvere-250-g","title":"Regobasic Powder 250 g","description":"\u003cp\u003e\u003cstrong\u003eRegobasic Polvere\u003c\/strong\u003e is a food supplement formulated with a balanced combination of mineral salts and sodium bicarbonate, designed to help maintain the body's acid-base balance. The product is indicated to combat gastric acidity and improve digestive function, supporting the body's general health. Thanks to its formulation, Regobasic Polvere helps counteract the negative effects resulting from a diet rich in proteins or habits that can affect the body's acidity.\u003c\/p\u003e\n\n\n\u003ch2\u003e Dosage and method of use\u003c\/h2\u003e\n\n\u003ch3\u003e How to take Regobasic Powder?\u003c\/h3\u003e\n\n     \u003cp\u003eIt is recommended to take \u003cstrong\u003eRegobasic Powder\u003c\/strong\u003e by diluting 1 teaspoon (about 3 g) in a glass of water (about 200 ml), preferably away from meals, up to 2 times a day. Mix well until the product is completely dissolved and drink immediately. It is important to follow the instructions of your doctor or nutritionist for proper and personalized use.\u003c\/p\u003e\n\n\n\u003ch2\u003e Average analysis\u003c\/h2\u003e\n\n\u003cp\u003e Per dose (3 g):\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSodium bicarbonate\u003c\/strong\u003e : 1000 mg\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eMineral salts\u003c\/strong\u003e :\u003c\/li\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e Magnesium: 250 mg\u003c\/li\u003e\n\n\u003cli\u003e Potassium: 150 mg\u003c\/li\u003e\n\n\u003cli\u003e Calcium: 120 mg\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Regobasic Powder contain?\u003c\/h3\u003e\n\n\u003cp\u003e The formula of \u003cstrong\u003eRegobasic Powder\u003c\/strong\u003e includes:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSodium bicarbonate\u003c\/strong\u003e : alkalizing substance that helps neutralize gastric acidity.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eMagnesium\u003c\/strong\u003e : supports normal muscle and nerve function.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003ePotassium\u003c\/strong\u003e : contributes to the maintenance of normal blood pressure and muscle function.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eCalcium\u003c\/strong\u003e : Helps maintain healthy bones and teeth and supports muscle function.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Regobasic Powder?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDo not exceed the recommended daily dose\u003c\/strong\u003e .\u003c\/li\u003e\n\n\u003cli\u003e Food supplements should not be used as a substitute for a balanced and varied diet and a healthy lifestyle.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eKeep out of reach of children under 3 years of age\u003c\/strong\u003e .\u003c\/li\u003e\n\n\u003cli\u003e Use during pregnancy and breastfeeding is not recommended unless otherwise indicated by your doctor.\u003c\/li\u003e\n\n\u003cli\u003e If you have any medical conditions or are taking medications, it is advisable to consult a doctor before use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Regobasic Powder?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eExpiry\u003c\/strong\u003e : The expiry date is shown on the package. Do not use the product after the date indicated.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eStorage\u003c\/strong\u003e : Store the product in a cool, dry place, away from heat and direct light. Close the package tightly after each use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e \u003cstrong\u003eRegobasic Powder\u003c\/strong\u003e is available in \u003cstrong\u003e250 g\u003c\/strong\u003e packs.\u003c\/p\u003e\n\n","brand":"PEGASO Srl","offers":[{"title":"Default Title","offer_id":40207825371251,"sku":"924181112","price":21.39,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/pegaso-srl-regobasic-polvere-250-g-farmacia-dottor-tili-1213793072.jpg?v=1767127709"},{"product_id":"fascia-thermacare-versatile-6-pezzi","title":"Thermacare Versatile Band 6 Pieces","description":"\u003cp\u003eThe \u003cstrong\u003eThermacare Versatile Band\u003c\/strong\u003e is a medical device designed to provide long-lasting relief from muscle and joint pain, thanks to its ability to emit constant therapeutic heat for up to 8 hours. Ideal for use on different parts of the body such as the back, neck, shoulders and joints, this versatile band helps to relax tense muscles, improve circulation and relieve pain related to muscle contractures and fatigue. Thanks to its flexible and comfortable design, it can be worn under clothing and allows freedom of movement during use.\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Fascia Thermacare Versatile?\u003c\/h3\u003e\n\n\u003col\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eOpening and application\u003c\/strong\u003e : Remove the band from the packaging and place it on the affected area, making sure that the heating pads are in direct contact with the skin.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eHeat Activation\u003c\/strong\u003e : The band begins to gradually heat up within 30 minutes of opening and provides constant heat for up to 8 hours.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eTreatment duration\u003c\/strong\u003e : Wear the band for at least 8 hours to obtain maximum therapeutic benefit. The band is comfortable to wear and can be used during daily activities.\u003c\/li\u003e\n\n\n\u003c\/ol\u003e\n\n\n\u003ch2\u003e Box contents\u003c\/h2\u003e\n\n\u003ch3\u003e What does the Thermacare Versatile Band contain?\u003c\/h3\u003e\n\n\u003cp\u003e The package contains:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003e6 disposable self-heating bands\u003c\/strong\u003e , designed to adapt to different areas of the body such as the back, neck and joints.\u003c\/li\u003e\n\n\u003cli\u003e Each band is individually packaged to ensure hygiene and freshness until use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Fascia Thermacare Versatile?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDo not use on damaged or irritated skin\u003c\/strong\u003e : Avoid use on open wounds, cuts or irritation.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eDo not use on people insensitive to heat\u003c\/strong\u003e : This product is not suitable for people with reduced thermal sensitivity or conditions that limit the perception of heat.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDisposable\u003c\/strong\u003e : The bands are designed for a single use and should not be reused.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eConsult a doctor\u003c\/strong\u003e : If you have any pre-existing medical conditions such as diabetes, pregnancy or circulatory problems, consult a doctor before use.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDo not apply on recent swelling or bruises\u003c\/strong\u003e : Applying heat may worsen the condition.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Fascia Thermacare Versatile?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eExpiry\u003c\/strong\u003e : The expiry date is indicated on the package. Do not use the product beyond the expiry date.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eStorage\u003c\/strong\u003e : Store the product in a cool, dry place, away from heat and direct light. Do not open the package until use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e The \u003cstrong\u003eThermacare Versatile Band\u003c\/strong\u003e is available in packs of \u003cstrong\u003e6 disposable bands\u003c\/strong\u003e , ideal for long-lasting relief from muscle and joint pain.\u003c\/p\u003e\n\n","brand":"ANGELINI SpA","offers":[{"title":"Default Title","offer_id":40207825961075,"sku":"981076110","price":20.37,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-spa-fascia-thermacare-versatile-6-pezzi-farmacia-dottor-tili-1213793087.jpg?v=1767127690"},{"product_id":"fasce-autoriscaldanti-a-calore-terapeutico-thermacare-collo-spalla-polso-6-pezzi","title":"Thermacare Therapeutic Heat Self-Heating Bands Neck Shoulder Wrist 6 Pieces","description":"\u003cp\u003e\u003cstrong\u003eThermacare Self-Heating Therapeutic Heat Wraps Neck Shoulder Wrist\u003c\/strong\u003e are a medical device designed to provide long-lasting relief from muscle and joint pain localized in specific areas such as the neck, shoulders and wrist. Thanks to their self-heating technology, these wraps emit constant therapeutic heat for up to 8 hours, helping to relax tense muscles and reduce pain associated with tension, contractures and muscle fatigue. The wraps are disposable and discreet, allowing for comfortable use during daily activities.\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Thermacare Therapeutic Heat Self-Heating Wraps Neck Shoulder Wrist?\u003c\/h3\u003e\n\n\u003col\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eOpening and application\u003c\/strong\u003e : Remove the band from the packaging and place it on the affected area, making sure that the heating pads are in direct contact with the skin.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eDuration of treatment\u003c\/strong\u003e : Wear the band for at least 8 hours to obtain maximum benefit. The heat activates gradually within 30 minutes of opening.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eComfort\u003c\/strong\u003e : The bands are designed to be worn under clothing, allowing you to continue your daily activities without hindrance.\u003c\/li\u003e\n\n\n\u003c\/ol\u003e\n\n\n\u003ch2\u003e Box contents\u003c\/h2\u003e\n\n\u003ch3\u003e What's in the Thermacare Therapeutic Heat Self-Heating Bandages Neck Shoulder Wrist package?\u003c\/h3\u003e\n\n\u003cp\u003e The package contains:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003e6 disposable self-heating bands\u003c\/strong\u003e , designed to fit different areas of the body such as the neck, shoulders and wrist.\u003c\/li\u003e\n\n\u003cli\u003e Each band is individually packaged to ensure maximum hygiene and protection until use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings of Thermacare Therapeutic Heat Self-Heating Bands Neck Shoulder Wrist?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDo not use on damaged skin\u003c\/strong\u003e : Avoid use on open wounds, burns or skin irritations.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eDo not use on people insensitive to heat\u003c\/strong\u003e : This device is not suitable for people with reduced thermal sensitivity or other medical conditions that limit the perception of heat.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSingle-use\u003c\/strong\u003e : The bands are single-use and should not be reused.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eConsult a doctor\u003c\/strong\u003e : If you have any pre-existing medical conditions such as diabetes, pregnancy or circulation problems, it is recommended that you consult a doctor before use.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDo not apply on recent swelling or bruises\u003c\/strong\u003e : Heat may aggravate the condition.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eKeep out of reach of children\u003c\/strong\u003e .\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Thermacare Therapeutic Heat Self-Heating Bandages Neck Shoulder Wrist?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eExpiry\u003c\/strong\u003e : The expiry date is indicated on the package. Do not use the product after this date.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eStorage\u003c\/strong\u003e : Store the bands in a cool, dry place, away from heat sources and direct sunlight. Open the package only when ready to use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e \u003cstrong\u003eThermacare Therapeutic Heat Self-Heating Wraps for Neck, Shoulder and Wrist\u003c\/strong\u003e are available in packs of \u003cstrong\u003e6 disposable wraps\u003c\/strong\u003e , ideal for long-lasting relief.\u003c\/p\u003e\n\n","brand":"ANGELINI SpA","offers":[{"title":"Default Title","offer_id":40207825993843,"sku":"981076096","price":20.37,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-spa-fasce-autoriscaldanti-a-calore-terapeutico-thermacare-collo-spalla-polso-6-pezzi-farmacia-dottor-tili-1213793088.jpg?v=1767127786"},{"product_id":"fascia-autoriscaldante-a-calore-terapeutico-thermacare-schiena-4-pezzi","title":"Thermacare Therapeutic Heat Self-Heating Band Back 4 Pieces","description":"\u003cp\u003eThe \u003cstrong\u003eThermacare Back Therapeutic Heat Self-Heating Band\u003c\/strong\u003e is a medical device designed to provide long-lasting relief from muscle and joint pain in the lower back and lumbar region. Thanks to its advanced thermal technology, the band provides constant, therapeutic heat for up to 8 hours, allowing muscles to relax and relieving tension. It is ideal for treating chronic or acute pain, as well as pain caused by fatigue or poor posture.\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Thermacare Therapeutic Heat Self-Heating Band for Back?\u003c\/h3\u003e\n\n\u003col\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eOpening and application\u003c\/strong\u003e : Remove the band from the packaging and place it directly on your lower back, with the heat pads facing your skin. Adjust the band around your waist using the adhesive tabs for a comfortable fit.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eTreatment duration\u003c\/strong\u003e : Wear the band for at least 8 hours to obtain maximum therapeutic benefit. The heat gradually activates within 30 minutes of application and provides a continuous effect throughout the entire treatment.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSafety and Comfort\u003c\/strong\u003e : The band is designed to be worn under clothing, allowing you to continue your daily activities without discomfort. Do not exceed 8 hours of consecutive use in a 24-hour period.\u003c\/li\u003e\n\n\n\u003c\/ol\u003e\n\n\n\u003ch2\u003e Box contents\u003c\/h2\u003e\n\n\u003ch3\u003e What does the Thermacare Therapeutic Heat Self-Heating Back Band contain?\u003c\/h3\u003e\n\n\u003cp\u003e The package contains:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003e4 disposable self-heating bands\u003c\/strong\u003e , specific for the lumbar and lower back area.\u003c\/li\u003e\n\n\u003cli\u003e Each band is individually packaged to preserve the effectiveness and freshness of the product until use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings of Thermacare Self-Heating Therapeutic Heat Back Wrap?\u003c\/h3\u003e\n\n\u003cul\u003e \n\u003cli\u003e\n\n\u003cstrong\u003eDo not use on damaged or irritated skin\u003c\/strong\u003e : Avoid use on wounds, cuts, burns or skin irritations.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDo not apply on recent swelling or bruising\u003c\/strong\u003e : Heat may aggravate the condition.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eDo not use on people insensitive to heat\u003c\/strong\u003e : This device is not indicated for people with reduced thermal sensitivity or conditions that limit the perception of heat.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSingle Use\u003c\/strong\u003e : The bands are designed for single use. Do not reuse.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eConsult a doctor\u003c\/strong\u003e : If you are pregnant, have diabetes, poor circulation or have any pre-existing medical conditions, consult a doctor before use.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eKeep out of reach of children\u003c\/strong\u003e .\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of the Thermacare Back Therapeutic Heat Wrap?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eExpiry\u003c\/strong\u003e : The expiry date is indicated on the package. Do not use the product after the expiry date.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eStorage\u003c\/strong\u003e : Store the product in a cool, dry place, away from heat sources and direct sunlight. Do not open the package until ready to use.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e The \u003cstrong\u003eThermacare Self-Heating Therapeutic Heat Back Wrap\u003c\/strong\u003e is available in packs of \u003cstrong\u003e4 disposable wraps\u003c\/strong\u003e , each designed to fit the lower back area.\u003c\/p\u003e\n\n","brand":"ANGELINI SpA","offers":[{"title":"Default Title","offer_id":40207826026611,"sku":"981042649","price":20.37,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-spa-fascia-autoriscaldante-a-calore-terapeutico-thermacare-schiena-4-pezzi-farmacia-dottor-tili-1213793056.jpg?v=1767127769"},{"product_id":"elmex-dentifricio-sensitive-con-fluoruro-amminico-2x75-ml","title":"Elmex Sensitive Toothpaste with Amine Fluoride 2x75 ml","description":"\u003cp\u003e\u003cstrong\u003eElmex Sensitive Toothpaste with Amine Fluoride\u003c\/strong\u003e is a toothpaste specifically formulated to offer effective protection to sensitive teeth. Thanks to the presence of \u003cstrong\u003eamine fluoride\u003c\/strong\u003e , Elmex creates a protective barrier around the exposed areas of the dentine, reducing tooth sensitivity and preventing discomfort caused by external stimuli such as hot, cold or sugary drinks. In addition, it protects tooth enamel by strengthening its resistance against the attack of acids that cause tooth decay.\u003c\/p\u003e\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\u003ch3\u003e When is Elmex Sensitive Toothpaste with Amine Fluoride indicated?\u003c\/h3\u003e\n\u003cp\u003e \u003cstrong\u003eElmex Sensitive Toothpaste\u003c\/strong\u003e is indicated for:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e People who suffer from tooth sensitivity, especially at the neck of the teeth.\u003c\/li\u003e\n\n\u003cli\u003e Prevention of tooth decay in exposed areas of the tooth, such as exposed dentin.\u003c\/li\u003e\n\n\u003cli\u003e Protection of tooth enamel thanks to the presence of \u003cstrong\u003eamine fluoride\u003c\/strong\u003e .\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003ch2\u003e Dosage and method of use\u003c\/h2\u003e\n\u003ch3\u003e How do I take Elmex Sensitive Toothpaste?\u003c\/h3\u003e\n\u003cp\u003e For optimal action, use \u003cstrong\u003eElmex Sensitive Toothpaste\u003c\/strong\u003e at least twice a day, preferably in the morning and evening. Apply a small amount of toothpaste to the toothbrush and gently brush your teeth for at least two minutes, focusing on sensitive areas. For intensive treatment, it is advisable to combine the use of the toothpaste with \u003cstrong\u003eElmex Sensitive\u003c\/strong\u003e mouthwash.\u003c\/p\u003e\n\u003ch2\u003e Side effects\u003c\/h2\u003e\n\u003ch3\u003e What are the side effects of Elmex Sensitive Toothpaste?\u003c\/h3\u003e\n\u003cp\u003e The use of \u003cstrong\u003eElmex Sensitive Toothpaste\u003c\/strong\u003e is generally well tolerated. However, in rare cases, some users may experience allergic reactions to the components of the product, such as irritation or redness of the gums. In case of adverse reactions, discontinue use and consult a dentist.\u003c\/p\u003e\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\u003ch3\u003e What are the warnings for Elmex Sensitive Toothpaste?\u003c\/h3\u003e\n\u003cul\u003e\n\n\u003cli\u003e Do not swallow the toothpaste.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children.\u003c\/li\u003e\n\n\u003cli\u003e If you accidentally swallow a significant amount of toothpaste, contact a doctor immediately.\u003c\/li\u003e\n\n\u003cli\u003e For people with serious dental or gum conditions, it is advisable to consult a dentist before using tooth sensitivity products.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\u003ch3\u003e What ingredients does Elmex Sensitive Toothpaste with Amine Fluoride contain?\u003c\/h3\u003e\n\u003cp\u003e The formula of \u003cstrong\u003eElmex Sensitive Toothpaste\u003c\/strong\u003e includes:\u003c\/p\u003e\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eAmine fluoride (Olaflur)\u003c\/strong\u003e : an active component that forms a protective barrier on the teeth and strengthens the enamel against acids.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSorbitol\u003c\/strong\u003e : sweetener that gives a pleasant, non-cariogenic taste.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eHydrated Silica\u003c\/strong\u003e : Gentle abrasive agent that effectively cleans teeth without damaging the enamel.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eAqua\u003c\/strong\u003e : hydrating base of the formulation.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSodium lauryl sulfate\u003c\/strong\u003e : foaming agent that promotes even distribution of toothpaste.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003ePEG-40\u003c\/strong\u003e : emulsifying agent that keeps the formulation stable.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\u003ch2\u003e Format\u003c\/h2\u003e\n\u003cp\u003e \u003cstrong\u003eElmex Sensitive Toothpaste with Amine Fluoride\u003c\/strong\u003e is available in \u003cstrong\u003e2 tubes of 75 ml\u003c\/strong\u003e , ideal for daily use and easy to carry.\u003c\/p\u003e","brand":"COLGATE-PALMOLIVE COMMERC.Srl","offers":[{"title":"Default Title","offer_id":40207826485363,"sku":"980248429","price":7.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/colgate-palmolive-commerc-srl-elmex-dentifricio-sensitive-con-fluoruro-amminico-2x75-ml-farmacia-dottor-tili-1213793082.jpg?v=1767127812"},{"product_id":"meridol-dentifricio-bitubo-75ml","title":"Meridol Bitubo Toothpaste 75ml","description":"\u003cp\u003e\u003cstrong\u003eMeridol Toothpaste\u003c\/strong\u003e is a specific treatment for sensitive and irritated gums. Thanks to its balanced formula, Meridol toothpaste works effectively to reduce the accumulation of bacterial plaque and promote gum regeneration. It contains amino fluoride and stannous fluoride, a combination that helps protect against tooth decay and helps strengthen tooth enamel. \u003cstrong\u003eMeridol\u003c\/strong\u003e is known for its gentle but efficient action, ideal for daily use without the risk of irritation.\u003c\/p\u003e\n\n\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\n\u003ch3\u003e When is Meridol Toothpaste indicated?\u003c\/h3\u003e\n\n\u003cp\u003e \u003cstrong\u003eMeridol Toothpaste\u003c\/strong\u003e is indicated for:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e People who suffer from sensitive or inflamed gums.\u003c\/li\u003e\n\n\u003cli\u003e Prevention of gum disease, such as gingivitis.\u003c\/li\u003e\n\n\u003cli\u003e Protection against cavities and plaque.\u003c\/li\u003e\n\n\u003cli\u003e Regeneration of irritated gums thanks to its soothing action.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Dosage and method of use\u003c\/h2\u003e\n\n\u003ch3\u003e How do I take Meridol Toothpaste?\u003c\/h3\u003e\n\n     \u003cp\u003eIt is recommended to use \u003cstrong\u003eMeridol Toothpaste\u003c\/strong\u003e at least twice a day, preferably after each meal. Apply a small amount of toothpaste to the toothbrush, brush your teeth and gums thoroughly for at least two minutes, then rinse thoroughly with water. For greater effectiveness, it is recommended to use it in combination with Meridol mouthwash.\u003c\/p\u003e\n\n\n\u003ch2\u003e Side effects\u003c\/h2\u003e\n\n\u003ch3\u003e What are the side effects of Meridol Toothpaste?\u003c\/h3\u003e\n\n\u003cp\u003e \u003cstrong\u003eMeridol Toothpaste\u003c\/strong\u003e is well tolerated by most users. However, in rare cases, an allergic reaction to one of the ingredients may occur. If irritation or adverse reactions occur, it is recommended to stop using the product and consult a doctor or dentist.\u003c\/p\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Meridol Toothpaste?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e Keep out of reach of children.\u003c\/li\u003e\n\n\u003cli\u003e Do not swallow the toothpaste.\u003c\/li\u003e\n\n         \u003cli\u003eIf you accidentally swallow a significant amount of toothpaste, contact a doctor immediately.\u003c\/li\u003e\n\n\u003cli\u003e If using for long periods of time or in combination with other gum treatments, consult a healthcare professional.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Meridol Toothpaste contain?\u003c\/h3\u003e\n\n\u003cp\u003e The formula of \u003cstrong\u003eMeridol Toothpaste\u003c\/strong\u003e includes:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eAmine fluoride (Olaflur)\u003c\/strong\u003e : helps protect teeth from decay and strengthens enamel.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eStannous fluoride\u003c\/strong\u003e : has an antibacterial action and helps reduce gum inflammation.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSorbitol\u003c\/strong\u003e : sweetener that provides a pleasant taste without causing tooth decay.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eAqua\u003c\/strong\u003e : Water base that hydrates the mouth.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSodium Lauryl Sulfate\u003c\/strong\u003e : Foaming agent for effective cleaning.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eHydrated silicon dioxide\u003c\/strong\u003e : gentle abrasive agent for deep cleaning without damaging the enamel.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n \n\u003ch2\u003eFormat\u003c\/h2\u003e\n\n\u003cp\u003e \u003cstrong\u003eMeridol Toothpaste\u003c\/strong\u003e is available in \u003cstrong\u003e100 ml\u003c\/strong\u003e format, ideal for daily use.\u003c\/p\u003e\n\n","brand":"COLGATE-PALMOLIVE COMMERC.Srl","offers":[{"title":"Default Title","offer_id":40207826550899,"sku":"976772208","price":7.43,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/colgate-palmolive-commerc-srl-meridol-dentifricio-bitubo-75ml-farmacia-dottor-tili-1213793083.jpg?v=1767127907"},{"product_id":"curasept-dna-ads-collutorio-0-20","title":"Curasept DNA Ads Mouthwash 0.20%","description":"\u003cp\u003e \u003cstrong\u003eCurasept ADS Mouthwash 0.20% DNA ADS\u003c\/strong\u003e is an intensive action mouthwash, indicated for the treatment of gingivitis and for the prevention of oral health problems, such as plaque and gum inflammation. Its formula enriched with sodium DNA, a natural derivative with restorative and anti-inflammatory properties, promotes the regeneration of gum tissue. This mouthwash contains 0.20% chlorhexidine, a broad-spectrum antibacterial agent that helps reduce plaque without staining teeth, thanks to the ADS (Anti Discoloration System).\u003c\/p\u003e\n\n\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\n     \u003ch3\u003eWhen is Curasept ADS Mouthwash 0.20% DNA ADS indicated?\u003c\/h3\u003e\n\n\u003cp\u003e \u003cstrong\u003eCurasept ADS Mouthwash\u003c\/strong\u003e is particularly indicated in the following cases:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e Prevention of dental plaque, which can lead to gum inflammation.\u003c\/li\u003e\n\n\u003cli\u003e Treatment of gingivitis and other oral inflammatory conditions.\u003c\/li\u003e\n\n\u003cli\u003e Post-operative use after dental procedures, such as tooth extractions or gum surgery, thanks to its soothing and regenerating action.\u003c\/li\u003e\n\n\u003cli\u003e For those who suffer from sensitive or irritated gums, this mouthwash has a gentle yet effective antibacterial action.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Dosage and method of use\u003c\/h2\u003e\n\n\u003ch3\u003e How do I take Curasept ADS Mouthwash 0.20% DNA ADS?\u003c\/h3\u003e\n\n     \u003cp\u003eIt is recommended to use \u003cstrong\u003eCurasept ADS Mouthwash\u003c\/strong\u003e twice a day, preferably in the morning and evening after brushing your teeth. Rinse with approximately 10 ml of pure product for at least 30 seconds. \u003cstrong\u003eDo not swallow\u003c\/strong\u003e . After using the mouthwash, it is recommended to avoid food and drink for at least 30 minutes, in order to maximize the effect of the treatment.\u003c\/p\u003e\n\n\u003cp\u003e \u003cstrong\u003eCurasept\u003c\/strong\u003e can be used for extended periods of treatment, but it is always advisable to follow the instructions of your dentist or dental hygienist for optimal use.\u003c\/p\u003e\n\n\n\u003ch2\u003e Contraindications\u003c\/h2\u003e\n\n\u003ch3\u003e What are the main contraindications of Curasept ADS Mouthwash 0.20% DNA ADS?\u003c\/h3\u003e\n\n\u003cp\u003e \u003cstrong\u003eCurasept\u003c\/strong\u003e is contraindicated in case of known hypersensitivity to one or more of its components. Do not use in case of known allergies to chlorhexidine or any other ingredient present in the formulation.\u003c\/p\u003e\n\n\n\u003ch2\u003e Side effects\u003c\/h2\u003e\n\n     \u003ch3\u003eWhat are the side effects of Curasept ADS Mouthwash 0.20% DNA ADS?\u003c\/h3\u003e\n\n\u003cp\u003e Side effects of \u003cstrong\u003eCurasept ADS\u003c\/strong\u003e mouthwash are rare, but in some cases a slight local irritation or burning sensation may occur, especially in the first few days of use. Thanks to the ADS system, it is very unlikely that dental stains or taste alterations, side effects that usually accompany chlorhexidine-based products, will form.\u003c\/p\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Curasept ADS Mouthwash 0.20% DNA ADS?\u003c\/h3\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e Do not ingest the product.\u003c\/li\u003e\n\n\u003cli\u003e Keep out of reach of children.\u003c\/li\u003e\n\n\u003cli\u003e Use under the supervision of a healthcare professional if pregnant or breastfeeding.\u003c\/li\u003e\n\n\u003cli\u003e After prolonged use, it is advisable to take a break from use to avoid imbalances in the oral bacterial flora.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Curasept ADS Mouthwash 0.20% DNA ADS?\u003c\/h3\u003e\n\n     \u003cp\u003e\u003cstrong\u003eCurasept ADS Mouthwash\u003c\/strong\u003e should be stored in a cool, dry place, away from direct heat sources and humidity. The expiry date is indicated on the packaging and on the bottle, and the product should not be used beyond that date. Make sure to close the bottle tightly after each use.\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Curasept ADS Mouthwash 0.20% DNA ADS contain?\u003c\/h3\u003e\n\n\u003cp\u003e The formula of \u003cstrong\u003eCurasept ADS Mouthwash 0.20%\u003c\/strong\u003e includes:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eChlorhexidine digluconate (0.20%)\u003c\/strong\u003e : antibacterial active ingredient that effectively reduces plaque.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSodium DNA\u003c\/strong\u003e : repairing agent that promotes the regeneration of gingival tissue.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSorbitol\u003c\/strong\u003e : non-cariogenic sweetener, which makes the mouthwash pleasant to taste.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003eSodium fluoride\u003c\/strong\u003e : helps protect tooth enamel.\u003c\/li\u003e\n\n\u003cli\u003e\n\n \u003cstrong\u003ePolyols\u003c\/strong\u003e : contribute to the hydrating and lubricating action of the mouthwash.\u003c\/li\u003e\n\n\u003cli\u003e \n\u003cstrong\u003eADS (Anti Discoloration System)\u003c\/strong\u003e : system that reduces the possibility of stains on the teeth.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e Curasept ADS Mouthwash 0.20% DNA ADS is available in \u003cstrong\u003e200 ml bottles\u003c\/strong\u003e .\u003c\/p\u003e\n\n","brand":"CURASEPT SpA","offers":[{"title":"Default Title","offer_id":40207826649203,"sku":"980299806","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/curasept-spa-curasept-dna-ads-collutorio-0-20-farmacia-dottor-tili-1213793079.jpg?v=1767127889"},{"product_id":"curasept-ads-dna-collutorio-0-12","title":"Curasept Ads DNA Mouthwash 0.12%","description":"\u003cp\u003e \u003cstrong\u003eCurasept Ads Dna Collutorio 012\u003c\/strong\u003e is a specific mouthwash for gum protection, which combines the effectiveness of chlorhexidine with the patented ADS (Anti Discoloration System) technology, designed to reduce the formation of stains on teeth. It is indicated for daily oral hygiene and to prevent gum inflammation, reducing disorders related to gingivitis and periodontitis. Thanks to the presence of sodium DNA, it also has a soothing and regenerating action on damaged gum tissue.\u003c\/p\u003e\n\n\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\n \u003ch3\u003eWhen is Curasept Ads Dna Collutorio 012 indicated?\u003c\/h3\u003e\n\n Curasept Ads Dna Collutorio 012 is indicated for those who suffer from gum inflammation, gingivitis, periodontitis or for those who need to prevent oral infections following dental surgery or the use of dentures. It is ideal for intensive treatment of the mouth, counteracting the formation of bacterial plaque without causing irritation or altering the natural color of the teeth thanks to ADS technology.\n\n\u003ch2\u003e Dosage and method of use\u003c\/h2\u003e\n\n\u003ch3\u003e How do I take Curasept Ads Dna Mouthwash 012?\u003c\/h3\u003e\n\n Use Curasept Ads Dna Collutorio 012 twice a day, preferably in the morning and evening, after brushing your teeth. Measure 10 ml of mouthwash with the appropriate dispenser and rinse your mouth thoroughly for at least 1 minute. Do not rinse with water after use. The treatment can be continued for a maximum of 15 days, unless otherwise indicated by your dentist or doctor.\n\n\u003ch2\u003e Contraindications\u003c\/h2\u003e\n\n \u003ch3\u003eWhat are the main contraindications of Curasept Ads Dna Collutorio 012?\u003c\/h3\u003e\n\n The use of Curasept Ads Dna Collutorio 012 is contraindicated in case of known hypersensitivity to its components, in particular to chlorhexidine or sodium DNA. In case of persistent irritation or adverse reactions, it is advisable to suspend use and consult a doctor.\n\n\u003ch2\u003e Side effects\u003c\/h2\u003e\n\n\u003ch3\u003e What are the side effects of Curasept Ads Dna Collutorio 012?\u003c\/h3\u003e\n\n Temporary alterations in taste or a local burning sensation may rarely occur in particularly sensitive individuals. In case of prolonged use beyond the recommended times, a slight staining of the teeth or tongue may occur, reversible with normal dental cleaning. If persistent side effects occur, consult your doctor or dentist.\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings of Curasept Ads Dna Collutorio 012?\u003c\/h3\u003e \nCurasept Ads Dna Collutorio 012 is intended for oral use and should not be swallowed. Avoid contact with eyes; in case of accidental contact, rinse immediately with plenty of water. Keep out of reach of children. Do not use the product beyond the expiry date indicated on the package. If you are pregnant or breastfeeding, consult a doctor before use.\n\n\u003ch2\u003e Expiry and storage\u003c\/h2\u003e\n\n\u003ch3\u003e What are the expiration dates and storage of Curasept Ads Dna Collutorio 012?\u003c\/h3\u003e\n\n Store the product in a cool, dry place, away from heat sources and direct sunlight. The expiry date is shown on the package; do not use the product beyond this date.\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n Curasept Ads Dna Collutorio 012 is available in a 200 ml bottle, complete with dispenser for practical and precise use.\n","brand":"CURASEPT SpA","offers":[{"title":"Default Title","offer_id":40207826681971,"sku":"980340475","price":8.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/curasept-spa-curasept-ads-dna-collutorio-0-12-farmacia-dottor-tili-1213793081.jpg?v=1767127870"},{"product_id":"gum-classic-409-spazzolino-morbido-compatto","title":"Gum Classic 409 Soft Compact Toothbrush","description":"\u003cdiv\u003e\n\n\u003cp\u003e\n \u003cstrong\u003eGum Classic 409 Soft Compact Toothbrush\u003c\/strong\u003e is a toothbrush designed for effective and gentle cleaning of teeth and gums. Its soft bristles are ideal for those with sensitive gums, ensuring thorough plaque removal without irritating the gums. Thanks to the compact head, you can easily reach all areas of the mouth, including the back teeth and interdental spaces. The ergonomic handle ensures a comfortable grip during use.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\n\u003ch3\u003e When is Gum Classic 409 Soft Compact Toothbrush indicated?\u003c\/h3\u003e\n\n\u003cp\u003e\n \u003cstrong\u003eGum Classic 409 Soft Compact Toothbrush\u003c\/strong\u003e is indicated for:\n - Those looking for a gentle toothbrush, suitable for sensitive gums.\n - Removing plaque without irritating the gums. \n- Effectively clean all areas of the mouth, even the most difficult to reach ones.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Gum Classic 409 Soft Compact Toothbrush?\u003c\/h3\u003e\n\n\u003cp\u003e\n Use \u003cstrong\u003eGum Classic 409 Toothbrush\u003c\/strong\u003e as a normal toothbrush. Apply a small amount of toothpaste and brush your teeth and gums using circular movements. Brush at least twice a day, preferably after main meals, to maintain good oral hygiene.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What is Gum Classic 409 Soft Compact Toothbrush made of?\u003c\/h3\u003e\n\n\u003cp\u003e\n \u003cstrong\u003eGum Classic 409\u003c\/strong\u003e is made with high quality nylon bristles, soft and rounded to ensure gentle and effective cleaning. The ergonomic handle is designed to provide comfort during use.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for Gum Classic 409 Soft Compact Toothbrush?\u003c\/h3\u003e\n\n\u003cp\u003e \nIt is recommended to replace the toothbrush every 3 months or when the bristles are worn. Do not use on severely inflamed gums without consulting a dentist.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e\n Package containing \u003cstrong\u003e1 toothbrush\u003c\/strong\u003e .\n\u003c\/p\u003e\n\n\n\u003c\/div\u003e\n\n","brand":"SUNSTAR ITALIANA Srl","offers":[{"title":"Default Title","offer_id":40207826747507,"sku":"902220298","price":4.37,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/sunstar-italiana-srl-gum-classic-409-spazzolino-morbido-compatto-farmacia-dottor-tili-1213793076.jpg?v=1767127950"},{"product_id":"profilattico-ansell-akuel-skyn-extra-lubrificato-b-6-pezzi","title":"Ansell Akuel Skyn ​​Extra Lubricated Condom B 6 Pieces","description":"\u003cdiv\u003e\n\n\u003cp\u003e\n \u003cstrong\u003eAnsell Akuel Skyn ​​Extra Lubricated Condom\u003c\/strong\u003e is a condom made of polyisoprene, an innovative latex-free material, ideal for those with allergies or sensitivity to latex. This condom offers a natural sensation and greater sensitivity, while ensuring safe protection. The extra lubricated version ensures greater comfort and facilitates penetration, reducing friction. Designed to protect against sexually transmitted diseases and prevent unwanted pregnancies, Ansell Akuel Skyn ​​is synonymous with reliability and comfort.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\n\u003ch3\u003e When is the Ansell Akuel Skyn ​​Extra Lubricated Condom indicated?\u003c\/h3\u003e\n\n\u003cp\u003e\n \u003cstrong\u003eAnsell Akuel Skyn ​​Extra Lubricated Condom\u003c\/strong\u003e is indicated for:\r \n- Protect against sexually transmitted diseases (STDs).\n - Prevent unwanted pregnancies during sexual intercourse.\n - People with latex sensitivity or allergy.\n - Improve comfort and reduce friction thanks to extra lubrication.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use the Ansell Akuel Skyn ​​Extra Lubricated Condom?\u003c\/h3\u003e\n\n\u003cp\u003e\n Open the package carefully, avoiding damaging the condom with nails or sharp objects. Apply \u003cstrong\u003eAnsell Akuel Skyn ​​Extra Lubricated\u003c\/strong\u003e to the erect penis before each sexual intercourse. Make sure the condom is well positioned and free of air bubbles. After use, dispose of the condom safely, without flushing it down the toilet.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Ansell Akuel Skyn ​​Extra Lubricated Condom contain?\u003c\/h3\u003e\n\n\u003cp\u003e\r \nThe \u003cstrong\u003eAnsell Akuel Skyn ​​Extra Lubricated Condom\u003c\/strong\u003e is made from polyisoprene, a latex-free material, and is lubricated with a non-spermicidal lubricant to improve comfort during intercourse.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for the Ansell Akuel Skyn ​​Extra Lubricated Condom?\u003c\/h3\u003e\n\n\u003cp\u003e\n Store in a cool, dry place away from heat and direct sunlight. Use a new condom for each sexual intercourse. Single-use product.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e\n Pack of \u003cstrong\u003e6 pieces\u003c\/strong\u003e .\n\u003c\/p\u003e\n\n\n\u003c\/div\u003e","brand":"NOVA ARGENTIA SpA","offers":[{"title":"Default Title","offer_id":40207827042419,"sku":"922914799","price":10.69,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/nova-argentia-spa-profilattico-ansell-akuel-skyn-extra-lubrificato-b-6-pezzi-farmacia-dottor-tili-1213793075.jpg?v=1767127990"},{"product_id":"profilattico-ansell-akuel-skin-original-b-6-pezzi","title":"Ansell Akuel Skin Original B Condom 6 Pieces","description":"\u003cdiv\u003e\n\n\u003cp\u003e\r \n\u003cstrong\u003eAnsell Akuel Skin Original Condom\u003c\/strong\u003e is a natural rubber latex condom that offers reliable protection during sexual intercourse. Featuring a thin thickness, it provides a natural sensation and high sensitivity, without compromising safety. The anatomical profile promotes a perfect fit and comfort during use, while the added lubricant facilitates intercourse and reduces the risk of breakage. Ansell Akuel Skin Original is designed to offer reliable protection against unwanted pregnancies and sexually transmitted diseases.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\n\u003ch3\u003e When is the Ansell Akuel Skin Original Condom indicated?\u003c\/h3\u003e\n\n\u003cp\u003e\n \u003cstrong\u003eAkuel Skin Original condom\u003c\/strong\u003e is indicated for:\n - Protect against sexually transmitted diseases (STDs).\n - Prevent unwanted pregnancies during sexual intercourse.\n - Ensure natural feel and high sensitivity during use.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e How to use\u003c\/h2\u003e\n\n   \u003ch3\u003eHow to use the Ansell Akuel Skin Original Condom?\u003c\/h3\u003e\n\n\u003cp\u003e\n Open the package carefully, avoiding damaging the condom with nails or sharp objects. Apply \u003cstrong\u003eAnsell Akuel Skin Original\u003c\/strong\u003e to the erect penis before each sexual intercourse, ensuring that the condom is well positioned and free of air bubbles. After use, dispose of the condom safely, without flushing it down the toilet.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Ansell Akuel Skin Original Condom contain?\u003c\/h3\u003e\n\n\u003cp\u003e\n The \u003cstrong\u003eAnsell Akuel Skin Original condom\u003c\/strong\u003e is made from natural rubber latex and lubricated with a non-spermicidal lubricant to improve comfort during intercourse.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings for the Ansell Akuel Skin Original Condom?\u003c\/h3\u003e\n\n\u003cp\u003e\r \nLatex condoms may cause allergic reactions in sensitive individuals. Store in a cool, dry place, away from heat and direct sunlight. Use a new condom for each sexual intercourse.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e\n Pack of \u003cstrong\u003e6 pieces\u003c\/strong\u003e .\n\u003c\/p\u003e\n\n\n\u003c\/div\u003e","brand":"NOVA ARGENTIA SpA","offers":[{"title":"Default Title","offer_id":40207827075187,"sku":"932378464","price":10.22,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/nova-argentia-spa-profilattico-ansell-akuel-skin-original-b-6-pezzi-farmacia-dottor-tili-1213793074.jpg?v=1767128087"},{"product_id":"somatoline-skin-expert-prevenzione-smagliature-200ml","title":"Somatoline Skin Expert Stretch Mark Prevention 200ml","description":"\u003cdiv\u003e\n\n\u003cp\u003e\r \n\u003cstrong\u003eSomatoline Skin Expert Stretch Mark Prevention\u003c\/strong\u003e is a specific treatment formulated to prevent the appearance of stretch marks and improve skin elasticity. Its advanced formula, enriched with regenerating and hydrating active ingredients, helps keep the skin elastic and toned, reducing the risk of stretch marks forming especially during pregnancy, weight changes and other situations that put stress on the skin. Ideal for daily use on areas such as the belly, hips, thighs and breasts.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Directions\u003c\/h2\u003e\n\n\u003ch3\u003e When is Somatoline Skin Expert Stretch Mark Prevention indicated?\u003c\/h3\u003e\n\n\u003cp\u003e\n \u003cstrong\u003eSomatoline Skin Expert Stretch Mark Prevention\u003c\/strong\u003e is indicated for:\n - Prevent the appearance of stretch marks during pregnancy, weight changes or other situations that can cause stretching of the skin.\n - Improve skin elasticity and tone.\n - Deeply hydrate, promoting long-term skin well-being.\n\u003c\/p\u003e\n\n\n   \u003ch2\u003eHow to use\u003c\/h2\u003e\n\n\u003ch3\u003e How to use Somatoline Skin Expert Stretch Mark Prevention?\u003c\/h3\u003e\n\n\u003cp\u003e\n Apply a generous amount of \u003cstrong\u003eSomatoline Skin Expert Stretch Mark Prevention\u003c\/strong\u003e daily to the areas most at risk, such as the belly, hips, thighs and breasts. Massage with circular movements until completely absorbed. Use consistently to obtain the best results, especially during periods of bodily change, such as pregnancy or weight changes.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Ingredients\u003c\/h2\u003e\n\n\u003ch3\u003e What ingredients does Somatoline Skin Expert Stretch Mark Prevention contain?\u003c\/h3\u003e\n\n\u003cp\u003e\n \u003cstrong\u003eSomatoline Skin Expert Stretch Mark Prevention\u003c\/strong\u003e contains hydrating and regenerating ingredients, such as sweet almond oil and shea butter, which help improve skin elasticity and prevent the formation of stretch marks. Its formula is dermatologically tested.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Warnings\u003c\/h2\u003e\n\n\u003ch3\u003e What are the warnings of Somatoline Skin Expert Stretch Mark Prevention?\u003c\/h3\u003e\n\n\u003cp\u003e\r \nAvoid contact with eyes. Do not apply to damaged or irritated skin. In case of allergic reaction, discontinue use and consult a doctor. Keep out of reach of children. Cosmetic product for external use.\n\u003c\/p\u003e\n\n\n\u003ch2\u003e Format\u003c\/h2\u003e\n\n\u003cp\u003e\n \u003cstrong\u003e200 ml\u003c\/strong\u003e bottle.\n\u003c\/p\u003e\n\n\n\u003c\/div\u003e","brand":"L.MANETTI-H.ROBERTS \u0026 C. SpA","offers":[{"title":"Default Title","offer_id":40207830450291,"sku":"983031612","price":25.11,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/l-manetti-h-roberts-c-spa-somatoline-skin-expert-prevenzione-smagliature-200ml-farmacia-dottor-tili-1213793063.jpg?v=1767128108"},{"product_id":"somatoline-emulsione-30-bustine-0-1-0-3","title":"Somatoline Emulsion 30 Sachets 0.1% + 0.3%","description":"\u003cp\u003e\u003cstrong\u003eSomatoline Emulsion 0.1% + 0.3%\u003c\/strong\u003e is a slimming and reducing treatment, designed to reduce localized fat and improve skin tone. Its formulation combines the effectiveness of specific active ingredients that promote the drainage of excess fluids and reduce water retention. Thanks to the sachet format, Somatoline Emulsion is easy to apply and dose, ensuring practicality and hygiene.\u003c\/p\u003e\n\n\u003cp\u003e \u003cstrong\u003eSomatoline Emulsion\u003c\/strong\u003e is indicated for:\u003c\/p\u003e\n\n\u003cul\u003e\n\n\u003cli\u003e Reduce localized fat on the hips, thighs, belly and other areas of the body.\u003c\/li\u003e\n\n\u003cli\u003e Promote fluid drainage and combat water retention.\u003c\/li\u003e\n\n\u003cli\u003e Improve skin tone and appearance.\u003c\/li\u003e\n\n\u003cli\u003e Ideal for localized slimming programs.\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eACTIVE INGREDIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eActive ingredients contained in Somatoline Emulsion 30 Sachets 0.1% + 0.3% - What is the active ingredient in Somatoline Emulsion 30 Sachets 0.1% + 0.3%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003e100 g of emulsion contain: levothyroxine 100 mg, escin 300 mg.\u003c\/span\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eEXCIPIENTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eComposition of Somatoline Emulsion 30 Sachets 0.1% + 0.3% - What does Somatoline Emulsion 30 Sachets 0.1% + 0.3% contain?\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eGlyceryl monostearate AE, xanthan gum, liquid paraffin, decyl oleate, non-crystallizing sorbitol 70%, polyacrylamide isoparaffin laureth-7, imidazolidinyl urea, methyl parahydroxybenzoate, propyl parahydroxybenzoate, citric acid monohydrate, rose perfume, purified water.\u003c\/span\u003e\u003cb\u003e\u003cbr\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eDIRECTIONS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eTherapeutic indications Somatoline Emulsion 30 Sachets 0.1% + 0.3% - Why is Somatoline Emulsion 30 Sachets 0.1% + 0.3% used? What is it for?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eLocalized adiposity states accompanied by cellulite. Indicated in adults.\u003c\/span\u003e\u003cb\u003e\u003cbr\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eCONTRAINDICATIONS - SIDE EFFECTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n \u003ch3 dir=\"ltr\"\u003e\u003cspan\u003eContraindications Somatoline Emulsion 30 Sachets 0.1% + 0.3% - When should Somatoline Emulsion 30 Sachets 0.1% + 0.3% not be used?\u003c\/span\u003e\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eHypersensitivity to the active substances or to any of the excipients. Intolerance to iodine. Generally contraindicated in pregnancy and during breastfeeding.\u003c\/span\u003e\u003cb\u003e\u003cbr\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eDOSAGE\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eQuantity and method of taking Somatoline Emulsion 30 Sachets 0.1% + 0.3% - How do you take Somatoline Emulsion 30 Sachets 0.1% + 0.3%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eSachets: apply locally 20 g of product per day (equal to 2 sachets) for the first two consecutive days, then 10 g of product (equal to 1 sachet) per day or every other day. If the product is to be used on the thighs, apply 1 sachet (10 g) for each thigh for the first two days. On the following days, half a sachet (5 g) per thigh. Multi-dose bottle with dispenser: (4 sprays correspond to 10 g of product). Apply locally 20 g of product per day (equal to 8 sprays) for the first two days, then 10 g of product (equal to 4 sprays) per day or every other day. If the product is to be used on the thighs, apply a dose corresponding to 4 sprays (10 g) for each thigh for the first two days. On the following days, 2 sprays (5 g) per thigh. To obtain 1 spray, press the dispenser all the way down. Each treatment cycle can last from a minimum of 15 - 20 days to a maximum of 2 - 3 months and can be repeated at various time intervals. Massage the product into the area to be treated (the surface of which should not, as a rule, exceed 15 cm on each side), until completely absorbed. Follow with a second, deeper massage, lasting a few minutes (5'-10'). If the skin is oily or thickened, it is advisable to first wash the area to be treated, dry well and then perform a simple massage until a slight redness occurs; then proceed with the application of the treatment; the clinical results generally begin to become evident towards the end of the second week of treatment. Safety and efficacy in children and adolescents have not yet been demonstrated. There are no data available.\u003c\/span\u003e\u003cb\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/b\u003e \u003cbr\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e\u003cspan\u003eCONSERVATION\u003c\/span\u003e\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eStorage Somatoline Emulsion 30 Sachets 0.1% + 0.3% - How do you store Somatoline Emulsion 30 Sachets 0.1% + 0.3%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThis medicinal product does not require any special storage conditions.\u003c\/span\u003e\u003cb\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eWARNINGS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eWarnings Somatoline Emulsion 30 Sachets 0.1% + 0.3% - About Somatoline Emulsion 30 Sachets 0.1% + 0.3% it is important to know that:\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThe use, especially if repeated or prolonged, of products for topical use can give rise to sensitization phenomena. If this occurs, interrupt the treatment and evaluate the need to establish an appropriate therapy. Do not use near mucous membranes. Contains para-hydroxybenzoates that can cause allergic reactions (even delayed).\u003c\/span\u003e\u003cb\u003e\u003cbr\u003e\u003cbr\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eINTERACTIONS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eInteractions Somatoline Emulsion 30 Sachets 0.1% + 0.3% - Which medicines or foods can modify the effect of Somatoline Emulsion 30 Sachets 0.1% + 0.3%?'\u003c\/span\u003e\n\u003c\/h3\u003e\n\n \u003cp dir=\"ltr\"\u003e\u003cspan\u003eThere are no phenomena of intolerance or incompatibility with other drugs.\u003c\/span\u003e\u003cb\u003e\u003cbr\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003eSIDE EFFECTS\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eLike all medicines, Somatoline Emulsion 30 Sachets 0.1% + 0.3% can cause side effects - What are the side effects of Somatoline Emulsion 30 Sachets 0.1% + 0.3%?\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eCases with symptoms attributable to altered thyroid function have been reported very rarely. Report any suspected adverse reactions.\u003c\/span\u003e\u003cb\u003e\u003cbr\u003e\u003c\/b\u003e\u003c\/p\u003e\n\n\u003cp dir=\"ltr\"\u003e\u003c\/p\u003e\n\n\u003ch2 dir=\"ltr\"\u003e \u003cspan\u003ePREGNANCY AND BREASTFEEDING\u003c\/span\u003e\n\u003c\/h2\u003e\n\n\u003ch3 dir=\"ltr\"\u003e \u003cspan\u003eIf you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Somatoline Emulsion 30 Sachets 0.1% + 0.3%\u003c\/span\u003e\n\u003c\/h3\u003e\n\n\u003cp dir=\"ltr\"\u003e \u003cspan\u003eThere are no known experimental or clinical data that argue against the use of the product during pregnancy. However, prudence recommends applying the product during pregnancy or breastfeeding.\u003c\/span\u003e\u003c\/p\u003e","brand":"L.MANETTI-H.ROBERTS \u0026 C. SpA","offers":[{"title":"Default Title","offer_id":40207831203955,"sku":"022816021","price":59.99,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/l-manetti-h-roberts-c-spa-somatoline-emulsione-30-bustine-0-1-0-3-farmacia-dottor-tili-1213793068.jpg?v=1767128208"}],"url":"https:\/\/www.dottortili.com\/en-eu\/collections\/base-price-discount-7.oembed?page=62","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}